,Sentence,ESG BERT Topic 1,ESG BERT Topic 2,ESG BERT Topic 3,Mapped Criteria Topic 1,Mapped Criteria Topic 2,Mapped Criteria Topic 3
Line 1,"2021    SUSTAINABILITY   REPORT ENVIRONMENTAL | SOCIAL | GOVERNANCECOMPANY PROFILE Corporate Overview  .
","('Business_Model_Resilience', 0.3859568238258362)","('Management_Of_Legal_And_Regulatory_Framework', 0.13908806443214417)","('Human_Rights_And_Community_Relations', 0.08810190111398697)","('NON-ESG', 0.3859568238258362)","('NON-ESG', 0.13908806443214417)","('NON-ESG', 0.08810190111398697)"
Line 2,"Mission and Guiding Principles.
","('Human_Rights_And_Community_Relations', 0.48951178789138794)","('Director_Removal', 0.06701233237981796)","('Employee_Engagement_Inclusion_And_Diversity', 0.057919107377529144)","('NON-ESG', 0.48951178789138794)","('NON-ESG', 0.06701233237981796)","('NON-ESG', 0.057919107377529144)"
Line 3,"Our Sustainability Commitment  .
","('Business_Model_Resilience', 0.4109761416912079)","('Product_Design_And_Lifecycle_Management', 0.1241399496793747)","('Supply_Chain_Management', 0.09202111512422562)","('NON-ESG', 0.4109761416912079)","('NON-ESG', 0.1241399496793747)","('NON-ESG', 0.09202111512422562)"
Line 4,"Our Approach to ESG .
","('Business_Model_Resilience', 0.5573867559432983)","('Systemic_Risk_Management', 0.07206973433494568)","('Supply_Chain_Management', 0.04861656203866005)","(['Codes of Business Conduct'], 0.5573867559432983)","('NON-ESG', 0.07206973433494568)","('NON-ESG', 0.04861656203866005)"
Line 5,"COVID -19  .
","('Competitive_Behavior', 0.21452823281288147)","('GHG_Emissions', 0.17528600990772247)","('Management_Of_Legal_And_Regulatory_Framework', 0.13778139650821686)","('NON-ESG', 0.21452823281288147)","('NON-ESG', 0.17528600990772247)","('NON-ESG', 0.13778139650821686)"
Line 6,"ENVIRONMENTAL Environmental Risk Management Policy  .
","('Physical_Impacts_Of_Climate_Change', 0.344616562128067)","('Business_Model_Resilience', 0.14965203404426575)","('Ecological_Impacts', 0.10354471951723099)","('NON-ESG', 0.344616562128067)","('NON-ESG', 0.14965203404426575)","('NON-ESG', 0.10354471951723099)"
Line 7,"Compliance  .
","('Management_Of_Legal_And_Regulatory_Framework', 0.33099278807640076)","('Business_Ethics', 0.3158797323703766)","('Product_Quality_And_Safety', 0.03956470638513565)","('NON-ESG', 0.33099278807640076)","('NON-ESG', 0.3158797323703766)","('NON-ESG', 0.03956470638513565)"
Line 8,"Continuous Improvement  .
","('Access_And_Affordability', 0.5638823509216309)","('Product_Quality_And_Safety', 0.049652084708213806)","('Critical_Incident_Risk_Management', 0.036384642124176025)","(['Health Outcome Contribution'], 0.5638823509216309)","('NON-ESG', 0.049652084708213806)","('NON-ESG', 0.036384642124176025)"
Line 9,"6  Business Integration  .
","('Business_Model_Resilience', 0.4448523223400116)","('Supply_Chain_Management', 0.09761708229780197)","('Systemic_Risk_Management', 0.0881785973906517)","('NON-ESG', 0.4448523223400116)","('NON-ESG', 0.09761708229780197)","('NON-ESG', 0.0881785973906517)"
Line 10,"Environment & Climate Change  .
","('Physical_Impacts_Of_Climate_Change', 0.8866551518440247)","('GHG_Emissions', 0.031187424436211586)","('Business_Model_Resilience', 0.01379129197448492)","(['Climate Change'], 0.8866551518440247)","('NON-ESG', 0.031187424436211586)","('NON-ESG', 0.01379129197448492)"
Line 11,"Health & Safety .
","('Employee_Health_And_Safety', 0.9481860995292664)","('Critical_Incident_Risk_Management', 0.010584035888314247)","('Product_Quality_And_Safety', 0.008064085617661476)","(['Operational Eco-Efficiency'], 0.9481860995292664)","('NON-ESG', 0.010584035888314247)","('NON-ESG', 0.008064085617661476)"
Line 12,"Communication & Education  .
","('Access_And_Affordability', 0.3808101713657379)","('Employee_Engagement_Inclusion_And_Diversity', 0.15011413395404816)","('Human_Rights_And_Community_Relations', 0.14196304976940155)","('NON-ESG', 0.3808101713657379)","('NON-ESG', 0.15011413395404816)","('NON-ESG', 0.14196304976940155)"
Line 13,"Environmental Targets  .
","('Management_Of_Legal_And_Regulatory_Framework', 0.19171738624572754)","('Human_Rights_And_Community_Relations', 0.16429349780082703)","('Energy_Management', 0.11676210165023804)","('NON-ESG', 0.19171738624572754)","('NON-ESG', 0.16429349780082703)","('NON-ESG', 0.11676210165023804)"
Line 14,"SOCIAL Talent  .
","('Employee_Engagement_Inclusion_And_Diversity', 0.6061339378356934)","('Human_Rights_And_Community_Relations', 0.0718621090054512)","('Employee_Health_And_Safety', 0.05069351568818092)","(['Human Capital Development'], 0.6061339378356934)","('NON-ESG', 0.0718621090054512)","('NON-ESG', 0.05069351568818092)"
Line 15,"Culture Promises  .
","('Employee_Engagement_Inclusion_And_Diversity', 0.2886216342449188)","('Competitive_Behavior', 0.09170772135257721)","('Human_Rights_And_Community_Relations', 0.06822528690099716)","('NON-ESG', 0.2886216342449188)","('NON-ESG', 0.09170772135257721)","('NON-ESG', 0.06822528690099716)"
Line 16,"Team Member Engagement  .
","('Employee_Engagement_Inclusion_And_Diversity', 0.189636692404747)","('Human_Rights_And_Community_Relations', 0.14593631029129028)","('Director_Removal', 0.12604176998138428)","('NON-ESG', 0.189636692404747)","('NON-ESG', 0.14593631029129028)","('NON-ESG', 0.12604176998138428)"
Line 17,"Performance Management  .
","('Employee_Engagement_Inclusion_And_Diversity', 0.23038016259670258)","('Business_Model_Resilience', 0.1343463808298111)","('Human_Rights_And_Community_Relations', 0.09833971410989761)","('NON-ESG', 0.23038016259670258)","('NON-ESG', 0.1343463808298111)","('NON-ESG', 0.09833971410989761)"
Line 18,"Learning and Development  .
","('Employee_Engagement_Inclusion_And_Diversity', 0.3272039294242859)","('Access_And_Affordability', 0.2476387917995453)","('Human_Rights_And_Community_Relations', 0.09552789479494095)","('NON-ESG', 0.3272039294242859)","('NON-ESG', 0.2476387917995453)","('NON-ESG', 0.09552789479494095)"
Line 19,"Global Mentoring Program  .
","('Access_And_Affordability', 0.3905305564403534)","('Employee_Engagement_Inclusion_And_Diversity', 0.23249779641628265)","('Human_Rights_And_Community_Relations', 0.05983063206076622)","('NON-ESG', 0.3905305564403534)","('NON-ESG', 0.23249779641628265)","('NON-ESG', 0.05983063206076622)"
Line 20,"Virtual Work Support  .
","('Product_Design_And_Lifecycle_Management', 0.18893520534038544)","('Energy_Management', 0.1520972102880478)","('Employee_Health_And_Safety', 0.11115949600934982)","('NON-ESG', 0.18893520534038544)","('NON-ESG', 0.1520972102880478)","('NON-ESG', 0.11115949600934982)"
Line 21,"Team Member Recognition  .
","('Employee_Engagement_Inclusion_And_Diversity', 0.28273624181747437)","('Director_Removal', 0.10610988736152649)","('Human_Rights_And_Community_Relations', 0.09523262083530426)","('NON-ESG', 0.28273624181747437)","('NON-ESG', 0.10610988736152649)","('NON-ESG', 0.09523262083530426)"
Line 22,"Talent Acquisition  .
","('Employee_Engagement_Inclusion_And_Diversity', 0.8670533895492554)","('Business_Model_Resilience', 0.011350668035447598)","('Customer_Privacy', 0.009504282847046852)","(['Human Capital Development'], 0.8670533895492554)","('NON-ESG', 0.011350668035447598)","('NON-ESG', 0.009504282847046852)"
Line 23,"Early Career / Development Rotational Programs .
","('Employee_Engagement_Inclusion_And_Diversity', 0.7428401708602905)","('Access_And_Affordability', 0.051594287157058716)","('Employee_Health_And_Safety', 0.024555819109082222)","(['Human Capital Development'], 0.7428401708602905)","('NON-ESG', 0.051594287157058716)","('NON-ESG', 0.024555819109082222)"
Line 24,"Global Mentoring Program  .
","('Access_And_Affordability', 0.3905305564403534)","('Employee_Engagement_Inclusion_And_Diversity', 0.23249779641628265)","('Human_Rights_And_Community_Relations', 0.05983063206076622)","('NON-ESG', 0.3905305564403534)","('NON-ESG', 0.23249779641628265)","('NON-ESG', 0.05983063206076622)"
Line 25,"Diversity, Equity & Inclusion .
","('Employee_Engagement_Inclusion_And_Diversity', 0.968018114566803)","('Human_Rights_And_Community_Relations', 0.0030056126415729523)","('Employee_Health_And_Safety', 0.0023357286117970943)","(['Human Capital Development'], 0.968018114566803)","('NON-ESG', 0.0030056126415729523)","('NON-ESG', 0.0023357286117970943)"
Line 26,"Health, Safety & Wellness .
","('Employee_Health_And_Safety', 0.5081234574317932)","('Product_Quality_And_Safety', 0.12358412146568298)","('Employee_Engagement_Inclusion_And_Diversity', 0.0755922943353653)","(['Operational Eco-Efficiency'], 0.5081234574317932)","('NON-ESG', 0.12358412146568298)","('NON-ESG', 0.0755922943353653)"
Line 27,"Pay Equity  .
","('Competitive_Behavior', 0.3743288815021515)","('Systemic_Risk_Management', 0.1275489628314972)","('Labor_Practices', 0.08634098619222641)","('NON-ESG', 0.3743288815021515)","('NON-ESG', 0.1275489628314972)","('NON-ESG', 0.08634098619222641)"
Line 28,"Collective Bargaining  .
","('Labor_Practices', 0.9667952656745911)","('Director_Removal', 0.003116433508694172)","('Supply_Chain_Management', 0.0022363176103681326)","(['Labor Practice Indicators'], 0.9667952656745911)","('NON-ESG', 0.003116433508694172)","('NON-ESG', 0.0022363176103681326)"
Line 29,"Discrimination Policy  .
","('Employee_Engagement_Inclusion_And_Diversity', 0.8701813220977783)","('Labor_Practices', 0.02498435415327549)","('Business_Ethics', 0.013659968972206116)","(['Human Capital Development'], 0.8701813220977783)","('NON-ESG', 0.02498435415327549)","('NON-ESG', 0.013659968972206116)"
Line 30,"Product Quality  .
","('Product_Design_And_Lifecycle_Management', 0.8102402091026306)","('Product_Quality_And_Safety', 0.07090743631124496)","('Selling_Practices_And_Product_Labeling', 0.02475384622812271)","(['Product Stewardship'], 0.8102402091026306)","('NON-ESG', 0.07090743631124496)","('NON-ESG', 0.02475384622812271)"
Line 31,"Supplier Code of Conduct  .
","('Supply_Chain_Management', 0.9079453349113464)","('Labor_Practices', 0.01491320226341486)","('Waste_And_Hazardous_Materials_Management', 0.0069217015989124775)","(['Supply Chain Management'], 0.9079453349113464)","('NON-ESG', 0.01491320226341486)","('NON-ESG', 0.0069217015989124775)"
Line 32,"Supplier Social Responsibility Audits  .
","('Supply_Chain_Management', 0.7892562747001648)","('Human_Rights_And_Community_Relations', 0.042162586003541946)","('Business_Model_Resilience', 0.019030138850212097)","(['Supply Chain Management'], 0.7892562747001648)","('NON-ESG', 0.042162586003541946)","('NON-ESG', 0.019030138850212097)"
Line 33,"Supplier Diligence  .
","('Supply_Chain_Management', 0.8829434514045715)","('Labor_Practices', 0.013449951075017452)","('Human_Rights_And_Community_Relations', 0.01159760169684887)","(['Supply Chain Management'], 0.8829434514045715)","('NON-ESG', 0.013449951075017452)","('NON-ESG', 0.01159760169684887)"
Line 34,"Supplier Quality Audits  .
","('Supply_Chain_Management', 0.9183954000473022)","('Labor_Practices', 0.008262102492153645)","('Waste_And_Hazardous_Materials_Management', 0.005336126312613487)","(['Supply Chain Management'], 0.9183954000473022)","('NON-ESG', 0.008262102492153645)","('NON-ESG', 0.005336126312613487)"
Line 35,"12Supplier Diversity Policy  .
","('Employee_Engagement_Inclusion_And_Diversity', 0.9720116257667542)","('Employee_Health_And_Safety', 0.0019992515444755554)","('Human_Rights_And_Community_Relations', 0.0019022179767489433)","(['Human Capital Development'], 0.9720116257667542)","('NON-ESG', 0.0019992515444755554)","('NON-ESG', 0.0019022179767489433)"
Line 36,"Management of Risks Associated with Use   of Critical Materials  .
","('Supply_Chain_Management', 0.616769552230835)","('Waste_And_Hazardous_Materials_Management', 0.144697368144989)","('Product_Design_And_Lifecycle_Management', 0.02271188423037529)","(['Supply Chain Management'], 0.616769552230835)","('NON-ESG', 0.144697368144989)","('NON-ESG', 0.02271188423037529)"
Line 37,"Animal Testing Policy  .
","('Management_Of_Legal_And_Regulatory_Framework', 0.24547246098518372)","('Product_Quality_And_Safety', 0.11540549248456955)","('Business_Ethics', 0.07773681730031967)","('NON-ESG', 0.24547246098518372)","('NON-ESG', 0.11540549248456955)","('NON-ESG', 0.07773681730031967)"
Line 38,"Clinical Trial Program  .
","('Competitive_Behavior', 0.14754880964756012)","('Customer_Welfare', 0.10367556661367416)","('Supply_Chain_Management', 0.07230972498655319)","('NON-ESG', 0.14754880964756012)","('NON-ESG', 0.10367556661367416)","('NON-ESG', 0.07230972498655319)"
Line 39,"Clinical Trial Transparency  .
","('Business_Ethics', 0.9422851800918579)","('Data_Security', 0.007773782592266798)","('Systemic_Risk_Management', 0.0049252379685640335)","(['Business Ethics'], 0.9422851800918579)","('NON-ESG', 0.007773782592266798)","('NON-ESG', 0.0049252379685640335)"
Line 40,"Grants, Donations and Funding .
","('Management_Of_Legal_And_Regulatory_Framework', 0.8462825417518616)","('Human_Rights_And_Community_Relations', 0.02091269940137863)","('GHG_Emissions', 0.01848936639726162)","(['Corporate Governance'], 0.8462825417518616)","('NON-ESG', 0.02091269940137863)","('NON-ESG', 0.01848936639726162)"
Line 41,"Zimmer Biomet Foundation  .
","('Management_Of_Legal_And_Regulatory_Framework', 0.11502531170845032)","('Customer_Welfare', 0.08520302921533585)","('Business_Ethics', 0.07380014657974243)","('NON-ESG', 0.11502531170845032)","('NON-ESG', 0.08520302921533585)","('NON-ESG', 0.07380014657974243)"
Line 42,"Zimmer Biomet Medical Missions  .
","('Critical_Incident_Risk_Management', 0.6282821297645569)","('Employee_Health_And_Safety', 0.14806605875492096)","('Access_And_Affordability', 0.03942634165287018)","(['Risk & Crisis Management'], 0.6282821297645569)","('NON-ESG', 0.14806605875492096)","('NON-ESG', 0.03942634165287018)"
Line 43,"Zimmer Biomet Corporate Grants  .
","('Management_Of_Legal_And_Regulatory_Framework', 0.8412678241729736)","('GHG_Emissions', 0.02010267972946167)","('Access_And_Affordability', 0.01775171048939228)","(['Corporate Governance'], 0.8412678241729736)","('NON-ESG', 0.02010267972946167)","('NON-ESG', 0.01775171048939228)"
Line 44,"Advancing Diversity, Equity and Inclusion  .
","('Employee_Engagement_Inclusion_And_Diversity', 0.9703764915466309)","('Human_Rights_And_Community_Relations', 0.0024896550457924604)","('Employee_Health_And_Safety', 0.0023052769247442484)","(['Human Capital Development'], 0.9703764915466309)","('NON-ESG', 0.0024896550457924604)","('NON-ESG', 0.0023052769247442484)"
Line 45,"Access to Healthcare .
","('Access_And_Affordability', 0.8997789025306702)","('Human_Rights_And_Community_Relations', 0.011929549276828766)","('Product_Quality_And_Safety', 0.009183968417346478)","(['Health Outcome Contribution'], 0.8997789025306702)","('NON-ESG', 0.011929549276828766)","('NON-ESG', 0.009183968417346478)"
Line 46,"Movement is Life  .
","('Business_Model_Resilience', 0.14139433205127716)","('Employee_Engagement_Inclusion_And_Diversity', 0.12489205598831177)","('Product_Design_And_Lifecycle_Management', 0.07734066992998123)","('NON-ESG', 0.14139433205127716)","('NON-ESG', 0.12489205598831177)","('NON-ESG', 0.07734066992998123)"
Line 47,"Patient Privacy and Data Security .
","('Data_Security', 0.8134377598762512)","('Customer_Privacy', 0.1101667582988739)","('Director_Removal', 0.006691740360110998)","(['Information Security/Cybersecurity & System Availability'], 0.8134377598762512)","('NON-ESG', 0.1101667582988739)","('NON-ESG', 0.006691740360110998)"
Line 48,"Privacy  .
","('Customer_Privacy', 0.6171815991401672)","('Data_Security', 0.19023634493350983)","('Labor_Practices', 0.018333427608013153)","(['Privacy Protection'], 0.6171815991401672)","('NON-ESG', 0.19023634493350983)","('NON-ESG', 0.018333427608013153)"
Line 49,"Data Security .
","('Data_Security', 0.9359430074691772)","('Customer_Privacy', 0.01165156438946724)","('Waste_And_Hazardous_Materials_Management', 0.004777421243488789)","(['Information Security/Cybersecurity & System Availability'], 0.9359430074691772)","('NON-ESG', 0.01165156438946724)","('NON-ESG', 0.004777421243488789)"
Line 50,"Data Usage  .
","('Customer_Privacy', 0.7940269708633423)","('Data_Security', 0.09321184456348419)","('Business_Model_Resilience', 0.010781035758554935)","(['Privacy Protection'], 0.7940269708633423)","('NON-ESG', 0.09321184456348419)","('NON-ESG', 0.010781035758554935)"
Line 51,"Ownership  .
","('Competitive_Behavior', 0.1631014049053192)","('Employee_Engagement_Inclusion_And_Diversity', 0.08115348219871521)","('Access_And_Affordability', 0.0576949343085289)","('NON-ESG', 0.1631014049053192)","('NON-ESG', 0.08115348219871521)","('NON-ESG', 0.0576949343085289)"
Line 52,"Cybersecurity  .
","('Data_Security', 0.6627269983291626)","('Business_Model_Resilience', 0.06883599609136581)","('Systemic_Risk_Management', 0.044365253299474716)","(['Information Security/Cybersecurity & System Availability'], 0.6627269983291626)","('NON-ESG', 0.06883599609136581)","('NON-ESG', 0.044365253299474716)"
Line 53,"GOVERNANCE Corporate Governance  .
","('Competitive_Behavior', 0.2616554796695709)","('Management_Of_Legal_And_Regulatory_Framework', 0.25847506523132324)","('Business_Ethics', 0.13982699811458588)","('NON-ESG', 0.2616554796695709)","('NON-ESG', 0.25847506523132324)","('NON-ESG', 0.13982699811458588)"
Line 54,"Audit Committee  .
","('Management_Of_Legal_And_Regulatory_Framework', 0.607505738735199)","('Business_Ethics', 0.10126495361328125)","('Director_Removal', 0.0715600997209549)","(['Corporate Governance'], 0.607505738735199)","('NON-ESG', 0.10126495361328125)","('NON-ESG', 0.0715600997209549)"
Line 55,"Compensation and Management Development Committee  .Corporate Governance Committee  .
","('Management_Of_Legal_And_Regulatory_Framework', 0.5486697554588318)","('Director_Removal', 0.123573899269104)","('Business_Ethics', 0.06374820321798325)","(['Corporate Governance'], 0.5486697554588318)","('NON-ESG', 0.123573899269104)","('NON-ESG', 0.06374820321798325)"
Line 56,"Quality, Regulatory and Technology Committee  .
","('Management_Of_Legal_And_Regulatory_Framework', 0.9464092254638672)","('Business_Ethics', 0.006604354828596115)","('Competitive_Behavior', 0.004103845451027155)","(['Corporate Governance'], 0.9464092254638672)","('NON-ESG', 0.006604354828596115)","('NON-ESG', 0.004103845451027155)"
Line 57,"Executive Compensation  .
","('Labor_Practices', 0.5361263751983643)","('Employee_Engagement_Inclusion_And_Diversity', 0.0988193154335022)","('Director_Removal', 0.08516910672187805)","(['Labor Practice Indicators'], 0.5361263751983643)","('NON-ESG', 0.0988193154335022)","('NON-ESG', 0.08516910672187805)"
Line 58,"Ethical Business Conduct  .
","('Business_Ethics', 0.931149423122406)","('Competitive_Behavior', 0.0060986909084022045)","('Customer_Privacy', 0.005235627759248018)","(['Business Ethics'], 0.931149423122406)","('NON-ESG', 0.0060986909084022045)","('NON-ESG', 0.005235627759248018)"
Line 59,"Countering Corruption  .
","('Business_Ethics', 0.9515849947929382)","('Competitive_Behavior', 0.005172057077288628)","('Systemic_Risk_Management', 0.004898949060589075)","(['Business Ethics'], 0.9515849947929382)","('NON-ESG', 0.005172057077288628)","('NON-ESG', 0.004898949060589075)"
Line 60,"Whistleblower Program .
","('Business_Ethics', 0.5784887671470642)","('Data_Security', 0.25695866346359253)","('Customer_Privacy', 0.02175302430987358)","(['Business Ethics'], 0.5784887671470642)","('NON-ESG', 0.25695866346359253)","('NON-ESG', 0.02175302430987358)"
Line 61,"Ethical Marketing  .
","('Business_Ethics', 0.4063655734062195)","('Competitive_Behavior', 0.09250180423259735)","('Customer_Privacy', 0.06600655615329742)","('NON-ESG', 0.4063655734062195)","('NON-ESG', 0.09250180423259735)","('NON-ESG', 0.06600655615329742)"
Line 62,"Zimmer Biomet’s Statement of Engagement   on Public Policy Issues  .
","('Management_Of_Legal_And_Regulatory_Framework', 0.6172706484794617)","('Human_Rights_And_Community_Relations', 0.1364983469247818)","('Physical_Impacts_Of_Climate_Change', 0.0409114845097065)","(['Corporate Governance'], 0.6172706484794617)","('NON-ESG', 0.1364983469247818)","('NON-ESG', 0.0409114845097065)"
Line 63,"How Zimmer Biomet Engages .
","('Competitive_Behavior', 0.31615492701530457)","('Customer_Welfare', 0.11331457644701004)","('Systemic_Risk_Management', 0.0730728805065155)","('NON-ESG', 0.31615492701530457)","('NON-ESG', 0.11331457644701004)","('NON-ESG', 0.0730728805065155)"
Line 64,"Industry Groups and Trade Associations  .
","('Management_Of_Legal_And_Regulatory_Framework', 0.53676837682724)","('Labor_Practices', 0.10666337609291077)","('Competitive_Behavior', 0.06482360512018204)","(['Corporate Governance'], 0.53676837682724)","('NON-ESG', 0.10666337609291077)","('NON-ESG', 0.06482360512018204)"
Line 65,"Political Contributions  .
","('Management_Of_Legal_And_Regulatory_Framework', 0.4382394552230835)","('Labor_Practices', 0.09067396819591522)","('Director_Removal', 0.06963133066892624)","('NON-ESG', 0.4382394552230835)","('NON-ESG', 0.09067396819591522)","('NON-ESG', 0.06963133066892624)"
Line 66,"2020 Sustainability Accounting Standards   Board Index  .
","('Management_Of_Legal_And_Regulatory_Framework', 0.36799734830856323)","('Systemic_Risk_Management', 0.1093265563249588)","('Business_Model_Resilience', 0.08599883317947388)","('NON-ESG', 0.36799734830856323)","('NON-ESG', 0.1093265563249588)","('NON-ESG', 0.08599883317947388)"
Line 67,"26Table of Contents *The disclosures in this report are for WholeCo Zimmer Biomet including Dental & Spine segmentCEO INTRODUCTION Every day, the Zimmer Biomet team works towards our mission   of alleviating pain and improving quality of life   for people around the world.
","('Employee_Health_And_Safety', 0.928917407989502)","('Critical_Incident_Risk_Management', 0.007516585290431976)","('Access_And_Affordability', 0.006565069779753685)","(['Operational Eco-Efficiency'], 0.928917407989502)","('NON-ESG', 0.007516585290431976)","('NON-ESG', 0.006565069779753685)"
Line 68,"We also work toward being a responsible corporate citizen.
","('Human_Rights_And_Community_Relations', 0.3959575593471527)","('Management_Of_Legal_And_Regulatory_Framework', 0.08519228547811508)","('Access_And_Affordability', 0.07322263717651367)","('NON-ESG', 0.3959575593471527)","('NON-ESG', 0.08519228547811508)","('NON-ESG', 0.07322263717651367)"
Line 69,"This Sustainability Report describes our annual accomplishments in  developing a more sustainable business, reducing waste and use of  natural resources, and improving the environmental performance of our  operations.
","('Ecological_Impacts', 0.9405209422111511)","('Product_Design_And_Lifecycle_Management', 0.010001862421631813)","('Business_Model_Resilience', 0.005407760385423899)","(['Natural Capital'], 0.9405209422111511)","('NON-ESG', 0.010001862421631813)","('NON-ESG', 0.005407760385423899)"
Line 70,"It also describes our commitment to the highest standards of  patient safety and quality in our products and services and to world-class  integrity and ethical business practices.
","('Product_Quality_And_Safety', 0.9039246439933777)","('Selling_Practices_And_Product_Labeling', 0.01294685062021017)","('Product_Design_And_Lifecycle_Management', 0.012438497506082058)","(['Product Quality & Recall Management'], 0.9039246439933777)","('NON-ESG', 0.01294685062021017)","('NON-ESG', 0.012438497506082058)"
Line 71,"In 2021, we continued to make strong progress against   our sustainability commitments.
","('Business_Model_Resilience', 0.4225398600101471)","('Product_Design_And_Lifecycle_Management', 0.09038786590099335)","('Management_Of_Legal_And_Regulatory_Framework', 0.05475056543946266)","('NON-ESG', 0.4225398600101471)","('NON-ESG', 0.09038786590099335)","('NON-ESG', 0.05475056543946266)"
Line 72,"As a company,   we are increasingly focused on advancing these initiatives   and even more ambitious about what we can achieve, together.
","('Management_Of_Legal_And_Regulatory_Framework', 0.41472920775413513)","('Human_Rights_And_Community_Relations', 0.1578303724527359)","('Business_Model_Resilience', 0.0726495161652565)","('NON-ESG', 0.41472920775413513)","('NON-ESG', 0.1578303724527359)","('NON-ESG', 0.0726495161652565)"
Line 73,"On behalf of all of us at Zimmer Biomet, I thank you   for your support.
","('Management_Of_Legal_And_Regulatory_Framework', 0.22966977953910828)","('Director_Removal', 0.12057721614837646)","('Business_Ethics', 0.09757812321186066)","('NON-ESG', 0.22966977953910828)","('NON-ESG', 0.12057721614837646)","('NON-ESG', 0.09757812321186066)"
Line 74,"I look forward to continuing to share   our progress with you as we move ahead.
","('Business_Model_Resilience', 0.45581313967704773)","('Human_Rights_And_Community_Relations', 0.11836251616477966)","('Director_Removal', 0.04812851920723915)","('NON-ESG', 0.45581313967704773)","('NON-ESG', 0.11836251616477966)","('NON-ESG', 0.04812851920723915)"
Line 75,"Bryan Hanson Chairman, President and CEO, Zimmer Biomet Corporate Overview Zimmer Biomet is a global medical technology leader with  a comprehensive portfolio designed to maximize mobility  and improve health.
","('Customer_Welfare', 0.3117517828941345)","('Product_Design_And_Lifecycle_Management', 0.2089332491159439)","('Product_Quality_And_Safety', 0.08769923448562622)","('NON-ESG', 0.3117517828941345)","('NON-ESG', 0.2089332491159439)","('NON-ESG', 0.08769923448562622)"
Line 76,"We seamlessly transform the patient  experience through our innovative products and suite of  integrated digital and robotic technologies that leverage  data, analytics and artificial intelligence.
","('Product_Design_And_Lifecycle_Management', 0.8525310754776001)","('Energy_Management', 0.01989142782986164)","('Customer_Welfare', 0.01744171977043152)","(['Product Stewardship'], 0.8525310754776001)","('NON-ESG', 0.01989142782986164)","('NON-ESG', 0.01744171977043152)"
Line 77,"With more than 90 years of trusted leadership and  proven expertise, Zimmer Biomet is positioned to deliver  the highest quality solutions to patients and providers.
","('Business_Model_Resilience', 0.20989234745502472)","('Product_Design_And_Lifecycle_Management', 0.16883236169815063)","('Access_And_Affordability', 0.0965544804930687)","('NON-ESG', 0.20989234745502472)","('NON-ESG', 0.16883236169815063)","('NON-ESG', 0.0965544804930687)"
Line 78,"Our legacy continues to come to life today through our  progressive culture of evolution and innovation.
","('Business_Model_Resilience', 0.24686592817306519)","('Product_Design_And_Lifecycle_Management', 0.22281892597675323)","('Employee_Engagement_Inclusion_And_Diversity', 0.14761027693748474)","('NON-ESG', 0.24686592817306519)","('NON-ESG', 0.22281892597675323)","('NON-ESG', 0.14761027693748474)"
Line 79,"For more information about our product portfolio, our  operations in more than 25 countries and sales in more  than 100 countries, or about joining our team, visit   www.zimmerbiomet.com or follow Zimmer Biomet   on Twitter at www.twitter.com/zimmerbiomet .Our Mission   Alleviate pain and improve the quality of life   for people around the world.
","('Product_Design_And_Lifecycle_Management', 0.8397092223167419)","('Selling_Practices_And_Product_Labeling', 0.03664509579539299)","('Customer_Welfare', 0.03275372087955475)","(['Product Stewardship'], 0.8397092223167419)","('NON-ESG', 0.03664509579539299)","('NON-ESG', 0.03275372087955475)"
Line 80,"Guiding Principles    • Respect the contributions and perspectives   of all team members.
","('Human_Rights_And_Community_Relations', 0.7055792808532715)","('Director_Removal', 0.04395436495542526)","('Employee_Engagement_Inclusion_And_Diversity', 0.0349479503929615)","(['Community Relations'], 0.7055792808532715)","('NON-ESG', 0.04395436495542526)","('NON-ESG', 0.0349479503929615)"
Line 81,"• Commit to the highest standards of patient safety,  quality and integrity.
","('Product_Quality_And_Safety', 0.43872156739234924)","('Employee_Health_And_Safety', 0.3937290608882904)","('Access_And_Affordability', 0.015717677772045135)","('NON-ESG', 0.43872156739234924)","('NON-ESG', 0.3937290608882904)","('NON-ESG', 0.015717677772045135)"
Line 82,"• Focus our resources in areas where we will   make a difference.
","('Human_Rights_And_Community_Relations', 0.7056883573532104)","('Business_Model_Resilience', 0.05552332475781441)","('Employee_Engagement_Inclusion_And_Diversity', 0.04483994096517563)","(['Community Relations'], 0.7056883573532104)","('NON-ESG', 0.05552332475781441)","('NON-ESG', 0.04483994096517563)"
Line 83,"• Ensure our return is equivalent to the value   we provide our customers and patients.
","('Competitive_Behavior', 0.27892163395881653)","('Business_Model_Resilience', 0.14771345257759094)","('Management_Of_Legal_And_Regulatory_Framework', 0.08338769525289536)","('NON-ESG', 0.27892163395881653)","('NON-ESG', 0.14771345257759094)","('NON-ESG', 0.08338769525289536)"
Line 84,"• Give back to our communities and people in need.
","('Human_Rights_And_Community_Relations', 0.8428218960762024)","('Access_And_Affordability', 0.06927510350942612)","('Critical_Incident_Risk_Management', 0.010347303934395313)","(['Community Relations'], 0.8428218960762024)","('NON-ESG', 0.06927510350942612)","('NON-ESG', 0.010347303934395313)"
Line 85,"Our Sustainability Commitment   Zimmer Biomet is committed to being a good corporate  citizen.
","('Business_Model_Resilience', 0.45846205949783325)","('Product_Design_And_Lifecycle_Management', 0.11397736519575119)","('Supply_Chain_Management', 0.08021610975265503)","('NON-ESG', 0.45846205949783325)","('NON-ESG', 0.11397736519575119)","('NON-ESG', 0.08021610975265503)"
Line 86,"Our global team is dedicated to sustainable  practices across the entire spectrum of the environmental,  social and governance platform.
","('Human_Rights_And_Community_Relations', 0.6427996158599854)","('Management_Of_Legal_And_Regulatory_Framework', 0.07355409860610962)","('Business_Model_Resilience', 0.05703587830066681)","(['Community Relations'], 0.6427996158599854)","('NON-ESG', 0.07355409860610962)","('NON-ESG', 0.05703587830066681)"
Line 87,"COMPANY PROFILE 2OUR APPROACH TO ESG We take a comprehensive and proactive approach to ESG.
","('Business_Model_Resilience', 0.7686639428138733)","('Systemic_Risk_Management', 0.052526168525218964)","('Supply_Chain_Management', 0.020098458975553513)","(['Codes of Business Conduct'], 0.7686639428138733)","('NON-ESG', 0.052526168525218964)","('NON-ESG', 0.020098458975553513)"
Line 88,"Our Board’s Corporate Governance Committee oversees  current and emerging political, social, environmental,  corporate citizenship and public policy issues for the  Company.
","('Human_Rights_And_Community_Relations', 0.3606410026550293)","('Management_Of_Legal_And_Regulatory_Framework', 0.35684049129486084)","('Business_Model_Resilience', 0.043972935527563095)","('NON-ESG', 0.3606410026550293)","('NON-ESG', 0.35684049129486084)","('NON-ESG', 0.043972935527563095)"
Line 89,"At the team member level, we have established a  functional ESG Working Group, comprised of team members  spanning multiple divisions of the organization, including  Human Resources, Operations, Environmental, Health,  Safety and Sustainability, Quality, Finance, Accounting,  Investor Relations, Communications, Government Affairs,  Legal and Compliance.
","('Management_Of_Legal_And_Regulatory_Framework', 0.692441463470459)","('Human_Rights_And_Community_Relations', 0.06175142526626587)","('Business_Ethics', 0.03573739901185036)","(['Corporate Governance'], 0.692441463470459)","('NON-ESG', 0.06175142526626587)","('NON-ESG', 0.03573739901185036)"
Line 90,"The ESG Working Group meets monthly to discuss Zimmer  Biomet’s ESG initiatives and identifies ways we can enhance  our ESG disclosures.
","('Business_Model_Resilience', 0.3735663890838623)","('Systemic_Risk_Management', 0.17528381943702698)","('Management_Of_Legal_And_Regulatory_Framework', 0.09430260211229324)","('NON-ESG', 0.3735663890838623)","('NON-ESG', 0.17528381943702698)","('NON-ESG', 0.09430260211229324)"
Line 91,"Our CEO and CFO receive monthly  updates on our ESG progress, while at the Board level,  the Corporate Governance Committee receives quarterly  reports.
","('Director_Removal', 0.2812293469905853)","('Management_Of_Legal_And_Regulatory_Framework', 0.23548655211925507)","('Business_Model_Resilience', 0.12933307886123657)","('NON-ESG', 0.2812293469905853)","('NON-ESG', 0.23548655211925507)","('NON-ESG', 0.12933307886123657)"
Line 92,"We proactively engage with ratings agencies and investors  to inform our ESG processes and provide the appropriate  level of transparency while using third party auditing  and benchmarking to pinpoint areas for continuous  improvement.
","('Business_Ethics', 0.9668228030204773)","('Management_Of_Legal_And_Regulatory_Framework', 0.0052262600511312485)","('Systemic_Risk_Management', 0.004465112462639809)","(['Business Ethics'], 0.9668228030204773)","('NON-ESG', 0.0052262600511312485)","('NON-ESG', 0.004465112462639809)"
Line 93,"3COMPANY AWARDS COVID-The COVID-19 pandemic has significantly affected Zimmer  Biomet’s financial results, but has not impacted the quality,  safety and efficacy of our products.
","('Product_Quality_And_Safety', 0.6587659120559692)","('Product_Design_And_Lifecycle_Management', 0.18467320501804352)","('Selling_Practices_And_Product_Labeling', 0.03807784616947174)","(['Product Quality & Recall Management'], 0.6587659120559692)","('NON-ESG', 0.18467320501804352)","('NON-ESG', 0.03807784616947174)"
Line 94,"Prior to COVID-19, Zimmer Biomet developed  comprehensive crisis response plans and initiated  contingency drills – including for pandemic events – across  our operations.
","('Critical_Incident_Risk_Management', 0.5580675005912781)","('Physical_Impacts_Of_Climate_Change', 0.28210705518722534)","('Systemic_Risk_Management', 0.030484069138765335)","(['Risk & Crisis Management'], 0.5580675005912781)","('NON-ESG', 0.28210705518722534)","('NON-ESG', 0.030484069138765335)"
Line 95,"This exercise helped prepare our business  and create enhanced disaster recovery plans that have been  a significant benefit throughout our response to COVID-19.
","('Critical_Incident_Risk_Management', 0.972380518913269)","('Employee_Health_And_Safety', 0.004413702059537172)","('Air_Quality', 0.002589654643088579)","(['Risk & Crisis Management'], 0.972380518913269)","('NON-ESG', 0.004413702059537172)","('NON-ESG', 0.002589654643088579)"
Line 96,"Throughout 2021, we continued to aggressively secure our  global supply chain and manage the unique challenges  presented by each new COVID-19 wave.
","('Supply_Chain_Management', 0.9523289799690247)","('Product_Design_And_Lifecycle_Management', 0.004349252674728632)","('Physical_Impacts_Of_Climate_Change', 0.0041772243566811085)","(['Supply Chain Management'], 0.9523289799690247)","('NON-ESG', 0.004349252674728632)","('NON-ESG', 0.0041772243566811085)"
Line 97,"Due to these  efforts, we continued to serve our customers without  compromising product quality and safety.All of our manufacturing sites and distribution centers  continued to operate throughout 2021 with enhanced  safety protocols.
","('Product_Quality_And_Safety', 0.9127402901649475)","('Employee_Health_And_Safety', 0.012443668209016323)","('Product_Design_And_Lifecycle_Management', 0.012055706232786179)","(['Product Quality & Recall Management'], 0.9127402901649475)","('NON-ESG', 0.012443668209016323)","('NON-ESG', 0.012055706232786179)"
Line 98,"Our vigilance and commitment to health  and safety ensured our team members in each region had  what they needed to operate in a safe environment and  meet our operational commitments.
","('Employee_Health_And_Safety', 0.9611891508102417)","('Critical_Incident_Risk_Management', 0.013325070962309837)","('Access_And_Affordability', 0.0028367885388433933)","(['Operational Eco-Efficiency'], 0.9611891508102417)","('NON-ESG', 0.013325070962309837)","('NON-ESG', 0.0028367885388433933)"
Line 99,"Our enhanced safety  protocols were openly shared with suppliers to further  secure our supply chain.
","('Supply_Chain_Management', 0.34124207496643066)","('Product_Quality_And_Safety', 0.28445085883140564)","('Employee_Health_And_Safety', 0.07853654026985168)","('NON-ESG', 0.34124207496643066)","('NON-ESG', 0.28445085883140564)","('NON-ESG', 0.07853654026985168)"
Line 100,"Most Zimmer Biomet team  members who were not directly responsible for or involved  in manufacturing operations and the supply chain worked  from home as an added safety measure to reduce risk of  infection and secure the supply chain.6Environmental Risk Management Policy Consistent with Zimmer Biomet’s Mission, Code of Business  Conduct and Ethics ( https:/ /www.zimmerbiomet.com/ en/about-us/our-impact.html ), and the Environmental,  Health, Safety, and Sustainability (EHSS) vision, we are  committed to our policy of conducting business in a safe  and environmentally sustainable manner that promotes the  health of our employees, customers, community and the  environment, specifically fighting climate change.
","('Supply_Chain_Management', 0.9208739995956421)","('Employee_Health_And_Safety', 0.01159053947776556)","('Labor_Practices', 0.007546115200966597)","(['Supply Chain Management'], 0.9208739995956421)","('NON-ESG', 0.01159053947776556)","('NON-ESG', 0.007546115200966597)"
Line 101,"Most Zimmer Biomet team  members who were not directly responsible for or involved  in manufacturing operations and the supply chain worked  from home as an added safety measure to reduce risk of  infection and secure the supply chain.6Environmental Risk Management Policy Consistent with Zimmer Biomet’s Mission, Code of Business  Conduct and Ethics ( https:/ /www.zimmerbiomet.com/ en/about-us/our-impact.html ), and the Environmental,  Health, Safety, and Sustainability (EHSS) vision, we are  committed to our policy of conducting business in a safe  and environmentally sustainable manner that promotes the  health of our employees, customers, community and the  environment, specifically fighting climate change.
","('Physical_Impacts_Of_Climate_Change', 0.8757117390632629)","('Human_Rights_And_Community_Relations', 0.024310018867254257)","('Business_Model_Resilience', 0.01875174790620804)","(['Climate Change'], 0.8757117390632629)","('NON-ESG', 0.024310018867254257)","('NON-ESG', 0.01875174790620804)"
Line 102,"The purpose of our Environmental Risk Management  Policy is to implement the principles of the EHSS programs  while implementing and sustaining global best practices.
","('Systemic_Risk_Management', 0.2315356731414795)","('Physical_Impacts_Of_Climate_Change', 0.18043585121631622)","('Management_Of_Legal_And_Regulatory_Framework', 0.1705998033285141)","('NON-ESG', 0.2315356731414795)","('NON-ESG', 0.18043585121631622)","('NON-ESG', 0.1705998033285141)"
Line 103,"Corporate and regional standards exist to support these  principles.
","('Management_Of_Legal_And_Regulatory_Framework', 0.485254168510437)","('Business_Ethics', 0.16159981489181519)","('Product_Quality_And_Safety', 0.09716372191905975)","('NON-ESG', 0.485254168510437)","('NON-ESG', 0.16159981489181519)","('NON-ESG', 0.09716372191905975)"
Line 104,"This policy applies to all locations worldwide and provides  uniform guidance for Zimmer Biomet EHSS teams to  manage and monitor risk within our global manufacturing  and distribution processes.
","('Systemic_Risk_Management', 0.8836075663566589)","('Business_Ethics', 0.020903553813695908)","('Supply_Chain_Management', 0.019782863557338715)","(['Risk & Crisis Management'], 0.8836075663566589)","('NON-ESG', 0.020903553813695908)","('NON-ESG', 0.019782863557338715)"
Line 105,"The EHSS Management System  delivers six main outcomes, as follows: Compliance We comply with, and often exceed the requirements of,  all applicable EHSS laws, regulations, Company EHSS  standards and other requirements to which we subscribe  related to all EHSS subject matter and risks.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8655136823654175)","('Product_Quality_And_Safety', 0.024857167154550552)","('Business_Ethics', 0.023527177050709724)","(['Corporate Governance'], 0.8655136823654175)","('NON-ESG', 0.024857167154550552)","('NON-ESG', 0.023527177050709724)"
Line 106,"We conduct  frequent audits and implement best practices to maintain  compliance with these requirements.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5379250049591064)","('Business_Ethics', 0.335055410861969)","('Product_Quality_And_Safety', 0.023200105875730515)","(['Corporate Governance'], 0.5379250049591064)","('NON-ESG', 0.335055410861969)","('NON-ESG', 0.023200105875730515)"
Line 107,"Continuous Improvement Zimmer Biomet establishes EHSS goals, objectives  and targets across our global business and strives to  continually improve our performance and publicly report  on our progress.
","('Business_Model_Resilience', 0.5261688828468323)","('Human_Rights_And_Community_Relations', 0.10469867289066315)","('Management_Of_Legal_And_Regulatory_Framework', 0.05039086565375328)","(['Codes of Business Conduct'], 0.5261688828468323)","('NON-ESG', 0.10469867289066315)","('NON-ESG', 0.05039086565375328)"
Line 108,"Our EHSS standards establish controls and  promote a positive EHSS culture.Business Integration   We integrate EHSS principles into business decisions to  proactively ensure the health and safety of our employees  and communities, while also promoting environmentally  sustainable practices.
","('Employee_Health_And_Safety', 0.8847362399101257)","('Human_Rights_And_Community_Relations', 0.04098016023635864)","('Product_Quality_And_Safety', 0.009791950695216656)","(['Operational Eco-Efficiency'], 0.8847362399101257)","('NON-ESG', 0.04098016023635864)","('NON-ESG', 0.009791950695216656)"
Line 109,"Specifically, we require that an  EHSS evaluation be integrated into product design,  manufacturing and distribution business processes and  services that will reduce EHSS risks, improve performance  throughout our operations, products and packaging across  their lifecycle, and promote pollution prevention.
","('Product_Design_And_Lifecycle_Management', 0.9537015557289124)","('Product_Quality_And_Safety', 0.008230462670326233)","('Selling_Practices_And_Product_Labeling', 0.00523685896769166)","(['Product Stewardship'], 0.9537015557289124)","('NON-ESG', 0.008230462670326233)","('NON-ESG', 0.00523685896769166)"
Line 110,"Environment & Climate Change To minimize our impact on the environment and address  climate change, we minimize waste and emissions, reuse  and recycle materials, promote renewable energy use,  reduce greenhouse gas emissions, and conserve energy  and water wherever feasible.
","('Physical_Impacts_Of_Climate_Change', 0.7268565893173218)","('GHG_Emissions', 0.1548481583595276)","('Business_Model_Resilience', 0.02469092421233654)","(['Climate Change'], 0.7268565893173218)","('NON-ESG', 0.1548481583595276)","('NON-ESG', 0.02469092421233654)"
Line 111,"Health & Safety Zimmer Biomet EHSS establishes health and safety  standards that promote a safe and healthy workplace by  striving continuously to reduce hazards and risks to prevent  workplace injuries and illnesses.
","('Employee_Health_And_Safety', 0.9846857786178589)","('Employee_Engagement_Inclusion_And_Diversity', 0.0017652623355388641)","('Critical_Incident_Risk_Management', 0.0015374310314655304)","(['Operational Eco-Efficiency'], 0.9846857786178589)","('NON-ESG', 0.0017652623355388641)","('NON-ESG', 0.0015374310314655304)"
Line 112,"Communication & Education Zimmer Biomet EHSS communicates our Environmental  Health and Safety Policy to employees, customers,  shareholders, suppliers, community and other  stakeholders.
","('Employee_Health_And_Safety', 0.9262902736663818)","('Product_Quality_And_Safety', 0.01070746872574091)","('Human_Rights_And_Community_Relations', 0.00994595792144537)","(['Operational Eco-Efficiency'], 0.9262902736663818)","('NON-ESG', 0.01070746872574091)","('NON-ESG', 0.00994595792144537)"
Line 113,"Zimmer Biomet EHSS standards, procedures  and other resources enable employees to implement this  policy and share best practices to promote continuous  improvement and enhance environmental, health and  safety performance.
","('Employee_Health_And_Safety', 0.8140347599983215)","('Product_Quality_And_Safety', 0.09993799775838852)","('Employee_Engagement_Inclusion_And_Diversity', 0.007194849196821451)","(['Operational Eco-Efficiency'], 0.8140347599983215)","('NON-ESG', 0.09993799775838852)","('NON-ESG', 0.007194849196821451)"
Line 114,"ENVIRONMENTAL Environmental Targets The environmental issues facing the world and the threat of  climate change warrant an urgent and immediate response.
","('Physical_Impacts_Of_Climate_Change', 0.9443882703781128)","('Business_Model_Resilience', 0.012036540545523167)","('GHG_Emissions', 0.005962260067462921)","(['Climate Change'], 0.9443882703781128)","('NON-ESG', 0.012036540545523167)","('NON-ESG', 0.005962260067462921)"
Line 115,"In 2020, Zimmer Biomet publicly committed to setting  science-based targets, which in 2021 were approved  through the Science Based Target Initiative.
","('GHG_Emissions', 0.21830414235591888)","('Management_Of_Legal_And_Regulatory_Framework', 0.18887275457382202)","('Ecological_Impacts', 0.09264228492975235)","('NON-ESG', 0.21830414235591888)","('NON-ESG', 0.18887275457382202)","('NON-ESG', 0.09264228492975235)"
Line 116,"https:/ /sciencebasedtargets.org/companies-taking- action#table We are committed to reducing absolute scope 1 and 2  greenhouse gas (GHG) emissions 55% by 2030 from a 2017  base year.
","('GHG_Emissions', 0.9694851636886597)","('Ecological_Impacts', 0.004283633083105087)","('Air_Quality', 0.002912400756031275)","(['Climate Change'], 0.9694851636886597)","('NON-ESG', 0.004283633083105087)","('NON-ESG', 0.002912400756031275)"
Line 117,"We have also committed to reduce absolute  scope 3 GHG emissions from purchased goods and  services to 15% by 2030 from a 2019 base year.
","('GHG_Emissions', 0.9649285078048706)","('Air_Quality', 0.005989323370158672)","('Physical_Impacts_Of_Climate_Change', 0.003325369907543063)","(['Climate Change'], 0.9649285078048706)","('NON-ESG', 0.005989323370158672)","('NON-ESG', 0.003325369907543063)"
Line 118,"More than  40% of our supply chain responded to our request for GHG  emission disclosures in 2021, our first year of focus on scope  3, furthering our efforts to reduce our carbon footprint.
","('GHG_Emissions', 0.9666310548782349)","('Air_Quality', 0.00455353083088994)","('Physical_Impacts_Of_Climate_Change', 0.003328001592308283)","(['Climate Change'], 0.9666310548782349)","('NON-ESG', 0.00455353083088994)","('NON-ESG', 0.003328001592308283)"
Line 119,"Furthermore, in July 2021, a large-scale solar farm,  Prospero II, for which Zimmer Biomet negotiated a Virtual  Power Purchase Agreement (VPPA), went into commercial  operation.
","('Energy_Management', 0.9169389009475708)","('Management_Of_Legal_And_Regulatory_Framework', 0.025661364197731018)","('GHG_Emissions', 0.007228064816445112)","(['Operational Eco-Efficiency'], 0.9169389009475708)","('NON-ESG', 0.025661364197731018)","('NON-ESG', 0.007228064816445112)"
Line 120,"The renewable energy generated from the solar  farm will offset 100% of our North American electrical load.
","('Energy_Management', 0.9740012288093567)","('Management_Of_Legal_And_Regulatory_Framework', 0.004565106239169836)","('GHG_Emissions', 0.002270299009978771)","(['Operational Eco-Efficiency'], 0.9740012288093567)","('NON-ESG', 0.004565106239169836)","('NON-ESG', 0.002270299009978771)"
Line 121,"In the second half of 2021, the renewable energy generated  for Zimmer Biomet was more than 5,474MWh, which  equates to nearly 39,000 Metric Tons of CO2 emissions  reduction, or 28% reduction of Zimmer Biomet’s scope 1  and 2 GHG emissions.
","('GHG_Emissions', 0.9678298234939575)","('Air_Quality', 0.004241179209202528)","('Ecological_Impacts', 0.0036295969039201736)","(['Climate Change'], 0.9678298234939575)","('NON-ESG', 0.004241179209202528)","('NON-ESG', 0.0036295969039201736)"
Line 122,"This amount of emissions reduction  is equivalent to nearly 19,500 metric tons of coal burned.
","('GHG_Emissions', 0.5589404702186584)","('Air_Quality', 0.2550579011440277)","('Energy_Management', 0.07961274683475494)","(['Climate Change'], 0.5589404702186584)","('NON-ESG', 0.2550579011440277)","('NON-ESG', 0.07961274683475494)"
Line 123,"We continue to pursue renewable energies in other regions  throughout the world to advance our commitment to  becoming a recognized leader within the environmental  space.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3072565197944641)","('Energy_Management', 0.24774809181690216)","('GHG_Emissions', 0.08799682557582855)","('NON-ESG', 0.3072565197944641)","('NON-ESG', 0.24774809181690216)","('NON-ESG', 0.08799682557582855)"
Line 124,"We have also outfitted all major manufacturing and  distribution sites globally with LED lighting, which is more  energy efficient than conventional bulbs.
","('Energy_Management', 0.9783756136894226)","('Product_Design_And_Lifecycle_Management', 0.00219938182272017)","('Air_Quality', 0.001850055530667305)","(['Operational Eco-Efficiency'], 0.9783756136894226)","('NON-ESG', 0.00219938182272017)","('NON-ESG', 0.001850055530667305)"
Line 125,"In addition, we actively participate in the Carbon Disclosure  Project (CDP), with a Climate Change 2021 ranking of B,  and a 2021 Supplier Engagement Rating of A-; you can see  our grades here.
","('Physical_Impacts_Of_Climate_Change', 0.8533459305763245)","('Supply_Chain_Management', 0.027550742030143738)","('Business_Model_Resilience', 0.027514848858118057)","(['Climate Change'], 0.8533459305763245)","('NON-ESG', 0.027550742030143738)","('NON-ESG', 0.027514848858118057)"
Line 126,"The Supplier Engagement Rating assesses  performance on governance, targets, scope 3 emissions,  and value chain engagement in the CDP Climate change  questionnaire.
","('Supply_Chain_Management', 0.9087356925010681)","('Physical_Impacts_Of_Climate_Change', 0.020360419526696205)","('Business_Model_Resilience', 0.009862001985311508)","(['Supply Chain Management'], 0.9087356925010681)","('NON-ESG', 0.020360419526696205)","('NON-ESG', 0.009862001985311508)"
Line 127,"Zimmer Biomet considers engagement of  our supply chain a key part of our environmental leadership  strategy.The following chart shows our scope 1 and 2 GHG emissions.
","('GHG_Emissions', 0.9170435070991516)","('Supply_Chain_Management', 0.014655891805887222)","('Physical_Impacts_Of_Climate_Change', 0.01025791373103857)","(['Climate Change'], 0.9170435070991516)","('NON-ESG', 0.014655891805887222)","('NON-ESG', 0.01025791373103857)"
Line 128,"Source: Zimmer Biomet internal invoice data and third party sources.
","('Customer_Privacy', 0.854591429233551)","('Data_Security', 0.07363463193178177)","('Business_Ethics', 0.007914007641375065)","(['Privacy Protection'], 0.854591429233551)","('NON-ESG', 0.07363463193178177)","('NON-ESG', 0.007914007641375065)"
Line 129,"Additionally, we are proud that 10 of our major manufacturing  and distribution sites are now zero waste to landfill, and we  continue to look for ways to increase recycling as we reduce  our landfill waste.
","('Waste_And_Hazardous_Materials_Management', 0.984229326248169)","('Water_And_Wastewater_Management', 0.0015159968752413988)","('Data_Security', 0.0012197773903608322)","(['Operational Eco-Efficiency'], 0.984229326248169)","('NON-ESG', 0.0015159968752413988)","('NON-ESG', 0.0012197773903608322)"
Line 130,"The following chart details our waste  streams for our global operations.
","('Waste_And_Hazardous_Materials_Management', 0.9812240600585938)","('Water_And_Wastewater_Management', 0.0021382456179708242)","('Air_Quality', 0.0018888774793595076)","(['Operational Eco-Efficiency'], 0.9812240600585938)","('NON-ESG', 0.0021382456179708242)","('NON-ESG', 0.0018888774793595076)"
Line 131,"Since 201 1, Zimmer Biomet has been a corporate sponsor of  ACRES Land Trust, Indiana’s oldest and largest membership- based nonprofit land conservation organization.
","('Ecological_Impacts', 0.9435259699821472)","('Water_And_Wastewater_Management', 0.01022441778331995)","('Human_Rights_And_Community_Relations', 0.005990447476506233)","(['Natural Capital'], 0.9435259699821472)","('NON-ESG', 0.01022441778331995)","('NON-ESG', 0.005990447476506233)"
Line 132,"ACRES  protects more than 7 ,200 acres of forests, wetlands,  grasslands and unique geological features in more than 1 15  nature preserves, many of which are open to the public.
","('Ecological_Impacts', 0.9770846962928772)","('GHG_Emissions', 0.002300374675542116)","('Waste_And_Hazardous_Materials_Management', 0.0018616117304190993)","(['Natural Capital'], 0.9770846962928772)","('NON-ESG', 0.002300374675542116)","('NON-ESG', 0.0018616117304190993)"
Line 133,"Talent One of Zimmer Biomet’s core strategic pillars is our  commitment to being a “Best and Preferred Place  to Work” and we advance that priority through a  comprehensive and integrated approach.
","('Business_Model_Resilience', 0.5927088856697083)","('Employee_Engagement_Inclusion_And_Diversity', 0.0628402978181839)","('Product_Design_And_Lifecycle_Management', 0.04799715057015419)","(['Codes of Business Conduct'], 0.5927088856697083)","('NON-ESG', 0.0628402978181839)","('NON-ESG', 0.04799715057015419)"
Line 134,"Below are  highlights of our 2021 achievements in this area.
","('Human_Rights_And_Community_Relations', 0.22048527002334595)","('Management_Of_Legal_And_Regulatory_Framework', 0.14597256481647491)","('Business_Model_Resilience', 0.12375447154045105)","('NON-ESG', 0.22048527002334595)","('NON-ESG', 0.14597256481647491)","('NON-ESG', 0.12375447154045105)"
Line 135,"Culture Promises Our Culture Promises describe a shared commitment  to deliver on our mission and build a stronger Zimmer  Biomet.
","('Employee_Engagement_Inclusion_And_Diversity', 0.4246886074542999)","('Business_Model_Resilience', 0.2003713697195053)","('Human_Rights_And_Community_Relations', 0.07293827831745148)","('NON-ESG', 0.4246886074542999)","('NON-ESG', 0.2003713697195053)","('NON-ESG', 0.07293827831745148)"
Line 136,"Shape Tomorrow is our promise to keep our  eyes on the future and create opportunities to move  the business forward.
","('Business_Model_Resilience', 0.8105246424674988)","('Physical_Impacts_Of_Climate_Change', 0.023453418165445328)","('Employee_Engagement_Inclusion_And_Diversity', 0.02007768116891384)","(['Codes of Business Conduct'], 0.8105246424674988)","('NON-ESG', 0.023453418165445328)","('NON-ESG', 0.02007768116891384)"
Line 137,"Ignite Collaboration reminds us  that we are coming together as one Zimmer Biomet  to collaborate and create winning outcomes.
","('Competitive_Behavior', 0.19435498118400574)","('Business_Model_Resilience', 0.10355740040540695)","('Product_Design_And_Lifecycle_Management', 0.08403884619474411)","('NON-ESG', 0.19435498118400574)","('NON-ESG', 0.10355740040540695)","('NON-ESG', 0.08403884619474411)"
Line 138,"Focus to  Win is a promise that we will maximize our impact for  patients and colleagues by working with clarity and  focus.
","('Access_And_Affordability', 0.38913556933403015)","('Employee_Engagement_Inclusion_And_Diversity', 0.11303842812776566)","('Human_Rights_And_Community_Relations', 0.10520519316196442)","('NON-ESG', 0.38913556933403015)","('NON-ESG', 0.11303842812776566)","('NON-ESG', 0.10520519316196442)"
Line 139,"These promises help us to work together to make  Zimmer Biomet a Best and Preferred Place to Work.
","('Business_Model_Resilience', 0.12301939725875854)","('Management_Of_Legal_And_Regulatory_Framework', 0.11542066931724548)","('Human_Rights_And_Community_Relations', 0.08692781627178192)","('NON-ESG', 0.12301939725875854)","('NON-ESG', 0.11542066931724548)","('NON-ESG', 0.08692781627178192)"
Line 140,"Team Member Engagement Through the implementation of a comprehensive  engagement strategy, we are engaging team members  frequently for a more holistic view of the team member  experience as we strive to be a Best and Preferred Place  to Work.
","('Employee_Engagement_Inclusion_And_Diversity', 0.26289793848991394)","('Human_Rights_And_Community_Relations', 0.22834201157093048)","('Employee_Health_And_Safety', 0.11631647497415543)","('NON-ESG', 0.26289793848991394)","('NON-ESG', 0.22834201157093048)","('NON-ESG', 0.11631647497415543)"
Line 141,"We use the valuable insights gained through our annual  team member engagement survey, frequent “pulse  checks”, and onboarding and exit surveys to inform our  priorities and improve our team members’ experience.
","('Employee_Engagement_Inclusion_And_Diversity', 0.23776662349700928)","('Human_Rights_And_Community_Relations', 0.1760871857404709)","('Director_Removal', 0.10103320330381393)","('NON-ESG', 0.23776662349700928)","('NON-ESG', 0.1760871857404709)","('NON-ESG', 0.10103320330381393)"
Line 142,"Our surveys assess five key drivers of engagement,  including purpose, culture, leadership, personal growth  and belonging.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7374624013900757)","('Human_Rights_And_Community_Relations', 0.08703674376010895)","('Business_Model_Resilience', 0.028446678072214127)","(['Human Capital Development'], 0.7374624013900757)","('NON-ESG', 0.08703674376010895)","('NON-ESG', 0.028446678072214127)"
Line 143,"In 2021, we implemented quarterly performance check- ins between managers and team members, creating  opportunities to align on priorities and report progress on key milestones.
","('Business_Model_Resilience', 0.25777292251586914)","('Human_Rights_And_Community_Relations', 0.18289366364479065)","('Systemic_Risk_Management', 0.12825457751750946)","('NON-ESG', 0.25777292251586914)","('NON-ESG', 0.18289366364479065)","('NON-ESG', 0.12825457751750946)"
Line 144,"Managers are also encouraged to  provide coaching and feedback during these valuable  conversations.
","('Employee_Engagement_Inclusion_And_Diversity', 0.22569943964481354)","('Human_Rights_And_Community_Relations', 0.1979377567768097)","('Access_And_Affordability', 0.07855162769556046)","('NON-ESG', 0.22569943964481354)","('NON-ESG', 0.1979377567768097)","('NON-ESG', 0.07855162769556046)"
Line 145,"As a result, team members reported  significant improvement in engagement with their  managers.
","('Human_Rights_And_Community_Relations', 0.18127121031284332)","('Employee_Engagement_Inclusion_And_Diversity', 0.14771859347820282)","('Director_Removal', 0.1268056482076645)","('NON-ESG', 0.18127121031284332)","('NON-ESG', 0.14771859347820282)","('NON-ESG', 0.1268056482076645)"
Line 146,"In response to our company-wide 2020  engagement survey results, we implemented a  global, social recognition platform.
","('Human_Rights_And_Community_Relations', 0.7582367062568665)","('Employee_Engagement_Inclusion_And_Diversity', 0.04566141590476036)","('Business_Model_Resilience', 0.041768573224544525)","(['Community Relations'], 0.7582367062568665)","('NON-ESG', 0.04566141590476036)","('NON-ESG', 0.041768573224544525)"
Line 147,"As a result, team  members also reported improved satisfaction with the  recognition they receive for their work.
","('Human_Rights_And_Community_Relations', 0.22539663314819336)","('Employee_Health_And_Safety', 0.1705659031867981)","('Employee_Engagement_Inclusion_And_Diversity', 0.07079851627349854)","('NON-ESG', 0.22539663314819336)","('NON-ESG', 0.1705659031867981)","('NON-ESG', 0.07079851627349854)"
Line 148,"As the COVID-19 pandemic continues, team members  reported the need to do even more to nurture well- being and deliver transparent communication, both of  which have been prioritized by our leadership team and  included in our 2022 action plans.
","('Human_Rights_And_Community_Relations', 0.6061499118804932)","('Access_And_Affordability', 0.07459323108196259)","('Employee_Health_And_Safety', 0.0419284962117672)","(['Community Relations'], 0.6061499118804932)","('NON-ESG', 0.07459323108196259)","('NON-ESG', 0.0419284962117672)"
Line 149,"We believe it is critically important to keep our team  members engaged through frequent and transparent  communication.
","('Business_Ethics', 0.6103562712669373)","('Director_Removal', 0.05892006680369377)","('Human_Rights_And_Community_Relations', 0.05439514294266701)","(['Business Ethics'], 0.6103562712669373)","('NON-ESG', 0.05892006680369377)","('NON-ESG', 0.05439514294266701)"
Line 150,"This is accomplished through town  hall meetings, video and written messages and various  other channels.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5011321902275085)","('Human_Rights_And_Community_Relations', 0.11490113288164139)","('Director_Removal', 0.0632229596376419)","(['Corporate Governance'], 0.5011321902275085)","('NON-ESG', 0.11490113288164139)","('NON-ESG', 0.0632229596376419)"
Line 151,"To stay connected throughout the  COVID-19 pandemic, our Chief Executive Officer kept  team members informed of our priorities, financial  results, management response and team member  health and safety through frequent video messages  and written communications.
","('Employee_Health_And_Safety', 0.9605237245559692)","('Critical_Incident_Risk_Management', 0.013947216793894768)","('Product_Quality_And_Safety', 0.002173371845856309)","(['Operational Eco-Efficiency'], 0.9605237245559692)","('NON-ESG', 0.013947216793894768)","('NON-ESG', 0.002173371845856309)"
Line 152,"Performance Management In 2021, we worked to further embed our new framework  and approach to performance management, which is  branded internally as “Performance Connections”.
","('Business_Model_Resilience', 0.28634190559387207)","('Systemic_Risk_Management', 0.2528642416000366)","('Competitive_Behavior', 0.07921749353408813)","('NON-ESG', 0.28634190559387207)","('NON-ESG', 0.2528642416000366)","('NON-ESG', 0.07921749353408813)"
Line 153,"In  addition to the quarterly check-ins mentioned above,  we formalized the mid-year Career Check-In through  which team members align opportunities to learn,  develop, and grow with their ambitions for the next  step(s) in their career.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8097636699676514)","('Business_Model_Resilience', 0.02433585375547409)","('Product_Design_And_Lifecycle_Management', 0.019274676218628883)","(['Human Capital Development'], 0.8097636699676514)","('NON-ESG', 0.02433585375547409)","('NON-ESG', 0.019274676218628883)"
Line 154,"As part of this, team members  create a talent profile that captures details of their  professional resume and document a career plan  that outlines next steps as a focal discussion point in  ongoing check-ins with their manager.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9230823516845703)","('Customer_Privacy', 0.008671225048601627)","('Employee_Health_And_Safety', 0.008136475458741188)","(['Human Capital Development'], 0.9230823516845703)","('NON-ESG', 0.008671225048601627)","('NON-ESG', 0.008136475458741188)"
Line 155,"SOCIAL Learning and Development  We support the learning and development needs of the  organization through a number of instructor/virtual training  courses.
","('Access_And_Affordability', 0.5625917911529541)","('Employee_Engagement_Inclusion_And_Diversity', 0.10005874186754227)","('Human_Rights_And_Community_Relations', 0.08008338510990143)","(['Health Outcome Contribution'], 0.5625917911529541)","('NON-ESG', 0.10005874186754227)","('NON-ESG', 0.08008338510990143)"
Line 156,"These include desktop application training (e.g.,  Excel, Word, PowerPoint), Coaching in the Moment, and  Insights Discovery.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3924942910671234)","('Business_Model_Resilience', 0.08098148554563522)","('Competitive_Behavior', 0.07504984736442566)","('NON-ESG', 0.3924942910671234)","('NON-ESG', 0.08098148554563522)","('NON-ESG', 0.07504984736442566)"
Line 157,"We continue to maintain, and take  on opportunities to improve, our Learning Management  System (LMS), branded internally as “iLearn”, which is the  primary delivery mechanism for Quality, Compliance, and  product-focused training that services 26,600 employees  and contractors, and houses over 34,000 courses globally.
","('Product_Quality_And_Safety', 0.33985430002212524)","('Employee_Engagement_Inclusion_And_Diversity', 0.09342654794454575)","('Access_And_Affordability', 0.09243093430995941)","('NON-ESG', 0.33985430002212524)","('NON-ESG', 0.09342654794454575)","('NON-ESG', 0.09243093430995941)"
Line 158,"Global Mentoring Program  We launched a pilot global mentoring program, Mentoring  Connections, to connect experienced Zimmer Biomet  professionals with team members who are eager to learn from  their experience.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3846668601036072)","('Access_And_Affordability', 0.20378480851650238)","('Human_Rights_And_Community_Relations', 0.06015189737081528)","('NON-ESG', 0.3846668601036072)","('NON-ESG', 0.20378480851650238)","('NON-ESG', 0.06015189737081528)"
Line 159,"We matched and trained mentor/mentee  pairs to embark on a six-month formal mentoring relationship.
","('Access_And_Affordability', 0.4427627921104431)","('Employee_Engagement_Inclusion_And_Diversity', 0.23370791971683502)","('Human_Rights_And_Community_Relations', 0.05313827469944954)","('NON-ESG', 0.4427627921104431)","('NON-ESG', 0.23370791971683502)","('NON-ESG', 0.05313827469944954)"
Line 160,"We will evaluate the experience and impact of the program for  pilot participants and plan to expand the program in 2022.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6462081074714661)","('Access_And_Affordability', 0.10138248652219772)","('Human_Rights_And_Community_Relations', 0.047165077179670334)","(['Corporate Governance'], 0.6462081074714661)","('NON-ESG', 0.10138248652219772)","('NON-ESG', 0.047165077179670334)"
Line 161,"Virtual Work Support  We launched virtual work global programming support  intended to help team members achieve success through  sustained remote work in response to the pandemic.
","('Critical_Incident_Risk_Management', 0.21936993300914764)","('Employee_Health_And_Safety', 0.19098536670207977)","('Access_And_Affordability', 0.11290425062179565)","('NON-ESG', 0.21936993300914764)","('NON-ESG', 0.19098536670207977)","('NON-ESG', 0.11290425062179565)"
Line 162,"This includes the creation of job aids and resources that  help team members and managers focus on building and  sustaining connections in the absence of regular, in-person  contact.
","('Employee_Health_And_Safety', 0.35071468353271484)","('Employee_Engagement_Inclusion_And_Diversity', 0.24390766024589539)","('Human_Rights_And_Community_Relations', 0.12323906272649765)","('NON-ESG', 0.35071468353271484)","('NON-ESG', 0.24390766024589539)","('NON-ESG', 0.12323906272649765)"
Line 163,"We also produced and shared four “fireside chats”  featuring our leadership team members sharing their  experiences and actionable tips of leading and working  virtually.
","('Human_Rights_And_Community_Relations', 0.4445071816444397)","('Employee_Engagement_Inclusion_And_Diversity', 0.09317117929458618)","('Business_Model_Resilience', 0.08956097066402435)","('NON-ESG', 0.4445071816444397)","('NON-ESG', 0.09317117929458618)","('NON-ESG', 0.08956097066402435)"
Line 164,"Chat topics focused on well-being, recognition,  mentoring, and accountability and engagement.
","('Human_Rights_And_Community_Relations', 0.8001123070716858)","('Access_And_Affordability', 0.07027500867843628)","('Employee_Engagement_Inclusion_And_Diversity', 0.021757936105132103)","(['Community Relations'], 0.8001123070716858)","('NON-ESG', 0.07027500867843628)","('NON-ESG', 0.021757936105132103)"
Line 165,"Team Member Recognition In 2021 we launched a new global, social recognition  platform, IGNITE, to recognize team members for the  remarkable work they do every day.
","('Employee_Health_And_Safety', 0.24750620126724243)","('Employee_Engagement_Inclusion_And_Diversity', 0.17879272997379303)","('Human_Rights_And_Community_Relations', 0.12214736640453339)","('NON-ESG', 0.24750620126724243)","('NON-ESG', 0.17879272997379303)","('NON-ESG', 0.12214736640453339)"
Line 166,"With a mobile app, team  members can give recognition to others from anywhere, at  any time.
","('Employee_Engagement_Inclusion_And_Diversity', 0.233770489692688)","('Employee_Health_And_Safety', 0.08774914592504501)","('Director_Removal', 0.07571560889482498)","('NON-ESG', 0.233770489692688)","('NON-ESG', 0.08774914592504501)","('NON-ESG', 0.07571560889482498)"
Line 167,"Talent Acquisition As part of our commitment to diversity, the Talent  Acquisition team partnered with our Employee Resource  Groups (ERGs), hiring managers and executive sponsors  to enhance our talent pools by engaging with new national  and campus partnerships.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9740918278694153)","('Employee_Health_And_Safety', 0.0024915493559092283)","('Business_Model_Resilience', 0.0017308410024270415)","(['Human Capital Development'], 0.9740918278694153)","('NON-ESG', 0.0024915493559092283)","('NON-ESG', 0.0017308410024270415)"
Line 168,"In 2021, Zimmer Biomet invested in our ERGs and diversity  recruitment programs with newly formed partnerships  with the following: Howard University, National Society of  Black Engineers, National Association of Asian American  Professionals, myGworks, FairyGodBoss, Hire Our Heroes,  National Sales Network, Girls Who Code, National Football  League, and Hispanic Alliance for Career Enhancement.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9740549325942993)","('Employee_Health_And_Safety', 0.002382695907726884)","('Business_Model_Resilience', 0.0014945381553843617)","(['Human Capital Development'], 0.9740549325942993)","('NON-ESG', 0.002382695907726884)","('NON-ESG', 0.0014945381553843617)"
Line 169,"Additionally, INROADS and Howard University were named  Zimmer Biomet’s campus and national partners for early  career diverse talent in 2021 in the United States.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9519466161727905)","('Employee_Health_And_Safety', 0.004811161197721958)","('Business_Model_Resilience', 0.003387593664228916)","(['Human Capital Development'], 0.9519466161727905)","('NON-ESG', 0.004811161197721958)","('NON-ESG', 0.003387593664228916)"
Line 170,"Early Career / Development Rotational  Programs In 2021, Zimmer Biomet sustained and enhanced our early  career talent programming in locations across the U.S.,  including full-time rotational development programs in  Finance and Quality.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9266695976257324)","('Employee_Health_And_Safety', 0.00774183077737689)","('Business_Model_Resilience', 0.005504894535988569)","(['Human Capital Development'], 0.9266695976257324)","('NON-ESG', 0.00774183077737689)","('NON-ESG', 0.005504894535988569)"
Line 171,"Enhancements include partnering  our early career hires with mentors from our global ERGs,  hosting professional development and socialization events.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6187227368354797)","('Access_And_Affordability', 0.12125515192747116)","('Product_Quality_And_Safety', 0.029580937698483467)","(['Human Capital Development'], 0.6187227368354797)","('NON-ESG', 0.12125515192747116)","('NON-ESG', 0.029580937698483467)"
Line 172,"In the United States, Zimmer Biomet’s robust finance  summer intern program is a direct pipeline for our full-time  Finance Development Program (FDP .) Approximately 60%  of our finance summer interns leave their internship with a  full-time job offer, which includes a competitive salary, sign- on bonus, and full benefits.
","('Employee_Engagement_Inclusion_And_Diversity', 0.4369548559188843)","('Labor_Practices', 0.3598712086677551)","('Employee_Health_And_Safety', 0.028644099831581116)","('NON-ESG', 0.4369548559188843)","('NON-ESG', 0.3598712086677551)","('NON-ESG', 0.028644099831581116)"
Line 173,"Our full-time rotational development programs are a  launch pad for college graduates.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6021298170089722)","('Access_And_Affordability', 0.14088143408298492)","('Labor_Practices', 0.025186719372868538)","(['Human Capital Development'], 0.6021298170089722)","('NON-ESG', 0.14088143408298492)","('NON-ESG', 0.025186719372868538)"
Line 174,"Participants rotate  across 3-4 areas of the global business for a diverse view  of their function and its processes, and at the conclusion  of their two-year program, participants “graduate” and are  promoted to next-level roles, which is on an accelerated  time schedule in comparison to peers with the same years  of experience.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7422259449958801)","('Business_Model_Resilience', 0.049024466425180435)","('Director_Removal', 0.02794802002608776)","(['Human Capital Development'], 0.7422259449958801)","('NON-ESG', 0.049024466425180435)","('NON-ESG', 0.02794802002608776)"
Line 175,"Global Benefits  Zimmer Biomet reviews our benefits each plan year,  considering both our team member population as well  as market benefit practices so we are competitive in our  offerings.
","('Competitive_Behavior', 0.9392045736312866)","('Systemic_Risk_Management', 0.00874580442905426)","('Customer_Welfare', 0.006021806970238686)","(['Business Ethics'], 0.9392045736312866)","('NON-ESG', 0.00874580442905426)","('NON-ESG', 0.006021806970238686)"
Line 176,"We understand how critical well-being is for our team  members and their families.
","('Human_Rights_And_Community_Relations', 0.5145270824432373)","('Access_And_Affordability', 0.15570387244224548)","('Employee_Health_And_Safety', 0.15310223400592804)","(['Community Relations'], 0.5145270824432373)","('NON-ESG', 0.15570387244224548)","('NON-ESG', 0.15310223400592804)"
Line 177,"Globally, initiatives are in  place or being implemented to provide health-promoting  activities that support sustainable behaviors among team  members, reducing physical and mental health risks,  improving the quality of life, and enhancing personal  effectiveness at work.
","('Employee_Health_And_Safety', 0.9764610528945923)","('Employee_Engagement_Inclusion_And_Diversity', 0.002487101359292865)","('Product_Design_And_Lifecycle_Management', 0.002342640422284603)","(['Operational Eco-Efficiency'], 0.9764610528945923)","('NON-ESG', 0.002487101359292865)","('NON-ESG', 0.002342640422284603)"
Line 178,"Also, in recent years, we have focused  on key areas for women, family and individual health.
","('Access_And_Affordability', 0.46568363904953003)","('Employee_Health_And_Safety', 0.17994968593120575)","('Human_Rights_And_Community_Relations', 0.14159592986106873)","('NON-ESG', 0.46568363904953003)","('NON-ESG', 0.17994968593120575)","('NON-ESG', 0.14159592986106873)"
Line 179,"Below are key areas in the U.S. where we continue to assess  and adjust as needed to support our team members.
","('Business_Model_Resilience', 0.4512788653373718)","('Employee_Engagement_Inclusion_And_Diversity', 0.08838968724012375)","('Systemic_Risk_Management', 0.06532786786556244)","('NON-ESG', 0.4512788653373718)","('NON-ESG', 0.08838968724012375)","('NON-ESG', 0.06532786786556244)"
Line 180,"• We continue to offer key preventative services and for  mothers, we provide opportunities to help support and  transition back to the workforce.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5626656413078308)","('Access_And_Affordability', 0.20851917564868927)","('Employee_Health_And_Safety', 0.04201642423868179)","(['Human Capital Development'], 0.5626656413078308)","('NON-ESG', 0.20851917564868927)","('NON-ESG', 0.04201642423868179)"
Line 181,"• We increased Infertility benefits and the number of  Parental Leave days while continuing to provide child  care discounts at multiple day care facilities.
","('Access_And_Affordability', 0.6561281681060791)","('Employee_Health_And_Safety', 0.059763357043266296)","('Employee_Engagement_Inclusion_And_Diversity', 0.05106645077466965)","(['Health Outcome Contribution'], 0.6561281681060791)","('NON-ESG', 0.059763357043266296)","('NON-ESG', 0.05106645077466965)"
Line 182,"• We understand our team members have individualized  needs and we offer programs to support them, such as  global employee assistance programs (EAP) counseling  and also benefits such as transgender surgery/medical  benefits.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7974455952644348)","('Employee_Health_And_Safety', 0.07019046694040298)","('Access_And_Affordability', 0.03091769851744175)","(['Human Capital Development'], 0.7974455952644348)","('NON-ESG', 0.07019046694040298)","('NON-ESG', 0.03091769851744175)"
Line 183,"Diversity, Equity & Inclusion Zimmer Biomet remains committed to creating, supporting  and celebrating diverse and equal workplaces and  communities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9747903347015381)","('Human_Rights_And_Community_Relations', 0.002327508293092251)","('Employee_Health_And_Safety', 0.0021158279851078987)","(['Human Capital Development'], 0.9747903347015381)","('NON-ESG', 0.002327508293092251)","('NON-ESG', 0.0021158279851078987)"
Line 184,"We continue to foster and embrace diversity  and inclusion within our team and our communities, and  commit our voices and our resources to community groups,  business platforms and other organizations united to  driving meaningful change and sustained improvement.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9715942740440369)","('Human_Rights_And_Community_Relations', 0.003346809186041355)","('Employee_Health_And_Safety', 0.002091627102345228)","(['Human Capital Development'], 0.9715942740440369)","('NON-ESG', 0.003346809186041355)","('NON-ESG', 0.002091627102345228)"
Line 185,"We believe that representation matters.
","('Business_Ethics', 0.3167177140712738)","('Management_Of_Legal_And_Regulatory_Framework', 0.22409452497959137)","('Competitive_Behavior', 0.14078086614608765)","('NON-ESG', 0.3167177140712738)","('NON-ESG', 0.22409452497959137)","('NON-ESG', 0.14078086614608765)"
Line 186,"As of December  31, 2021, women made up 35.1% of our total employee  population, and 25.1% of positions at Director level and  above.
","('Employee_Engagement_Inclusion_And_Diversity', 0.4009426236152649)","('Labor_Practices', 0.39486071467399597)","('Director_Removal', 0.04254307597875595)","('NON-ESG', 0.4009426236152649)","('NON-ESG', 0.39486071467399597)","('NON-ESG', 0.04254307597875595)"
Line 187,"People of Color (POC) made up 22.1% of our total  employee population in the U.S., and comprised 15.2% of  positions at Director level and above.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9693915843963623)","('Labor_Practices', 0.002935288706794381)","('Employee_Health_And_Safety', 0.0025928595568984747)","(['Human Capital Development'], 0.9693915843963623)","('NON-ESG', 0.002935288706794381)","('NON-ESG', 0.0025928595568984747)"
Line 188,"We have established  2026 representation goals for women and POC in the  organization, guided by internal and external benchmarks.
","('Employee_Engagement_Inclusion_And_Diversity', 0.927169919013977)","('Labor_Practices', 0.010161238722503185)","('Competitive_Behavior', 0.009421654976904392)","(['Human Capital Development'], 0.927169919013977)","('NON-ESG', 0.010161238722503185)","('NON-ESG', 0.009421654976904392)"
Line 189,"Core to Zimmer Biomet’s values is our commitment to  stand together against hatred, discrimination and injustice,  and we advance these values through our actions and  investments.
","('Employee_Engagement_Inclusion_And_Diversity', 0.28631195425987244)","('Business_Ethics', 0.20567111670970917)","('Human_Rights_And_Community_Relations', 0.1788514405488968)","('NON-ESG', 0.28631195425987244)","('NON-ESG', 0.20567111670970917)","('NON-ESG', 0.1788514405488968)"
Line 190,"With this in mind, we have committed to the  following initiatives to drive and accelerate change within  our own organization and around the globe.
","('Human_Rights_And_Community_Relations', 0.37223580479621887)","('Business_Model_Resilience', 0.17556269466876984)","('Physical_Impacts_Of_Climate_Change', 0.07883785665035248)","('NON-ESG', 0.37223580479621887)","('NON-ESG', 0.17556269466876984)","('NON-ESG', 0.07883785665035248)"
Line 191,"We have  shared these commitments publicly and are tracking our  progress against them:    • Engage our more than 20,000 global team members in  cultural awareness and inclusion programming.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9277627468109131)","('Human_Rights_And_Community_Relations', 0.0163735244423151)","('Access_And_Affordability', 0.0075308047235012054)","(['Human Capital Development'], 0.9277627468109131)","('NON-ESG', 0.0163735244423151)","('NON-ESG', 0.0075308047235012054)"
Line 192,"• Invest $1 million and provide executive sponsorship to  support ongoing programs and elevate the impact of  our ERGs. • Commit at least $5 million over five years through the  Zimmer Biomet Foundation to nonprofit organizations  globally dedicated to combating racism and supporting  diversity, equality and justice.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9668335914611816)","('Human_Rights_And_Community_Relations', 0.003503151936456561)","('Employee_Health_And_Safety', 0.002850460819900036)","(['Human Capital Development'], 0.9668335914611816)","('NON-ESG', 0.003503151936456561)","('NON-ESG', 0.002850460819900036)"
Line 193,"The Zimmer Biomet  Foundation is an independent, nonprofit organization  established in 2018 to address the needs of our global  community.
","('Access_And_Affordability', 0.40406888723373413)","('Human_Rights_And_Community_Relations', 0.31800025701522827)","('Employee_Engagement_Inclusion_And_Diversity', 0.04351223260164261)","('NON-ESG', 0.40406888723373413)","('NON-ESG', 0.31800025701522827)","('NON-ESG', 0.04351223260164261)"
Line 194,"You can read more about the Zimmer  Biomet Foundation below.
","('Competitive_Behavior', 0.2709445655345917)","('Customer_Welfare', 0.13256560266017914)","('Management_Of_Legal_And_Regulatory_Framework', 0.08132204413414001)","('NON-ESG', 0.2709445655345917)","('NON-ESG', 0.13256560266017914)","('NON-ESG', 0.08132204413414001)"
Line 195,"• Match, through the Zimmer Biomet Foundation,  employee financial contributions to nonprofit  organizations, including those dedicated to combating  racism and supporting diversity, equality and justice.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9736942648887634)","('Employee_Health_And_Safety', 0.002236238680779934)","('Human_Rights_And_Community_Relations', 0.0021433718502521515)","(['Human Capital Development'], 0.9736942648887634)","('NON-ESG', 0.002236238680779934)","('NON-ESG', 0.0021433718502521515)"
Line 196,"• Expand our student and early career internship  programs to attract and develop more Black leaders.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9334979057312012)","('Access_And_Affordability', 0.0071347979828715324)","('Employee_Health_And_Safety', 0.00593434926122427)","(['Human Capital Development'], 0.9334979057312012)","('NON-ESG', 0.0071347979828715324)","('NON-ESG', 0.00593434926122427)"
Line 197,"• Continue our financial support of Movement is Life, a  multidisciplinary coalition seeking to eliminate racial,  ethnic and gender disparities in muscle and joint  health.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9760103821754456)","('Human_Rights_And_Community_Relations', 0.0016760737635195255)","('Employee_Health_And_Safety', 0.001640807488001883)","(['Human Capital Development'], 0.9760103821754456)","('NON-ESG', 0.0016760737635195255)","('NON-ESG', 0.001640807488001883)"
Line 198,"Health, Safety & Wellness The physical and mental health, financial well-being  and work/life balance of our team members are vital to  accomplishing our Mission and achieving our goals.
","('Employee_Health_And_Safety', 0.9158965945243835)","('Employee_Engagement_Inclusion_And_Diversity', 0.01874118112027645)","('Product_Design_And_Lifecycle_Management', 0.008410223759710789)","(['Operational Eco-Efficiency'], 0.9158965945243835)","('NON-ESG', 0.01874118112027645)","('NON-ESG', 0.008410223759710789)"
Line 199,"We  sponsor wellness programs designed to enhance physical,  financial and mental well-being, and encourage participation  in these programs through regular communications,  educational sessions and other incentives.
","('Access_And_Affordability', 0.47358760237693787)","('Employee_Health_And_Safety', 0.24402768909931183)","('Employee_Engagement_Inclusion_And_Diversity', 0.05467771366238594)","('NON-ESG', 0.47358760237693787)","('NON-ESG', 0.24402768909931183)","('NON-ESG', 0.05467771366238594)"
Line 200,"We are also intensely focused on the health and safety of  our team members in the workplace.
","('Employee_Health_And_Safety', 0.9821738004684448)","('Employee_Engagement_Inclusion_And_Diversity', 0.0020850442815572023)","('Critical_Incident_Risk_Management', 0.0017347385874018073)","(['Operational Eco-Efficiency'], 0.9821738004684448)","('NON-ESG', 0.0020850442815572023)","('NON-ESG', 0.0017347385874018073)"
Line 201,"Our environmental,  health and safety team constantly monitors various metrics  to ensure we are providing the safest environment in which  to work.
","('Employee_Health_And_Safety', 0.9714034795761108)","('Critical_Incident_Risk_Management', 0.007959093898534775)","('Employee_Engagement_Inclusion_And_Diversity', 0.0018800058169290423)","(['Operational Eco-Efficiency'], 0.9714034795761108)","('NON-ESG', 0.007959093898534775)","('NON-ESG', 0.0018800058169290423)"
Line 202,"In 2021, our Total Recordable Incident Rate, which  is defined as recordable incidents multiplied by 200,000  hours worked divided by total hours worked, was 0.29 and  our Lost Time Incident Rate, which is defined as lost time  incidents multiplied by 200,000 hours worked divided by  total hours worked, was 0.14.
","('Employee_Health_And_Safety', 0.7958076000213623)","('Labor_Practices', 0.11138108372688293)","('Critical_Incident_Risk_Management', 0.009564907290041447)","(['Operational Eco-Efficiency'], 0.7958076000213623)","('NON-ESG', 0.11138108372688293)","('NON-ESG', 0.009564907290041447)"
Line 203,"Pay Equity We are committed to our pay equity process and we conduct  annual pay equity reviews.
","('Labor_Practices', 0.40891245007514954)","('Management_Of_Legal_And_Regulatory_Framework', 0.13851867616176605)","('Competitive_Behavior', 0.10616955906152725)","('NON-ESG', 0.40891245007514954)","('NON-ESG', 0.13851867616176605)","('NON-ESG', 0.10616955906152725)"
Line 204,"Our comprehensive pay equity  review covers pay, promotions and new hire practices.
","('Labor_Practices', 0.9652177691459656)","('Employee_Engagement_Inclusion_And_Diversity', 0.004876270890235901)","('Director_Removal', 0.003831258276477456)","(['Labor Practice Indicators'], 0.9652177691459656)","('NON-ESG', 0.004876270890235901)","('NON-ESG', 0.003831258276477456)"
Line 205,"This  includes various types of pay, such as base salary, bonus,  long-term incentives and new hire sign-on awards (cash or  equity).
","('Labor_Practices', 0.9662687182426453)","('Employee_Engagement_Inclusion_And_Diversity', 0.004439817275851965)","('Director_Removal', 0.002976522780954838)","(['Labor Practice Indicators'], 0.9662687182426453)","('NON-ESG', 0.004439817275851965)","('NON-ESG', 0.002976522780954838)"
Line 206,"Prior to 2019, the pay equity review was focused on gender  differences, with any identified pay issue also being  reviewed for ethnicity against similarly situated positions.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9435591697692871)","('Labor_Practices', 0.017575232312083244)","('Customer_Privacy', 0.0032263610046356916)","(['Human Capital Development'], 0.9435591697692871)","('NON-ESG', 0.017575232312083244)","('NON-ESG', 0.0032263610046356916)"
Line 207,"Starting in 2019, we further enhanced our analysis to review  pay differences by gender, age, ethnicity and location, and  in 2020 engaged a new external partner with increased  analytical capabilities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9740093946456909)","('Customer_Privacy', 0.002005957532674074)","('Employee_Health_And_Safety', 0.0017885291017591953)","(['Human Capital Development'], 0.9740093946456909)","('NON-ESG', 0.002005957532674074)","('NON-ESG', 0.0017885291017591953)"
Line 208,"Each year we assess our analysis  capabilities to identify areas of opportunity.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6190569400787354)","('Business_Model_Resilience', 0.08029966801404953)","('Human_Rights_And_Community_Relations', 0.05839354172348976)","(['Human Capital Development'], 0.6190569400787354)","('NON-ESG', 0.08029966801404953)","('NON-ESG', 0.05839354172348976)"
Line 209,"10Human Resources coordinates Zimmer Biomet’s process to  address any issues identified from the pay equity analysis.
","('Systemic_Risk_Management', 0.5043285489082336)","('Management_Of_Legal_And_Regulatory_Framework', 0.09915432333946228)","('Competitive_Behavior', 0.06532896310091019)","(['Risk & Crisis Management'], 0.5043285489082336)","('NON-ESG', 0.09915432333946228)","('NON-ESG', 0.06532896310091019)"
Line 210,"Individuals identified in the annual pay equity review  continue to have their annual progress monitored in order  to ensure that any pay issues are resolved.
","('Labor_Practices', 0.8623124957084656)","('Management_Of_Legal_And_Regulatory_Framework', 0.0404968224465847)","('Business_Ethics', 0.0190292838960886)","(['Labor Practice Indicators'], 0.8623124957084656)","('NON-ESG', 0.0404968224465847)","('NON-ESG', 0.0190292838960886)"
Line 211,"Collective Bargaining Zimmer Biomet has more than 20,000 active team members  globally, approximately 200 of whom are affiliated with a  U.S. collective bargaining agreement.
","('Labor_Practices', 0.971727192401886)","('Director_Removal', 0.002602987689897418)","('Supply_Chain_Management', 0.002150192391127348)","(['Labor Practice Indicators'], 0.971727192401886)","('NON-ESG', 0.002602987689897418)","('NON-ESG', 0.002150192391127348)"
Line 212,"Discrimination Policy Zimmer Biomet is an equal opportunity employer and is fully  committed to a policy of treating all of our team members  and job applicants equally.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9134399890899658)","('Labor_Practices', 0.022678717970848083)","('Employee_Health_And_Safety', 0.007839763537049294)","(['Human Capital Development'], 0.9134399890899658)","('NON-ESG', 0.022678717970848083)","('NON-ESG', 0.007839763537049294)"
Line 213,"We take all reasonable steps to employ, train and promote  team members on the basis of their experience, abilities and  qualifications without regard to race, color, ethnic origin,  nationality, national origin, religion or belief, sex, sexual  orientation, gender reassignment, age, marital or civil  partnership status or disability.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9734650254249573)","('Employee_Health_And_Safety', 0.0025475563015788794)","('Customer_Privacy', 0.0019828593358397484)","(['Human Capital Development'], 0.9734650254249573)","('NON-ESG', 0.0025475563015788794)","('NON-ESG', 0.0019828593358397484)"
Line 214,"We also take all reasonable steps to provide a work  environment in which all team members are treated with  respect and dignity and that is free of harassment based  upon an employee’s race, color, ethnic origin, nationality,  national origin, religion or belief, sex, sexual orientation,  gender reassignment, age, marital or civil partnership  status or disability.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9710611701011658)","('Employee_Health_And_Safety', 0.003992503974586725)","('Customer_Privacy', 0.0023604303132742643)","(['Human Capital Development'], 0.9710611701011658)","('NON-ESG', 0.003992503974586725)","('NON-ESG', 0.0023604303132742643)"
Line 215,"Zimmer Biomet does not condone any form of harassment,  whether engaged in by team members or by outside third  parties who do business with us.
","('Business_Ethics', 0.3854425251483917)","('Employee_Health_And_Safety', 0.15421780943870544)","('Labor_Practices', 0.09749139845371246)","('NON-ESG', 0.3854425251483917)","('NON-ESG', 0.15421780943870544)","('NON-ESG', 0.09749139845371246)"
Line 216,"Product Quality  Zimmer Biomet is committed to best-in-class product  quality and the robustness of our Quality Management  System.
","('Product_Design_And_Lifecycle_Management', 0.9129719138145447)","('Product_Quality_And_Safety', 0.03390052169561386)","('Customer_Welfare', 0.005166384857147932)","(['Product Stewardship'], 0.9129719138145447)","('NON-ESG', 0.03390052169561386)","('NON-ESG', 0.005166384857147932)"
Line 217,"Every site has a stringent internal quality audit  program.
","('Business_Ethics', 0.8289087414741516)","('Systemic_Risk_Management', 0.03516944497823715)","('Management_Of_Legal_And_Regulatory_Framework', 0.02675619348883629)","(['Business Ethics'], 0.8289087414741516)","('NON-ESG', 0.03516944497823715)","('NON-ESG', 0.02675619348883629)"
Line 218,"In addition, we have an independent corporate quality audit program and are audited periodically by  external regulatory bodies such as the U.S. Food and  Drug Administration (FDA) and other regulatory and  nongovernmental competent authorities around the world.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8634219765663147)","('Business_Ethics', 0.03351487219333649)","('Product_Quality_And_Safety', 0.02163407765328884)","(['Corporate Governance'], 0.8634219765663147)","('NON-ESG', 0.03351487219333649)","('NON-ESG', 0.02163407765328884)"
Line 219,"Our internal corporate audit and external audit results are  closely monitored and reported at regular management  review meetings, and we maintain a detailed set of key  performance indicators in the quality area.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3592919409275055)","('Business_Ethics', 0.3048943281173706)","('Systemic_Risk_Management', 0.14064383506774902)","('NON-ESG', 0.3592919409275055)","('NON-ESG', 0.3048943281173706)","('NON-ESG', 0.14064383506774902)"
Line 220,"In addition,  the Quality, Regulatory and Technology Committee of  the Board of Directors receives a comprehensive quality  presentation at each quarterly meeting.
","('Director_Removal', 0.6936649084091187)","('Management_Of_Legal_And_Regulatory_Framework', 0.09263178706169128)","('Business_Ethics', 0.030570661649107933)","(['Anti-Crime Policy & Measures'], 0.6936649084091187)","('NON-ESG', 0.09263178706169128)","('NON-ESG', 0.030570661649107933)"
Line 221,"We have multiple manufacturing sites proactively  participating in the Medical Device Innovation Consortium  (MDIC) and the FDA Case for Quality Voluntary Improvement  program.
","('Product_Quality_And_Safety', 0.2489098608493805)","('Product_Design_And_Lifecycle_Management', 0.1190384179353714)","('Competitive_Behavior', 0.10459806025028229)","('NON-ESG', 0.2489098608493805)","('NON-ESG', 0.1190384179353714)","('NON-ESG', 0.10459806025028229)"
Line 222,"For more information on this program, visit  www.fda.gov/medical-devices/quality-and-compliance- medical-devices/ case-quality Furthermore, we have a stringent supply chain monitoring  program inclusive of quality, delivery and cost measures.
","('Supply_Chain_Management', 0.9321997165679932)","('Product_Design_And_Lifecycle_Management', 0.008653877303004265)","('Labor_Practices', 0.005101421382278204)","(['Supply Chain Management'], 0.9321997165679932)","('NON-ESG', 0.008653877303004265)","('NON-ESG', 0.005101421382278204)"
Line 223,"In recent years, Zimmer Biomet has made substantial  progress on quality system enhancements and remediation  across our network.
","('Critical_Incident_Risk_Management', 0.30724793672561646)","('Employee_Health_And_Safety', 0.2606605291366577)","('Water_And_Wastewater_Management', 0.06849730759859085)","('NON-ESG', 0.30724793672561646)","('NON-ESG', 0.2606605291366577)","('NON-ESG', 0.06849730759859085)"
Line 224,"As of December 2021, we had one  pending FDA Warning Letter, which pertains to our Warsaw,  Indiana North Campus facility.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5468112826347351)","('Product_Quality_And_Safety', 0.0917237251996994)","('Competitive_Behavior', 0.06044233217835426)","(['Corporate Governance'], 0.5468112826347351)","('NON-ESG', 0.0917237251996994)","('NON-ESG', 0.06044233217835426)"
Line 225,"While the Warning Letter  at the Warsaw North facility remains active, following an  FDA re-inspection in 2020, the FDA classified the site as  Voluntary Action Indicated, or VAI.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7894867658615112)","('Product_Quality_And_Safety', 0.04224320873618126)","('GHG_Emissions', 0.02201925218105316)","(['Corporate Governance'], 0.7894867658615112)","('NON-ESG', 0.04224320873618126)","('NON-ESG', 0.02201925218105316)"
Line 226,"Zimmer Biomet (Warsaw  North Campus facility) is partnering with FDA and MDIC  as part of an industry pilot study (Accelerate Sustainable  Capability) to help improve product quality and safety,  enable compliance actions to be closed faster, and structure  systems for sustainable continuous improvement.
","('Product_Quality_And_Safety', 0.8830815553665161)","('Product_Design_And_Lifecycle_Management', 0.03708114102482796)","('Selling_Practices_And_Product_Labeling', 0.01149946078658104)","(['Product Quality & Recall Management'], 0.8830815553665161)","('NON-ESG', 0.03708114102482796)","('NON-ESG', 0.01149946078658104)"
Line 227,"The pilot  program leverages a maturity assessment program that  includes action plans with FDA reviews.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9215186238288879)","('Competitive_Behavior', 0.008710192516446114)","('GHG_Emissions', 0.007024869322776794)","(['Corporate Governance'], 0.9215186238288879)","('NON-ESG', 0.008710192516446114)","('NON-ESG', 0.007024869322776794)"
Line 228,"We have made significant investments in Quality  Management System remediation and upgrades over the  past four years.
","('Critical_Incident_Risk_Management', 0.13223393261432648)","('Product_Quality_And_Safety', 0.11735448241233826)","('Physical_Impacts_Of_Climate_Change', 0.09556527435779572)","('NON-ESG', 0.13223393261432648)","('NON-ESG', 0.11735448241233826)","('NON-ESG', 0.09556527435779572)"
Line 229,"While these enhancements continue, we are  very encouraged that these efforts have already resulted in  a significant reduction in FDA product recalls during that  time.
","('Product_Quality_And_Safety', 0.5427801609039307)","('Selling_Practices_And_Product_Labeling', 0.16756723821163177)","('Product_Design_And_Lifecycle_Management', 0.07967892289161682)","(['Product Quality & Recall Management'], 0.5427801609039307)","('NON-ESG', 0.16756723821163177)","('NON-ESG', 0.07967892289161682)"
Line 230,"In 2021, the FDA reportable recall total was 5, which  was a 75% improvement compared to 2020.
","('Product_Quality_And_Safety', 0.40984439849853516)","('Employee_Health_And_Safety', 0.1100965365767479)","('Critical_Incident_Risk_Management', 0.07785069942474365)","('NON-ESG', 0.40984439849853516)","('NON-ESG', 0.1100965365767479)","('NON-ESG', 0.07785069942474365)"
Line 231,"YearClass 1  RecallsClass 2  RecallsClass 3  RecallsForms  ReceivedWarning  Letters  Received 2016 1 40 1 3 2017 1 62 0 7 2018 1 48 0 3 2019 1 24 0 3 2020 0 21 0 1 2021 1 4 0 0 1112We are advancing automation in manufacturing, quality  systems and inspection and measurement methods such as  Manufacturing Execution System (MES), Design Controls  and Risk Management Software (The Vault), and InfinityQS.
","('Business_Ethics', 0.25685903429985046)","('Product_Quality_And_Safety', 0.19355617463588715)","('Critical_Incident_Risk_Management', 0.1326718032360077)","('NON-ESG', 0.25685903429985046)","('NON-ESG', 0.19355617463588715)","('NON-ESG', 0.1326718032360077)"
Line 232,"A Product Lifecycle Management tool, Windchill, is in the  midst of a global implementation to simplify regulatory  compliance while simultaneously increasing new product  speed to market.
","('Product_Design_And_Lifecycle_Management', 0.6565185189247131)","('Product_Quality_And_Safety', 0.12664583325386047)","('Management_Of_Legal_And_Regulatory_Framework', 0.05816570296883583)","(['Product Stewardship'], 0.6565185189247131)","('NON-ESG', 0.12664583325386047)","('NON-ESG', 0.05816570296883583)"
Line 233,"The global use of this tool will create an  ability for resources to work across the network seamlessly  and formulate a single approach to deliverable completion.
","('Systemic_Risk_Management', 0.1572221964597702)","('Business_Model_Resilience', 0.15098831057548523)","('Supply_Chain_Management', 0.11907533556222916)","('NON-ESG', 0.1572221964597702)","('NON-ESG', 0.15098831057548523)","('NON-ESG', 0.11907533556222916)"
Line 234,"In addition to the Quality Begins With Me  program launched  in 2020, an upgraded compliance hotline process was  launched across Zimmer Biomet in 2021 with a campaign  called “ If You See Something, Say Something ”.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5297427177429199)","('Product_Quality_And_Safety', 0.13127385079860687)","('Business_Ethics', 0.13047946989536285)","(['Corporate Governance'], 0.5297427177429199)","('NON-ESG', 0.13127385079860687)","('NON-ESG', 0.13047946989536285)"
Line 235,"Both the  program and the hotline help us continue to promote a  “blame free” culture where we drive appropriate behaviors,  empower team members to promote operational  excellence, and maintain focus on quality and compliance.
","('Business_Ethics', 0.49365946650505066)","('Management_Of_Legal_And_Regulatory_Framework', 0.18630197644233704)","('Product_Quality_And_Safety', 0.059417955577373505)","('NON-ESG', 0.49365946650505066)","('NON-ESG', 0.18630197644233704)","('NON-ESG', 0.059417955577373505)"
Line 236,"We have continued with Green Belt and Black Belt  certification programs so team members learn and apply  LEAN tools to reduce waste, drive out variation (by applying  Define, Measure, Analyze, Improve and Control problem- solving), and make data-driven decisions through proven  quality tools and statistical methods.
","('Waste_And_Hazardous_Materials_Management', 0.4678509533405304)","('Employee_Health_And_Safety', 0.125921368598938)","('Product_Quality_And_Safety', 0.1257695108652115)","('NON-ESG', 0.4678509533405304)","('NON-ESG', 0.125921368598938)","('NON-ESG', 0.1257695108652115)"
Line 237,"We are also working toward compliance and certification  with the European Union Medical Device Regulation  standards by 2024.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9263814091682434)","('Product_Quality_And_Safety', 0.016633300110697746)","('Competitive_Behavior', 0.004487266298383474)","(['Corporate Governance'], 0.9263814091682434)","('NON-ESG', 0.016633300110697746)","('NON-ESG', 0.004487266298383474)"
Line 238,"Supplier Code of Conduct  We are committed to achieving and maintaining the highest  standards of corporate integrity and ethical behavior, and  we expect our suppliers to conduct business with the same  high standards.
","('Business_Ethics', 0.8727146983146667)","('Labor_Practices', 0.022788310423493385)","('Supply_Chain_Management', 0.010729866102337837)","(['Business Ethics'], 0.8727146983146667)","('NON-ESG', 0.022788310423493385)","('NON-ESG', 0.010729866102337837)"
Line 239,"To establish guidelines for such standards,  Zimmer Biomet has instituted a Code of Supplier Conduct,  available at www.zimmerbiomet.com/content/dam/zimmer-biomet/ sourcing/Zimmer-Biomet-Supplier-Code-of-Conduct.pdf At a minimum, suppliers must conduct business in  accordance with all applicable country, state, and local  laws and regulations covering the jurisdictions in which  they operate, including, without limitation, laws relating  to employment, human rights, the environment, health  and safety and trade.
","('Supply_Chain_Management', 0.8936569690704346)","('Labor_Practices', 0.016648706048727036)","('Human_Rights_And_Community_Relations', 0.011930013075470924)","(['Supply Chain Management'], 0.8936569690704346)","('NON-ESG', 0.016648706048727036)","('NON-ESG', 0.011930013075470924)"
Line 240,"To establish guidelines for such standards,  Zimmer Biomet has instituted a Code of Supplier Conduct,  available at www.zimmerbiomet.com/content/dam/zimmer-biomet/ sourcing/Zimmer-Biomet-Supplier-Code-of-Conduct.pdf At a minimum, suppliers must conduct business in  accordance with all applicable country, state, and local  laws and regulations covering the jurisdictions in which  they operate, including, without limitation, laws relating  to employment, human rights, the environment, health  and safety and trade.
","('Management_Of_Legal_And_Regulatory_Framework', 0.11483896523714066)","('Competitive_Behavior', 0.11004437506198883)","('Business_Ethics', 0.07547919452190399)","('NON-ESG', 0.11483896523714066)","('NON-ESG', 0.11004437506198883)","('NON-ESG', 0.07547919452190399)"
Line 241,"Each supplier is to comply with  the commercial best practices of the supplier’s industry.
","('Supply_Chain_Management', 0.9304715991020203)","('Product_Design_And_Lifecycle_Management', 0.007563911844044924)","('Labor_Practices', 0.006466931197792292)","(['Supply Chain Management'], 0.9304715991020203)","('NON-ESG', 0.007563911844044924)","('NON-ESG', 0.006466931197792292)"
Line 242,"Zimmer Biomet reserves the right to decline to deal with  suppliers who do not comply with the law or our standards.We have also taken steps to ensure that slavery and human  trafficking is not taking place in our supply chains or any  parts of our business operations through the UK Modern  Slavery Act of 2015 and the California Transparency in  Supply Chains Act of 2010.
","('Supply_Chain_Management', 0.5639582872390747)","('Labor_Practices', 0.11709638684988022)","('Business_Ethics', 0.07108519971370697)","(['Supply Chain Management'], 0.5639582872390747)","('NON-ESG', 0.11709638684988022)","('NON-ESG', 0.07108519971370697)"
Line 243,"www.zimmerbiomet.com/content/dam/zb-corporate/en/ suppliers/global-and-nam/uk-modern-slavery-act-and- california-transparency-in-supply-chain-act-statement.pdf Supplier Social Responsibility Audits Zimmer Biomet conducts Social Responsibility audits  with all new suppliers in high risk regions and on existing  suppliers every three years.
","('Supply_Chain_Management', 0.9333685636520386)","('Labor_Practices', 0.006622955668717623)","('Systemic_Risk_Management', 0.006035991478711367)","(['Supply Chain Management'], 0.9333685636520386)","('NON-ESG', 0.006622955668717623)","('NON-ESG', 0.006035991478711367)"
Line 244,"The audit investigates child  labor; forced labor and human trafficking; disciplinary  practices; working hours and compensation; environmental  protection; health and safety; and management practices.
","('Labor_Practices', 0.9735592603683472)","('Employee_Health_And_Safety', 0.00305054965429008)","('Employee_Engagement_Inclusion_And_Diversity', 0.002219734713435173)","(['Labor Practice Indicators'], 0.9735592603683472)","('NON-ESG', 0.00305054965429008)","('NON-ESG', 0.002219734713435173)"
Line 245,"Forty-seven suppliers were audited in 2019 with no major  findings.
","('Supply_Chain_Management', 0.8499428629875183)","('Systemic_Risk_Management', 0.025088801980018616)","('Labor_Practices', 0.01035451702773571)","(['Supply Chain Management'], 0.8499428629875183)","('NON-ESG', 0.025088801980018616)","('NON-ESG', 0.01035451702773571)"
Line 246,"The next round of Social Responsibility audits will  occur in 2022 and focus on high-risk suppliers.
","('Supply_Chain_Management', 0.7407013773918152)","('Human_Rights_And_Community_Relations', 0.04523571580648422)","('Product_Design_And_Lifecycle_Management', 0.028120139613747597)","(['Supply Chain Management'], 0.7407013773918152)","('NON-ESG', 0.04523571580648422)","('NON-ESG', 0.028120139613747597)"
Line 247,"Supplier Diligence For all new proposed international suppliers, due diligence  investigations are conducted by the Zimmer Biomet  Compliance team to make sure the third party is not on  a blocked person list, a specially designated national  watchlist or otherwise a prohibited party.
","('Supply_Chain_Management', 0.8960497379302979)","('Labor_Practices', 0.014696726575493813)","('Systemic_Risk_Management', 0.009851617738604546)","(['Supply Chain Management'], 0.8960497379302979)","('NON-ESG', 0.014696726575493813)","('NON-ESG', 0.009851617738604546)"
Line 248,"This global due  diligence review starts at the front end of the request  process.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8712778091430664)","('Business_Ethics', 0.022366898134350777)","('Human_Rights_And_Community_Relations', 0.011008254252374172)","(['Corporate Governance'], 0.8712778091430664)","('NON-ESG', 0.022366898134350777)","('NON-ESG', 0.011008254252374172)"
Line 249,"Ongoing due diligence is conducted periodically  for existing suppliers.
","('Supply_Chain_Management', 0.8173843026161194)","('Management_Of_Legal_And_Regulatory_Framework', 0.02236150950193405)","('GHG_Emissions', 0.017310626804828644)","(['Supply Chain Management'], 0.8173843026161194)","('NON-ESG', 0.02236150950193405)","('NON-ESG', 0.017310626804828644)"
Line 250,"Supplier Quality Audits New and existing supplier audit plans are established based  on the applicable Quality Management System (QMS)  requirement for the product/service the supplier provides.
","('Supply_Chain_Management', 0.6137323975563049)","('Product_Design_And_Lifecycle_Management', 0.1998867392539978)","('Product_Quality_And_Safety', 0.036305706948041916)","(['Supply Chain Management'], 0.6137323975563049)","('NON-ESG', 0.1998867392539978)","('NON-ESG', 0.036305706948041916)"
Line 251,"The applicable QMS requirements are focused on FDA  and International Organization for Standardization (ISO)  standards.
","('Management_Of_Legal_And_Regulatory_Framework', 0.44628721475601196)","('Product_Quality_And_Safety', 0.2118382751941681)","('Competitive_Behavior', 0.03755159676074982)","('NON-ESG', 0.44628721475601196)","('NON-ESG', 0.2118382751941681)","('NON-ESG', 0.03755159676074982)"
Line 252,"These standards include FDA 21 CFR 820 and  ISO 13485.
","('Management_Of_Legal_And_Regulatory_Framework', 0.45296868681907654)","('Product_Quality_And_Safety', 0.27772772312164307)","('Competitive_Behavior', 0.03094753623008728)","('NON-ESG', 0.45296868681907654)","('NON-ESG', 0.27772772312164307)","('NON-ESG', 0.03094753623008728)"
Line 253,"Zimmer Biomet has three global documents detailing the  process: (i) the Supplier Questionnaire is used to collect  a variety of information on the supplier, including an  overview of the supplier’s quality system; (ii) the Supplier  Qualification Report determines which audit plan will be  followed and the supplier’s risk classification; and (iii) the  Supplier Audit Report details the information found during  the audit and the attendees.13All information gathered from the auditing process is stored  in a global system and accessible to all Zimmer Biomet  businesses.
","('Supply_Chain_Management', 0.9182721376419067)","('Labor_Practices', 0.009225195273756981)","('Systemic_Risk_Management', 0.007907821796834469)","(['Supply Chain Management'], 0.9182721376419067)","('NON-ESG', 0.009225195273756981)","('NON-ESG', 0.007907821796834469)"
Line 254,"Zimmer Biomet has three global documents detailing the  process: (i) the Supplier Questionnaire is used to collect  a variety of information on the supplier, including an  overview of the supplier’s quality system; (ii) the Supplier  Qualification Report determines which audit plan will be  followed and the supplier’s risk classification; and (iii) the  Supplier Audit Report details the information found during  the audit and the attendees.13All information gathered from the auditing process is stored  in a global system and accessible to all Zimmer Biomet  businesses.
","('Access_And_Affordability', 0.3304372727870941)","('Management_Of_Legal_And_Regulatory_Framework', 0.14725275337696075)","('Data_Security', 0.06129337474703789)","('NON-ESG', 0.3304372727870941)","('NON-ESG', 0.14725275337696075)","('NON-ESG', 0.06129337474703789)"
Line 255,"Supplier Diversity Policy We believe that a diverse supply chain strengthens our ability  to carry out our Mission and improve the communities in  which we live and work.
","('Supply_Chain_Management', 0.687598466873169)","('Employee_Engagement_Inclusion_And_Diversity', 0.08887789398431778)","('Labor_Practices', 0.05097063258290291)","(['Supply Chain Management'], 0.687598466873169)","('NON-ESG', 0.08887789398431778)","('NON-ESG', 0.05097063258290291)"
Line 256,"Zimmer Biomet’s Supplier Diversity  Policy in the United States assists in establishing and  maintaining business relationships with suppliers that are  either certified in diverse categories by the Small Business  Administration or self-certified where applicable.
","('Supply_Chain_Management', 0.5668598413467407)","('Employee_Engagement_Inclusion_And_Diversity', 0.1532898247241974)","('Labor_Practices', 0.045135147869586945)","(['Supply Chain Management'], 0.5668598413467407)","('NON-ESG', 0.1532898247241974)","('NON-ESG', 0.045135147869586945)"
Line 257,"We assign a Small Business Liaison Officer (SBLO) as an  administrator for the Supplier Diversity Program.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9014104604721069)","('Access_And_Affordability', 0.009517813101410866)","('Labor_Practices', 0.00919308327138424)","(['Human Capital Development'], 0.9014104604721069)","('NON-ESG', 0.009517813101410866)","('NON-ESG', 0.00919308327138424)"
Line 258,"The SBLO  assures that reports documenting procurement levels,  broken down by supplier classification, are prepared as  requested by government agencies and contract groups.
","('Supply_Chain_Management', 0.9399700164794922)","('Labor_Practices', 0.00696942675858736)","('Product_Design_And_Lifecycle_Management', 0.0050484840758144855)","(['Supply Chain Management'], 0.9399700164794922)","('NON-ESG', 0.00696942675858736)","('NON-ESG', 0.0050484840758144855)"
Line 259,"Annual Summary Subcontract Reports and Year End  Supplementary Small Disadvantaged Business (SDB)  Reports are submitted according to the Department of  Defense.
","('Management_Of_Legal_And_Regulatory_Framework', 0.799704372882843)","('Systemic_Risk_Management', 0.03670260310173035)","('Director_Removal', 0.019802452996373177)","(['Corporate Governance'], 0.799704372882843)","('NON-ESG', 0.03670260310173035)","('NON-ESG', 0.019802452996373177)"
Line 260,"Zimmer Biomet’s diversity reporting obligations to the  U.S. Federal Government include spending in the United  States and Puerto Rico in the following six diverse supplier  categories annually: 1.
","('Supply_Chain_Management', 0.9173977375030518)","('Product_Design_And_Lifecycle_Management', 0.010566717945039272)","('Customer_Welfare', 0.00622051116079092)","(['Supply Chain Management'], 0.9173977375030518)","('NON-ESG', 0.010566717945039272)","('NON-ESG', 0.00622051116079092)"
Line 261,"Historically Underutilized Business Zone Small  Business (HUBZone)  2.
","('Business_Model_Resilience', 0.27937445044517517)","('Systemic_Risk_Management', 0.26250702142715454)","('Supply_Chain_Management', 0.11633702367544174)","('NON-ESG', 0.27937445044517517)","('NON-ESG', 0.26250702142715454)","('NON-ESG', 0.11633702367544174)"
Line 262,"Service-Disabled Veteran-Owned Small Business  (SDVOSB)  3.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8647586107254028)","('Employee_Health_And_Safety', 0.029805142432451248)","('Labor_Practices', 0.014402681961655617)","(['Human Capital Development'], 0.8647586107254028)","('NON-ESG', 0.029805142432451248)","('NON-ESG', 0.014402681961655617)"
Line 263,"Small Business (SB)  4.
","('Systemic_Risk_Management', 0.43569236993789673)","('Business_Model_Resilience', 0.1649651974439621)","('Competitive_Behavior', 0.06785938143730164)","('NON-ESG', 0.43569236993789673)","('NON-ESG', 0.1649651974439621)","('NON-ESG', 0.06785938143730164)"
Line 264,"Small Disadvantaged Business (SDB)  5.
","('Human_Rights_And_Community_Relations', 0.24315908551216125)","('Access_And_Affordability', 0.22182758152484894)","('Employee_Engagement_Inclusion_And_Diversity', 0.1828286051750183)","('NON-ESG', 0.24315908551216125)","('NON-ESG', 0.22182758152484894)","('NON-ESG', 0.1828286051750183)"
Line 265,"Veteran-Owned Small Business (VOSB)  6.
","('Supply_Chain_Management', 0.22179405391216278)","('Business_Model_Resilience', 0.1294419765472412)","('Systemic_Risk_Management', 0.12202490121126175)","('NON-ESG', 0.22179405391216278)","('NON-ESG', 0.1294419765472412)","('NON-ESG', 0.12202490121126175)"
Line 266,"Women-Owned Small Business (WOSB)   Management of Risks Associated   with Use of Critical Materials   Zimmer Biomet has a Global Supply Risk Management  process.
","('Supply_Chain_Management', 0.9021927714347839)","('Waste_And_Hazardous_Materials_Management', 0.018238626420497894)","('Product_Design_And_Lifecycle_Management', 0.011478432454168797)","(['Supply Chain Management'], 0.9021927714347839)","('NON-ESG', 0.018238626420497894)","('NON-ESG', 0.011478432454168797)"
Line 267,"We have established a systematic approach to: • Ensure continuity of supply for goods and services • Proactively manage (identify, assess, mitigate and  monitor) potential supply risks which may result in  product delays and/or revenue impact to the business • Ensure that a global process is being utilized across the  Zimmer Biomet Global Sourcing OrganizationA key component in risk monitoring is the financial impacts  that might occur in raw material scarcity and/or physical  disruptions of Zimmer Biomet’s own operations or in the  operations of our supply chain.
","('Supply_Chain_Management', 0.9269806146621704)","('Product_Design_And_Lifecycle_Management', 0.016605651006102562)","('Systemic_Risk_Management', 0.00479794992133975)","(['Supply Chain Management'], 0.9269806146621704)","('NON-ESG', 0.016605651006102562)","('NON-ESG', 0.00479794992133975)"
Line 268,"We have established a systematic approach to: • Ensure continuity of supply for goods and services • Proactively manage (identify, assess, mitigate and  monitor) potential supply risks which may result in  product delays and/or revenue impact to the business • Ensure that a global process is being utilized across the  Zimmer Biomet Global Sourcing OrganizationA key component in risk monitoring is the financial impacts  that might occur in raw material scarcity and/or physical  disruptions of Zimmer Biomet’s own operations or in the  operations of our supply chain.
","('Supply_Chain_Management', 0.9419716596603394)","('Labor_Practices', 0.004957206547260284)","('Physical_Impacts_Of_Climate_Change', 0.004446292761713266)","(['Supply Chain Management'], 0.9419716596603394)","('NON-ESG', 0.004957206547260284)","('NON-ESG', 0.004446292761713266)"
Line 269,"To mitigate these risks,  Zimmer Biomet uses a third party to rank our top suppliers  against 73 financial ratios on a scale of 1-100 to understand  the overall financial health of these suppliers.
","('Supply_Chain_Management', 0.9472306370735168)","('Systemic_Risk_Management', 0.004475492984056473)","('Physical_Impacts_Of_Climate_Change', 0.004232489503920078)","(['Supply Chain Management'], 0.9472306370735168)","('NON-ESG', 0.004475492984056473)","('NON-ESG', 0.004232489503920078)"
Line 270,"It is considered  to have substantive strategic impact on Zimmer Biomet’s  business if suppliers score below a 20 in this rating.
","('Supply_Chain_Management', 0.846778929233551)","('Product_Design_And_Lifecycle_Management', 0.038610298186540604)","('Business_Model_Resilience', 0.03486322984099388)","(['Supply Chain Management'], 0.846778929233551)","('NON-ESG', 0.038610298186540604)","('NON-ESG', 0.03486322984099388)"
Line 271,"Through a third-party vendor, we obtain international  private company financial statements and have a greater  than 85% success rate (and above 90% in certain markets)  to measure the core health of a supplier out to 36 months,  and predicting probability of default over 12 to 18 months  via a quantitative model to generate a rating.
","('Systemic_Risk_Management', 0.9028456807136536)","('Supply_Chain_Management', 0.03842339292168617)","('Business_Model_Resilience', 0.007241290528327227)","(['Risk & Crisis Management'], 0.9028456807136536)","('NON-ESG', 0.03842339292168617)","('NON-ESG', 0.007241290528327227)"
Line 272,"Animal Testing Policy Zimmer Biomet’s use of animal testing is consistent with  animal welfare acts around the world.
","('Management_Of_Legal_And_Regulatory_Framework', 0.23632682859897614)","('Product_Quality_And_Safety', 0.13834580779075623)","('Business_Ethics', 0.07998890429735184)","('NON-ESG', 0.23632682859897614)","('NON-ESG', 0.13834580779075623)","('NON-ESG', 0.07998890429735184)"
Line 273,"We use animal  testing when required to demonstrate biological safety for  our products that cannot be demonstrated by laboratory  benchtop tests or when required to demonstrate  compliance with medical device regulations.
","('Product_Quality_And_Safety', 0.9017736911773682)","('Selling_Practices_And_Product_Labeling', 0.015319474041461945)","('Product_Design_And_Lifecycle_Management', 0.008624217472970486)","(['Product Quality & Recall Management'], 0.9017736911773682)","('NON-ESG', 0.015319474041461945)","('NON-ESG', 0.008624217472970486)"
Line 274,"The laboratories that Zimmer Biomet engages for animal  testing typically have American Association for Accreditation  of Laboratory Animal Care (AAALAC) certification or have  their own animal research committee (i.e., an independent  review committee) to ensure compliance with national  animal welfare acts.
","('Management_Of_Legal_And_Regulatory_Framework', 0.12763682007789612)","('Product_Quality_And_Safety', 0.11731372028589249)","('Ecological_Impacts', 0.09155674278736115)","('NON-ESG', 0.12763682007789612)","('NON-ESG', 0.11731372028589249)","('NON-ESG', 0.09155674278736115)"
Line 275,"Zimmer Biomet does not perform  animal testing directly; the work is contracted to labs.
","('GHG_Emissions', 0.2456415593624115)","('Selling_Practices_And_Product_Labeling', 0.10364258289337158)","('Customer_Welfare', 0.09513991326093674)","('NON-ESG', 0.2456415593624115)","('NON-ESG', 0.10364258289337158)","('NON-ESG', 0.09513991326093674)"
Line 276,"Clinical Trial Program We operate a robust global clinical research program that  strives to collect meaningful clinical evidence to support our  vast portfolio of products that ultimately help alleviate pain  and improve the quality of life for people around the world.
","('Customer_Welfare', 0.18675479292869568)","('Access_And_Affordability', 0.15204347670078278)","('Employee_Health_And_Safety', 0.12169207632541656)","('NON-ESG', 0.18675479292869568)","('NON-ESG', 0.15204347670078278)","('NON-ESG', 0.12169207632541656)"
Line 277,"Our clinical research programs support the safety and  effectiveness of our products, services and technologies  in a compliant and transparent manner.
","('Product_Quality_And_Safety', 0.8356585502624512)","('Selling_Practices_And_Product_Labeling', 0.04441295936703682)","('Product_Design_And_Lifecycle_Management', 0.025246495380997658)","(['Product Quality & Recall Management'], 0.8356585502624512)","('NON-ESG', 0.04441295936703682)","('NON-ESG', 0.025246495380997658)"
Line 278,"Zimmer Biomet- supported clinical trials are conducted across many  different programs, including sponsored multi-center  global clinical trials, as well as Company supported smaller  investigator initiated clinical trials.
","('Competitive_Behavior', 0.15448753535747528)","('Access_And_Affordability', 0.15194368362426758)","('Customer_Welfare', 0.13578346371650696)","('NON-ESG', 0.15448753535747528)","('NON-ESG', 0.15194368362426758)","('NON-ESG', 0.13578346371650696)"
Line 279,"Zimmer Biomet conducts studies all over the world that are  managed by our global Clinical Affairs teams.
","('Access_And_Affordability', 0.15512050688266754)","('Customer_Welfare', 0.1359376758337021)","('Competitive_Behavior', 0.08763335645198822)","('NON-ESG', 0.15512050688266754)","('NON-ESG', 0.1359376758337021)","('NON-ESG', 0.08763335645198822)"
Line 280,"These teams  manage our regulated and post-market studies and are  located in key locations across the globe.
","('Competitive_Behavior', 0.41234079003334045)","('Management_Of_Legal_And_Regulatory_Framework', 0.26347750425338745)","('Systemic_Risk_Management', 0.13082246482372284)","('NON-ESG', 0.41234079003334045)","('NON-ESG', 0.26347750425338745)","('NON-ESG', 0.13082246482372284)"
Line 281,"In all instances,  these programs and teams adhere to Zimmer Biomet  policies and procedures that incorporate the standards set  forth in the International Conference on Harmonization, the  Declaration of Helsinki, Good Clinical Practice guidelines  and the AdvaMed Code of Ethics.
","('Business_Ethics', 0.6519699096679688)","('Management_Of_Legal_And_Regulatory_Framework', 0.20503975450992584)","('Product_Quality_And_Safety', 0.03569578006863594)","(['Business Ethics'], 0.6519699096679688)","('NON-ESG', 0.20503975450992584)","('NON-ESG', 0.03569578006863594)"
Line 282,"To protect the rights, privacy, safety and well-being of  clinical trial participants, Zimmer Biomet has an overarching  global procedure for Conducting Clinical Research  Involving Human Subjects.
","('Product_Quality_And_Safety', 0.5565508008003235)","('Customer_Welfare', 0.09064780175685883)","('Selling_Practices_And_Product_Labeling', 0.08500029891729355)","(['Product Quality & Recall Management'], 0.5565508008003235)","('NON-ESG', 0.09064780175685883)","('NON-ESG', 0.08500029891729355)"
Line 283,"This procedure also ensures  that the clinical research from our clinical trials is qualified  and reliable and can be used by worldwide regulatory  authorities.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5996262431144714)","('Competitive_Behavior', 0.10063914209604263)","('Access_And_Affordability', 0.056084491312503815)","(['Corporate Governance'], 0.5996262431144714)","('NON-ESG', 0.10063914209604263)","('NON-ESG', 0.056084491312503815)"
Line 284,"As part of our procedures, clinical trials are  reviewed and approved by several cross-functional internal  committees, including a Clinical Investigation Review  Committee and a Clinical Research Review Committee.
","('Management_Of_Legal_And_Regulatory_Framework', 0.18274681270122528)","('Competitive_Behavior', 0.12748228013515472)","('Access_And_Affordability', 0.10724551975727081)","('NON-ESG', 0.18274681270122528)","('NON-ESG', 0.12748228013515472)","('NON-ESG', 0.10724551975727081)"
Line 285,"Clinical trials are only approved if they are scientifically  sound, meet a well-defined business need and are within fair  market value calculations.
","('Competitive_Behavior', 0.18523983657360077)","('Customer_Welfare', 0.15714888274669647)","('Management_Of_Legal_And_Regulatory_Framework', 0.09030180424451828)","('NON-ESG', 0.18523983657360077)","('NON-ESG', 0.15714888274669647)","('NON-ESG', 0.09030180424451828)"
Line 286,"Clinical trial support can range  from monetary funding, providing in-kind product, or even  the loaning of specialized instrumentation and equipment.
","('Customer_Welfare', 0.1412992626428604)","('Competitive_Behavior', 0.13834546506404877)","('Access_And_Affordability', 0.12610061466693878)","('NON-ESG', 0.1412992626428604)","('NON-ESG', 0.13834546506404877)","('NON-ESG', 0.12610061466693878)"
Line 287,"In addition to the internal Zimmer Biomet review and  approval processes, all clinical studies are required to be  reviewed and approved by an Institutional Review Board  or Ethics Committee that is independent of both Zimmer  Biomet and the participating investigational centers.
","('Management_Of_Legal_And_Regulatory_Framework', 0.47407498955726624)","('Competitive_Behavior', 0.08313442766666412)","('Access_And_Affordability', 0.06714966148138046)","('NON-ESG', 0.47407498955726624)","('NON-ESG', 0.08313442766666412)","('NON-ESG', 0.06714966148138046)"
Line 288,"Clinical Trial Transparency Zimmer Biomet supports clinical research to foster  advances in clinical knowledge and furthering medical  device development related to our products and  programs.
","('Customer_Welfare', 0.2756030857563019)","('Product_Design_And_Lifecycle_Management', 0.16061411798000336)","('Competitive_Behavior', 0.10762885212898254)","('NON-ESG', 0.2756030857563019)","('NON-ESG', 0.16061411798000336)","('NON-ESG', 0.10762885212898254)"
Line 289,"As such, clinical trial transparency is required  to appropriately contribute to and comply with the  International Committee of Medical Journal Editors (ICMJE) initiative and Food and Drug Administration Amendments  Act (FDAAA) requirements by utilizing ClinicalTrials.gov to  register our active clinical studies and study results once  they are available.
","('Business_Ethics', 0.9285711646080017)","('Management_Of_Legal_And_Regulatory_Framework', 0.010191668756306171)","('Systemic_Risk_Management', 0.00912115816026926)","(['Business Ethics'], 0.9285711646080017)","('NON-ESG', 0.010191668756306171)","('NON-ESG', 0.00912115816026926)"
Line 290,"All study results are posted, regardless  of whether the trial is deemed successful or failed to meet  the primary end point.
","('Competitive_Behavior', 0.28149956464767456)","('Management_Of_Legal_And_Regulatory_Framework', 0.22404806315898895)","('Access_And_Affordability', 0.06410011649131775)","('NON-ESG', 0.28149956464767456)","('NON-ESG', 0.22404806315898895)","('NON-ESG', 0.06410011649131775)"
Line 291,"A sample listing of Zimmer Biomet  clinical trials can be found at ClinicalTrials.gov .
","('Competitive_Behavior', 0.14961422979831696)","('Customer_Welfare', 0.12960410118103027)","('GHG_Emissions', 0.10510283708572388)","('NON-ESG', 0.14961422979831696)","('NON-ESG', 0.12960410118103027)","('NON-ESG', 0.10510283708572388)"
Line 292,"Grants, Donations and Funding Zimmer Biomet Foundation Zimmer Biomet is committed to our guiding principle of  giving back to our communities and people in need.
","('Human_Rights_And_Community_Relations', 0.5449279546737671)","('Access_And_Affordability', 0.2127295732498169)","('Management_Of_Legal_And_Regulatory_Framework', 0.05392857640981674)","(['Community Relations'], 0.5449279546737671)","('NON-ESG', 0.2127295732498169)","('NON-ESG', 0.05392857640981674)"
Line 293,"The Zimmer Biomet Foundation is an independent,  philanthropic, nonprofit organization established in 2018  to address the needs of our global community.
","('Access_And_Affordability', 0.38663405179977417)","('Human_Rights_And_Community_Relations', 0.3353908360004425)","('Employee_Engagement_Inclusion_And_Diversity', 0.03055393695831299)","('NON-ESG', 0.38663405179977417)","('NON-ESG', 0.3353908360004425)","('NON-ESG', 0.03055393695831299)"
Line 294,"The mission  of the Zimmer Biomet Foundation is to improve the quality  of life for our communities by providing resources to help:  build healthy communities, advance Science, Technology,  Engineering and Math (STEM) education, provide disaster  relief and address healthcare disparities while advancing  diversity, equity and inclusion.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9646793007850647)","('Human_Rights_And_Community_Relations', 0.003876236267387867)","('Access_And_Affordability', 0.003201404120773077)","(['Human Capital Development'], 0.9646793007850647)","('NON-ESG', 0.003876236267387867)","('NON-ESG', 0.003201404120773077)"
Line 295,"Zimmer Biomet continued  to fund the Zimmer Biomet Foundation with a large  contribution in 2021, allowing for continued charitable work  globally.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5879843235015869)","('Access_And_Affordability', 0.06282155215740204)","('Business_Ethics', 0.04084106534719467)","(['Corporate Governance'], 0.5879843235015869)","('NON-ESG', 0.06282155215740204)","('NON-ESG', 0.04084106534719467)"
Line 296,"From supporting Zimmer Biomet team members’ charitable  programs, to funding community efforts in line with its  pillars, the Zimmer Biomet Foundation donated nearly $2.7  million in charitable grants in 2021.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6685099005699158)","('Access_And_Affordability', 0.10167907178401947)","('Human_Rights_And_Community_Relations', 0.0278293676674366)","(['Corporate Governance'], 0.6685099005699158)","('NON-ESG', 0.10167907178401947)","('NON-ESG', 0.0278293676674366)"
Line 297,"The Zimmer Biomet Foundation continued the Team  Member Relief Fund to support team members facing  financial hardship due to personal or catastrophic reasons,  including COVID-19.
","('Systemic_Risk_Management', 0.1522863656282425)","('Human_Rights_And_Community_Relations', 0.1293479949235916)","('Employee_Health_And_Safety', 0.12929634749889374)","('NON-ESG', 0.1522863656282425)","('NON-ESG', 0.1293479949235916)","('NON-ESG', 0.12929634749889374)"
Line 298,"Since its inception, the Fund has  provided more than $1 million in relief grants to team  members.
","('Management_Of_Legal_And_Regulatory_Framework', 0.41005104780197144)","('Access_And_Affordability', 0.2049921303987503)","('Human_Rights_And_Community_Relations', 0.15772463381290436)","('NON-ESG', 0.41005104780197144)","('NON-ESG', 0.2049921303987503)","('NON-ESG', 0.15772463381290436)"
Line 299,"14Zimmer Biomet Medical Missions Zimmer Biomet donated orthopedic products to  support more than 15 philanthropic medical mission  trips in 2021 to help patients in need around the globe.
","('Access_And_Affordability', 0.6166722178459167)","('Product_Design_And_Lifecycle_Management', 0.07297445088624954)","('Critical_Incident_Risk_Management', 0.041265733540058136)","(['Health Outcome Contribution'], 0.6166722178459167)","('NON-ESG', 0.07297445088624954)","('NON-ESG', 0.041265733540058136)"
Line 300,"Due to the ongoing pandemic, several planned medical  mission trips were postponed and rescheduled for  future dates.
","('Critical_Incident_Risk_Management', 0.2981535792350769)","('Physical_Impacts_Of_Climate_Change', 0.14294730126857758)","('Employee_Health_And_Safety', 0.09846194833517075)","('NON-ESG', 0.2981535792350769)","('NON-ESG', 0.14294730126857758)","('NON-ESG', 0.09846194833517075)"
Line 301,"Zimmer Biomet continued our unique partnership  with Faith in Practice by donating a replenishment of  implant inventory necessary to continually perform  charitable surgeries in Guatemala.
","('Access_And_Affordability', 0.28815555572509766)","('Management_Of_Legal_And_Regulatory_Framework', 0.14498132467269897)","('Customer_Welfare', 0.0909244641661644)","('NON-ESG', 0.28815555572509766)","('NON-ESG', 0.14498132467269897)","('NON-ESG', 0.0909244641661644)"
Line 302,"Faith in Practice  (www.faithinpractice.org)  is committed to serving  the poor of Guatemala through short-term medical  mission trips that take an integrated approach to care  that strives to reach those in the greatest need.
","('Access_And_Affordability', 0.837874174118042)","('Human_Rights_And_Community_Relations', 0.046784237027168274)","('Critical_Incident_Risk_Management', 0.019501036033034325)","(['Health Outcome Contribution'], 0.837874174118042)","('NON-ESG', 0.046784237027168274)","('NON-ESG', 0.019501036033034325)"
Line 303,"Zimmer Biomet supported many other organizations- -including One World Surgery, Bayside Medical  Missions, Operation Walk, and more--to care for  underprivileged patients in need in Dominican  Republic, Honduras, Ecuador, Kenya and more.
","('Access_And_Affordability', 0.902976930141449)","('Product_Quality_And_Safety', 0.012955879792571068)","('Human_Rights_And_Community_Relations', 0.008093089796602726)","(['Health Outcome Contribution'], 0.902976930141449)","('NON-ESG', 0.012955879792571068)","('NON-ESG', 0.008093089796602726)"
Line 304,"Additionally, we continue to support charitable  surgeries in the U.S. by donating implants through  Americares.
","('Access_And_Affordability', 0.40922731161117554)","('Management_Of_Legal_And_Regulatory_Framework', 0.17232917249202728)","('Business_Ethics', 0.05352518707513809)","('NON-ESG', 0.40922731161117554)","('NON-ESG', 0.17232917249202728)","('NON-ESG', 0.05352518707513809)"
Line 305,"In 2021, Americares was able to  support approximately 40 charitable surgeries in  the U.S. with Zimmer Biomet implants.
","('Access_And_Affordability', 0.32087504863739014)","('Management_Of_Legal_And_Regulatory_Framework', 0.13627246022224426)","('Business_Ethics', 0.07750865817070007)","('NON-ESG', 0.32087504863739014)","('NON-ESG', 0.13627246022224426)","('NON-ESG', 0.07750865817070007)"
Line 306,"Americares   (www.americares.org)  saves lives and improves health  for people affected by poverty or disaster so they can  reach their full potential.
","('Employee_Health_And_Safety', 0.2742055058479309)","('Human_Rights_And_Community_Relations', 0.23358546197414398)","('Access_And_Affordability', 0.1998852789402008)","('NON-ESG', 0.2742055058479309)","('NON-ESG', 0.23358546197414398)","('NON-ESG', 0.1998852789402008)"
Line 307,"In addition, the Zimmer Biomet Foundation matched team  member donations to over 500 nonprofit organizations with  a dollar-for-dollar match.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7658251523971558)","('Business_Ethics', 0.02073509618639946)","('Ecological_Impacts', 0.018461886793375015)","(['Corporate Governance'], 0.7658251523971558)","('NON-ESG', 0.02073509618639946)","('NON-ESG', 0.018461886793375015)"
Line 308,"Nearly $400,000 combined from  team member contributions and the Foundation match was  contributed to charities in 2021.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6849966645240784)","('Human_Rights_And_Community_Relations', 0.07293868809938431)","('Access_And_Affordability', 0.0565614253282547)","(['Corporate Governance'], 0.6849966645240784)","('NON-ESG', 0.07293868809938431)","('NON-ESG', 0.0565614253282547)"
Line 309,"We proudly support team members volunteering in their  communities and abroad by offering resources to match  team members with volunteer opportunities and work  policies that allow them to take the time to support their  community.
","('Human_Rights_And_Community_Relations', 0.3054215610027313)","('Employee_Health_And_Safety', 0.26861006021499634)","('Access_And_Affordability', 0.13502247631549835)","('NON-ESG', 0.3054215610027313)","('NON-ESG', 0.26861006021499634)","('NON-ESG', 0.13502247631549835)"
Line 310,"For the first year collectively capturing data on the  volunteer program, team members logged close to 3,000  hours of giving back to their community.
","('Human_Rights_And_Community_Relations', 0.4146307706832886)","('Access_And_Affordability', 0.2452736496925354)","('Employee_Health_And_Safety', 0.07002970576286316)","('NON-ESG', 0.4146307706832886)","('NON-ESG', 0.2452736496925354)","('NON-ESG', 0.07002970576286316)"
Line 311,"Some of those  organizations include Feed My Starving Children, Prospect  Hospice Limited, Bumbleance Ireland (Saoirse Foundation) and the United Way.
","('Access_And_Affordability', 0.7645359039306641)","('Human_Rights_And_Community_Relations', 0.04808058217167854)","('Employee_Health_And_Safety', 0.02197250910103321)","(['Health Outcome Contribution'], 0.7645359039306641)","('NON-ESG', 0.04808058217167854)","('NON-ESG', 0.02197250910103321)"
Line 312,"In addition, team members organized  several collection drives to provide needed items for back- to-school efforts and help during the holidays.
","('Access_And_Affordability', 0.708414614200592)","('Management_Of_Legal_And_Regulatory_Framework', 0.03682566434144974)","('Product_Design_And_Lifecycle_Management', 0.02998809702694416)","(['Health Outcome Contribution'], 0.708414614200592)","('NON-ESG', 0.03682566434144974)","('NON-ESG', 0.02998809702694416)"
Line 313,"The Zimmer Biomet Foundation created the Zimmer Biomet  Scholarship Fund for dependents of team members in the  U.S. For the inaugural year, 10 recipients were selected  to receive $2,500 for educational costs toward college  expenses.
","('Access_And_Affordability', 0.4009850025177002)","('Management_Of_Legal_And_Regulatory_Framework', 0.16320861876010895)","('Employee_Engagement_Inclusion_And_Diversity', 0.09825565665960312)","('NON-ESG', 0.4009850025177002)","('NON-ESG', 0.16320861876010895)","('NON-ESG', 0.09825565665960312)"
Line 314,"The Foundation continued to contribute to COVID relief  efforts through Americares, as well as match team member  donations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7022557258605957)","('Human_Rights_And_Community_Relations', 0.05680800974369049)","('Access_And_Affordability', 0.039182424545288086)","(['Corporate Governance'], 0.7022557258605957)","('NON-ESG', 0.05680800974369049)","('NON-ESG', 0.039182424545288086)"
Line 315,"Funding was provided to the Red Cross to  assist with efforts following the flooding in Europe.
","('Access_And_Affordability', 0.43414032459259033)","('Human_Rights_And_Community_Relations', 0.14953623712062836)","('Critical_Incident_Risk_Management', 0.08570726215839386)","('NON-ESG', 0.43414032459259033)","('NON-ESG', 0.14953623712062836)","('NON-ESG', 0.08570726215839386)"
Line 316,"With  the earthquake disaster in Haiti in 2021, Zimmer Biomet  donated external fixation devices to nonprofit organizations  to help patients in need.
","('Critical_Incident_Risk_Management', 0.9644991755485535)","('Employee_Health_And_Safety', 0.00625845929607749)","('Physical_Impacts_Of_Climate_Change', 0.004577073268592358)","(['Risk & Crisis Management'], 0.9644991755485535)","('NON-ESG', 0.00625845929607749)","('NON-ESG', 0.004577073268592358)"
Line 317,"Additionally, in late December  2021, we donated burn care equipment to assist with the  aftermath of the Haiti fuel truck explosion.
","('Critical_Incident_Risk_Management', 0.921021044254303)","('Employee_Health_And_Safety', 0.017197372391819954)","('Air_Quality', 0.014578298665583134)","(['Risk & Crisis Management'], 0.921021044254303)","('NON-ESG', 0.017197372391819954)","('NON-ESG', 0.014578298665583134)"
Line 318,"The Zimmer Biomet Foundation also supported the  Indiana Chamber Foundation’s Accelerating Indiana  Vision 2025 program.
","('Management_Of_Legal_And_Regulatory_Framework', 0.38324886560440063)","('Access_And_Affordability', 0.20855368673801422)","('Business_Model_Resilience', 0.06003484129905701)","('NON-ESG', 0.38324886560440063)","('NON-ESG', 0.20855368673801422)","('NON-ESG', 0.06003484129905701)"
Line 319,"The initiative has a number of  important dimensions, including broadband access, urban  development, K-12 STEM curricula and advancing Diversity,  Equity and Inclusion.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9712551236152649)","('Human_Rights_And_Community_Relations', 0.002324518747627735)","('Access_And_Affordability', 0.0023099479731172323)","(['Human Capital Development'], 0.9712551236152649)","('NON-ESG', 0.002324518747627735)","('NON-ESG', 0.0023099479731172323)"
Line 320,"The ZBF continued support of STEM- related activities through the local school system in Warsaw,  Indiana, home of Zimmer Biomet’s global headquarters.
","('Access_And_Affordability', 0.6717261075973511)","('Employee_Engagement_Inclusion_And_Diversity', 0.08273781836032867)","('Customer_Welfare', 0.026796560734510422)","(['Health Outcome Contribution'], 0.6717261075973511)","('NON-ESG', 0.08273781836032867)","('NON-ESG', 0.026796560734510422)"
Line 321,"Zimmer Biomet Corporate Grants In 2021, Zimmer Biomet provided grants, donations and  funding for numerous educational and philanthropic  projects.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8063492774963379)","('Access_And_Affordability', 0.06819586455821991)","('Human_Rights_And_Community_Relations', 0.01804652437567711)","(['Corporate Governance'], 0.8063492774963379)","('NON-ESG', 0.06819586455821991)","('NON-ESG', 0.01804652437567711)"
Line 322,"These included grants to support orthopedic  post-graduate medical education, including funding  to OMeGA Medical Grants Association.
","('Access_And_Affordability', 0.7876567244529724)","('Employee_Engagement_Inclusion_And_Diversity', 0.02647116594016552)","('Management_Of_Legal_And_Regulatory_Framework', 0.019803743809461594)","(['Health Outcome Contribution'], 0.7876567244529724)","('NON-ESG', 0.02647116594016552)","('NON-ESG', 0.019803743809461594)"
Line 323,"OMeGA   (www.omegamedicalgrants.org)  is an independent  legal entity with a singular mission: to award and  administer grants for graduate orthopedic medical  education through an open, accessible process  designed to safeguard against potential conflicts of  interest and to ensure transparency in the allocation of  resources.
","('Access_And_Affordability', 0.4200451076030731)","('Management_Of_Legal_And_Regulatory_Framework', 0.19977229833602905)","('Business_Ethics', 0.050380948930978775)","('NON-ESG', 0.4200451076030731)","('NON-ESG', 0.19977229833602905)","('NON-ESG', 0.050380948930978775)"
Line 324,"Zimmer Biomet also provided educational grants to  support independent medical education conferences  that promote scientific knowledge, medical  advancement and the delivery of effective healthcare.
","('Access_And_Affordability', 0.5876713395118713)","('Management_Of_Legal_And_Regulatory_Framework', 0.05816184729337692)","('Ecological_Impacts', 0.05046195164322853)","(['Health Outcome Contribution'], 0.5876713395118713)","('NON-ESG', 0.05816184729337692)","('NON-ESG', 0.05046195164322853)"
Line 325,"In addition, Zimmer Biomet provided grants to third- party organizations for independent research to  advance patient treatment designed for improved  outcomes.
","('Access_And_Affordability', 0.5726476907730103)","('Customer_Welfare', 0.0762607678771019)","('Product_Quality_And_Safety', 0.05365760996937752)","(['Health Outcome Contribution'], 0.5726476907730103)","('NON-ESG', 0.0762607678771019)","('NON-ESG', 0.05365760996937752)"
Line 326,"1516Advancing Diversity, Equity and Inclusion The Zimmer Biomet Foundation has partnered with many  nonprofit organizations to advance diversity, equity and  inclusion, particularly related to disparities and career  development in healthcare.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9759389162063599)","('Employee_Health_And_Safety', 0.001993067329749465)","('Human_Rights_And_Community_Relations', 0.0015191470738500357)","(['Human Capital Development'], 0.9759389162063599)","('NON-ESG', 0.001993067329749465)","('NON-ESG', 0.0015191470738500357)"
Line 327,"As part of the large-scale partnership with the National  Association for the Advancement of Colored People  (NAACP) to focus on expanding medical access for people  of color, our funding has supported the creation of the  organization’s Learning and Impact Team and seed funding  to support a partnership with Brookings Institute to develop  the Black Asset Index.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9498722553253174)","('Access_And_Affordability', 0.007094237487763166)","('Human_Rights_And_Community_Relations', 0.0053824265487492085)","(['Human Capital Development'], 0.9498722553253174)","('NON-ESG', 0.007094237487763166)","('NON-ESG', 0.0053824265487492085)"
Line 328,"Funding was also provided to support programs that  promote diversity and multiculturalism in medical schools  and in surgeon professional development, as well as  industry minority initiatives to raise orthopedic treatment  awareness and support higher education.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9748510718345642)","('Human_Rights_And_Community_Relations', 0.0017207225318998098)","('Employee_Health_And_Safety', 0.0017180840950459242)","(['Human Capital Development'], 0.9748510718345642)","('NON-ESG', 0.0017207225318998098)","('NON-ESG', 0.0017180840950459242)"
Line 329,"One example  of diversity-related funding is the support we provide to  The Perry Initiative, which is committed to inspiring young  women to be leaders in the fields of orthopedic surgery and  engineering.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9688832759857178)","('Employee_Health_And_Safety', 0.00329587422311306)","('Access_And_Affordability', 0.0021157360170036554)","(['Human Capital Development'], 0.9688832759857178)","('NON-ESG', 0.00329587422311306)","('NON-ESG', 0.0021157360170036554)"
Line 330,"Zimmer Biomet is the Founding Sponsor of Nth  Dimensions, an educational nonprofit organization created  to help increase diversity of women and underrepresented  minorities in the field of orthopedics, including pre- medical students, medical students and residents.
","('Employee_Engagement_Inclusion_And_Diversity', 0.974886953830719)","('Employee_Health_And_Safety', 0.0020309349056333303)","('Human_Rights_And_Community_Relations', 0.0018496273551136255)","(['Human Capital Development'], 0.974886953830719)","('NON-ESG', 0.0020309349056333303)","('NON-ESG', 0.0018496273551136255)"
Line 331,"We are  a corporate partner of the J.
","('Management_Of_Legal_And_Regulatory_Framework', 0.24709102511405945)","('Business_Ethics', 0.12593093514442444)","('Business_Model_Resilience', 0.0861358791589737)","('NON-ESG', 0.24709102511405945)","('NON-ESG', 0.12593093514442444)","('NON-ESG', 0.0861358791589737)"
Line 332,"Robert Gladden Orthopedic  Society, a multi-cultural organization with a mission to  increase diversity within the orthopedic profession.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9661065936088562)","('Employee_Health_And_Safety', 0.003693502163514495)","('Access_And_Affordability', 0.0024702141527086496)","(['Human Capital Development'], 0.9661065936088562)","('NON-ESG', 0.003693502163514495)","('NON-ESG', 0.0024702141527086496)"
Line 333,"We  also provide support to the Ruth Jackson Orthopedic  Society, which is dedicated to advancing the science and  practice of orthopedic surgery among women, as well as  the American Association of Latino Orthopedic Surgeons,  which represents not only members of Latino descent,  but all orthopedists who treat members of the Latino and  Hispanic communities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9461283087730408)","('Employee_Health_And_Safety', 0.0061814128421247005)","('Access_And_Affordability', 0.005757033359259367)","(['Human Capital Development'], 0.9461283087730408)","('NON-ESG', 0.0061814128421247005)","('NON-ESG', 0.005757033359259367)"
Line 334,"The Zimmer Biomet Foundation also collaborated with  Zimmer Biomet’s global Employee Resource Groups to  support nonprofit organizations that align with the focus of  each group, and enhance the positive impact we can make  across all areas of inclusion.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9591233730316162)","('Employee_Health_And_Safety', 0.005207305774092674)","('Access_And_Affordability', 0.0041713104583323)","(['Human Capital Development'], 0.9591233730316162)","('NON-ESG', 0.005207305774092674)","('NON-ESG', 0.0041713104583323)"
Line 335,"NAACP https:/ /naacp.org/Nth Dimensions www.nthdimensions.org Perry Initiative https:/ /perryinitiative.org/ Ruth Jackson Orthopedic Society http:/ /www.rjos.org/  Access to Healthcare Movement is Life Since 2004, Zimmer Biomet has funded initiatives that  focus on defining and reducing musculoskeletal disparities.
","('Employee_Health_And_Safety', 0.31571272015571594)","('Access_And_Affordability', 0.2782095968723297)","('Employee_Engagement_Inclusion_And_Diversity', 0.14343370497226715)","('NON-ESG', 0.31571272015571594)","('NON-ESG', 0.2782095968723297)","('NON-ESG', 0.14343370497226715)"
Line 336,"Movement is Life , a multi-disciplinary coalition, partners  with thought leaders and national member organizations  aligned to create sustainable change in marginalized  populations.
","('Human_Rights_And_Community_Relations', 0.7300485372543335)","('Access_And_Affordability', 0.06415635347366333)","('Labor_Practices', 0.05180629342794418)","(['Community Relations'], 0.7300485372543335)","('NON-ESG', 0.06415635347366333)","('NON-ESG', 0.05180629342794418)"
Line 337,"The coalition is dedicated to the elimination of  racial, ethnic, geographic and gender disparities in muscle  and joint health by promoting physical mobility to improve  quality of life among African American, Hispanic and rural  women.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9767307639122009)","('Employee_Health_And_Safety', 0.002051310148090124)","('Human_Rights_And_Community_Relations', 0.001599563518539071)","(['Human Capital Development'], 0.9767307639122009)","('NON-ESG', 0.002051310148090124)","('NON-ESG', 0.001599563518539071)"
Line 338,"Movement is Life programs include: • Operation Change, a community-based public health  intervention focused on positive behavior modification  in individuals who suffer from joint pain and chronic  comorbid conditions such as diabetes and obesity.
","('Access_And_Affordability', 0.42401430010795593)","('Employee_Health_And_Safety', 0.1259937882423401)","('Customer_Welfare', 0.05916813015937805)","('NON-ESG', 0.42401430010795593)","('NON-ESG', 0.1259937882423401)","('NON-ESG', 0.05916813015937805)"
Line 339,"Due  to limitations related to COVID-19, in 2021 Movement  is Life created a monthly, virtual Operation Change  series focused on educational topics and movement.
","('Access_And_Affordability', 0.49238330125808716)","('Employee_Engagement_Inclusion_And_Diversity', 0.06467171758413315)","('Employee_Health_And_Safety', 0.054925788193941116)","('NON-ESG', 0.49238330125808716)","('NON-ESG', 0.06467171758413315)","('NON-ESG', 0.054925788193941116)"
Line 340,"• The “Start Moving Start Living” website that serves  as a repository for culturally competent patient  communication tools to raise awareness about the  health risks associated with immobility in the United  States.
","('Employee_Health_And_Safety', 0.8613216280937195)","('Access_And_Affordability', 0.01764962449669838)","('Critical_Incident_Risk_Management', 0.017460893839597702)","(['Operational Eco-Efficiency'], 0.8613216280937195)","('NON-ESG', 0.01764962449669838)","('NON-ESG', 0.017460893839597702)"
Line 341,"• A “Health Disparities” podcast focused on critical  issues including social determinants of health,  environmental impact on marginalized communities  and structural barriers to equitable healthcare.
","('Human_Rights_And_Community_Relations', 0.8579705357551575)","('Access_And_Affordability', 0.04216323047876358)","('Employee_Engagement_Inclusion_And_Diversity', 0.022442150861024857)","(['Community Relations'], 0.8579705357551575)","('NON-ESG', 0.04216323047876358)","('NON-ESG', 0.022442150861024857)"
Line 342,"More  than 1 10 podcasts have been recorded.
","('Data_Security', 0.1074642613530159)","('Employee_Engagement_Inclusion_And_Diversity', 0.08746197819709778)","('Business_Ethics', 0.07118048518896103)","('NON-ESG', 0.1074642613530159)","('NON-ESG', 0.08746197819709778)","('NON-ESG', 0.07118048518896103)"
Line 343,"The podcasts  can be found on the Movement is Life Caucus website.
","('Competitive_Behavior', 0.10165105760097504)","('Management_Of_Legal_And_Regulatory_Framework', 0.07772891223430634)","('Business_Model_Resilience', 0.06903653591871262)","('NON-ESG', 0.10165105760097504)","('NON-ESG', 0.07772891223430634)","('NON-ESG', 0.06903653591871262)"
Line 344,"• A monthly virtual speaker forum to include nationally  recognized experts on topics such as political  determinants of health, structural bias and safety net  hospitals.
","('Employee_Health_And_Safety', 0.8751991391181946)","('Product_Quality_And_Safety', 0.026124969124794006)","('Access_And_Affordability', 0.018298499286174774)","(['Operational Eco-Efficiency'], 0.8751991391181946)","('NON-ESG', 0.026124969124794006)","('NON-ESG', 0.018298499286174774)"
Line 345,"• In 2021, Movement is Life hosted its 1 1th Caucus,  attracting more than 200 participants including  policy makers, community advocates, academicians,  providers, healthcare professionals and patients  with the goal of educating and elevating critical  messaging regarding the impact of the coronavirus  on marginalized communities.
","('Human_Rights_And_Community_Relations', 0.918140172958374)","('Access_And_Affordability', 0.017482712864875793)","('Employee_Engagement_Inclusion_And_Diversity', 0.01086695957928896)","(['Community Relations'], 0.918140172958374)","('NON-ESG', 0.017482712864875793)","('NON-ESG', 0.01086695957928896)"
Line 346,"The Caucus featured  many nationally known and published speakers such  as Daniel Dawes, Garth Graham, Wayne Riley and Elvis  Francois to address the impact of structural racism and  social determinants of health.
","('Employee_Engagement_Inclusion_And_Diversity', 0.42727985978126526)","('Business_Ethics', 0.220314621925354)","('Human_Rights_And_Community_Relations', 0.09465183317661285)","('NON-ESG', 0.42727985978126526)","('NON-ESG', 0.220314621925354)","('NON-ESG', 0.09465183317661285)"
Line 347,"17Patient Privacy and Data Security At Zimmer Biomet, the patient is always the patient, and  never the product.
","('Data_Security', 0.879688560962677)","('Customer_Privacy', 0.046907659620046616)","('Business_Ethics', 0.008733122609555721)","(['Information Security/Cybersecurity & System Availability'], 0.879688560962677)","('NON-ESG', 0.046907659620046616)","('NON-ESG', 0.008733122609555721)"
Line 348,"Patient data is used to improve outcomes  and create value for patients and their care teams through  our algorithms, systems and products in order to support  our commitment to the highest standards of patient safety,  quality and integrity.
","('Product_Quality_And_Safety', 0.8566960096359253)","('Employee_Health_And_Safety', 0.035806577652692795)","('Product_Design_And_Lifecycle_Management', 0.016251705586910248)","(['Product Quality & Recall Management'], 0.8566960096359253)","('NON-ESG', 0.035806577652692795)","('NON-ESG', 0.016251705586910248)"
Line 349,"Our commitment to protecting patient and customer data is  embodied in our four Privacy and Data Security Pillars: • Privacy.
","('Data_Security', 0.7621963620185852)","('Customer_Privacy', 0.1581076830625534)","('Waste_And_Hazardous_Materials_Management', 0.006777672562748194)","(['Information Security/Cybersecurity & System Availability'], 0.7621963620185852)","('NON-ESG', 0.1581076830625534)","('NON-ESG', 0.006777672562748194)"
Line 350,"Privacy is a fundamental human right and we  maintain robust practices to help ensure that that right  is protected.
","('Data_Security', 0.8565462827682495)","('Customer_Privacy', 0.055529531091451645)","('Business_Ethics', 0.009147041477262974)","(['Information Security/Cybersecurity & System Availability'], 0.8565462827682495)","('NON-ESG', 0.055529531091451645)","('NON-ESG', 0.009147041477262974)"
Line 351,"Patients and customers decide what they  share with us.
","('Competitive_Behavior', 0.2342536896467209)","('Management_Of_Legal_And_Regulatory_Framework', 0.14988431334495544)","('Customer_Welfare', 0.11718210577964783)","('NON-ESG', 0.2342536896467209)","('NON-ESG', 0.14988431334495544)","('NON-ESG', 0.11718210577964783)"
Line 352,"• Security.
","('Data_Security', 0.893089771270752)","('Energy_Management', 0.00665604043751955)","('Director_Removal', 0.006648247130215168)","(['Information Security/Cybersecurity & System Availability'], 0.893089771270752)","('NON-ESG', 0.00665604043751955)","('NON-ESG', 0.006648247130215168)"
Line 353,"Zimmer Biomet protects the data that  patients and customers entrust us with through  strong safeguards.
","('Data_Security', 0.5841894149780273)","('Business_Ethics', 0.18445493280887604)","('Customer_Privacy', 0.09398578852415085)","(['Information Security/Cybersecurity & System Availability'], 0.5841894149780273)","('NON-ESG', 0.18445493280887604)","('NON-ESG', 0.09398578852415085)"
Line 354,"Among other measures, we apply  encryption in transit and at rest, scheduled annual  security risk assessments and penetration testing by  third parties.
","('Data_Security', 0.9574370980262756)","('Business_Ethics', 0.004671456292271614)","('Systemic_Risk_Management', 0.003488528775051236)","(['Information Security/Cybersecurity & System Availability'], 0.9574370980262756)","('NON-ESG', 0.004671456292271614)","('NON-ESG', 0.003488528775051236)"
Line 355,"• Data usage.
","('Customer_Privacy', 0.8695544004440308)","('Data_Security', 0.05096687003970146)","('Waste_And_Hazardous_Materials_Management', 0.0061536976136267185)","(['Privacy Protection'], 0.8695544004440308)","('NON-ESG', 0.05096687003970146)","('NON-ESG', 0.0061536976136267185)"
Line 356,"We only use customer and patient data  to provide the services we have agreed upon, and for  purposes that are compatible with providing those  services.
","('Customer_Privacy', 0.9379469156265259)","('Data_Security', 0.005652690306305885)","('Selling_Practices_And_Product_Labeling', 0.004369972739368677)","(['Privacy Protection'], 0.9379469156265259)","('NON-ESG', 0.005652690306305885)","('NON-ESG', 0.004369972739368677)"
Line 357,"• Ownership.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2084650695323944)","('Competitive_Behavior', 0.12915441393852234)","('Business_Model_Resilience', 0.05261562764644623)","('NON-ESG', 0.2084650695323944)","('NON-ESG', 0.12915441393852234)","('NON-ESG', 0.05261562764644623)"
Line 358,"We put patients and customers in control  of their data and have established tools and processes  that give patients easy options to exercise their rights  with respect to their personal data.
","('Customer_Privacy', 0.9670354723930359)","('Data_Security', 0.0034548959229141474)","('Selling_Practices_And_Product_Labeling', 0.002225919160991907)","(['Privacy Protection'], 0.9670354723930359)","('NON-ESG', 0.0034548959229141474)","('NON-ESG', 0.002225919160991907)"
Line 359,"Privacy There have never been more opportunities to use  information collected in the course of treatment to create  innovative solutions to improve patient outcomes.
","('Customer_Privacy', 0.7043780088424683)","('Data_Security', 0.1962057501077652)","('Business_Ethics', 0.010890455916523933)","(['Privacy Protection'], 0.7043780088424683)","('NON-ESG', 0.1962057501077652)","('NON-ESG', 0.010890455916523933)"
Line 360,"At the  same time, the importance of protecting patient privacy  has never been higher.
","('Customer_Privacy', 0.48417091369628906)","('Data_Security', 0.3536837100982666)","('Competitive_Behavior', 0.013066945597529411)","('NON-ESG', 0.48417091369628906)","('NON-ESG', 0.3536837100982666)","('NON-ESG', 0.013066945597529411)"
Line 361,"Privacy is built into our products and services by design  and by default.
","('Data_Security', 0.4976356327533722)","('Customer_Privacy', 0.34283408522605896)","('Business_Ethics', 0.021296707913279533)","('NON-ESG', 0.4976356327533722)","('NON-ESG', 0.34283408522605896)","('NON-ESG', 0.021296707913279533)"
Line 362,"By taking this approach, we accommodate  privacy in an effective and user-friendly way.
","('Customer_Privacy', 0.5856151580810547)","('Data_Security', 0.26290014386177063)","('Labor_Practices', 0.014617251232266426)","(['Privacy Protection'], 0.5856151580810547)","('NON-ESG', 0.26290014386177063)","('NON-ESG', 0.014617251232266426)"
Line 363,"Zimmer Biomet has engaged with OneTrust, the  industry-leading privacy management solution, to  embed privacy in our products and services.
","('Data_Security', 0.8660099506378174)","('Customer_Privacy', 0.03605598956346512)","('Business_Ethics', 0.020789261907339096)","(['Information Security/Cybersecurity & System Availability'], 0.8660099506378174)","('NON-ESG', 0.03605598956346512)","('NON-ESG', 0.020789261907339096)"
Line 364,"Our  mymobility® platform, for example, is supported with  a dedicated portal for individuals to exercise their  privacy rights, with user-friendly features such as  explanatory hovertext, local-language accessibility,  and automated identity verification.
","('Customer_Privacy', 0.8864834904670715)","('Data_Security', 0.05662764981389046)","('Business_Ethics', 0.0037370016798377037)","(['Privacy Protection'], 0.8864834904670715)","('NON-ESG', 0.05662764981389046)","('NON-ESG', 0.0037370016798377037)"
Line 365,"We want to make  it as easy as possible for patients to communicate their  privacy preferences.Data Security Zimmer Biomet implements and verifies stringent  security requirements to protect data we hold for  patients and customers.
","('Data_Security', 0.9406984448432922)","('Customer_Privacy', 0.019223734736442566)","('Waste_And_Hazardous_Materials_Management', 0.003357331734150648)","(['Information Security/Cybersecurity & System Availability'], 0.9406984448432922)","('NON-ESG', 0.019223734736442566)","('NON-ESG', 0.003357331734150648)"
Line 366,"These include a broad  array of controls, including encryption, third-party  penetration testing, malware defenses, access  limitations and auditing.
","('Data_Security', 0.9540966749191284)","('Business_Ethics', 0.004666073713451624)","('Systemic_Risk_Management', 0.004613553639501333)","(['Information Security/Cybersecurity & System Availability'], 0.9540966749191284)","('NON-ESG', 0.004666073713451624)","('NON-ESG', 0.004613553639501333)"
Line 367,"We also have our compliance  with security requirements arising under the Health  Insurance Portability and Accountability Act (HIPAA),  General Data Protection Regulation (GDPR), California  Consumer Privacy Act (CCPA), LGPD (Brazil), China’s  Personal Information Protection Law (PIPL) and other  key data protection regulations reviewed and verified  by third-party experts.
","('Data_Security', 0.719890832901001)","('Customer_Privacy', 0.18603070080280304)","('Business_Ethics', 0.00901469774544239)","(['Information Security/Cybersecurity & System Availability'], 0.719890832901001)","('NON-ESG', 0.18603070080280304)","('NON-ESG', 0.00901469774544239)"
Line 368,"We are transparent regarding  our security controls so that customers can understand  and document the ways in which their information is  protected.
","('Data_Security', 0.8358773589134216)","('Customer_Privacy', 0.09959106147289276)","('Business_Ethics', 0.007937760092318058)","(['Information Security/Cybersecurity & System Availability'], 0.8358773589134216)","('NON-ESG', 0.09959106147289276)","('NON-ESG', 0.007937760092318058)"
Line 369,"Data Usage Zimmer Biomet ensures that information is only  collected, used and disclosed for permissible purposes.
","('Customer_Privacy', 0.9505586624145508)","('Data_Security', 0.011575552634894848)","('Waste_And_Hazardous_Materials_Management', 0.0028929419349879026)","(['Privacy Protection'], 0.9505586624145508)","('NON-ESG', 0.011575552634894848)","('NON-ESG', 0.0028929419349879026)"
Line 370,"Through our contracts with customers, notice and  consent forms, and other means, we are transparent  about the ways we use information to create value for  patients and providers.
","('Customer_Privacy', 0.6884089112281799)","('Business_Ethics', 0.034861788153648376)","('Management_Of_Legal_And_Regulatory_Framework', 0.03374107927083969)","(['Privacy Protection'], 0.6884089112281799)","('NON-ESG', 0.034861788153648376)","('NON-ESG', 0.03374107927083969)"
Line 371,"We have implemented robust  policies, procedures and trainings designed to ensure  that patients’ and customers’ information is being  handled consistent with those statements.
","('Customer_Privacy', 0.8952218294143677)","('Data_Security', 0.010945957154035568)","('Business_Ethics', 0.010703458450734615)","(['Privacy Protection'], 0.8952218294143677)","('NON-ESG', 0.010945957154035568)","('NON-ESG', 0.010703458450734615)"
Line 372,"Ownership The patient, provider and Zimmer Biomet each have  rights and responsibilities regarding data collected in  the course of treatment.
","('Access_And_Affordability', 0.35224097967147827)","('Management_Of_Legal_And_Regulatory_Framework', 0.16817286610603333)","('Customer_Privacy', 0.05248146131634712)","('NON-ESG', 0.35224097967147827)","('NON-ESG', 0.16817286610603333)","('NON-ESG', 0.05248146131634712)"
Line 373,"Zimmer Biomet’s customer engagements, patient  consents and notices and other privacy and information  security practices are designed to ensure that these  rights and responsibilities are respected.Cybersecurity A strong cybersecurity program is essential in today’s  business landscape and we have continued to invest in  people, processes and next generation cybersecurity  technology solutions to combat this evolving risk.
","('Data_Security', 0.9641749858856201)","('Customer_Privacy', 0.005328484810888767)","('Business_Ethics', 0.002905809786170721)","(['Information Security/Cybersecurity & System Availability'], 0.9641749858856201)","('NON-ESG', 0.005328484810888767)","('NON-ESG', 0.002905809786170721)"
Line 374,"Cyber  threats are emerging and evolving daily so we continue to  manage these cyber-risks in alignment with industry best  practices and frameworks.
","('Data_Security', 0.9126562476158142)","('Systemic_Risk_Management', 0.02437645196914673)","('Physical_Impacts_Of_Climate_Change', 0.009804430417716503)","(['Information Security/Cybersecurity & System Availability'], 0.9126562476158142)","('NON-ESG', 0.02437645196914673)","('NON-ESG', 0.009804430417716503)"
Line 375,"Our commitment to cybersecurity includes a programmatic  approach aiming to protect the confidentiality, integrity  and availability of our systems, data and products.
","('Data_Security', 0.9220349788665771)","('Customer_Privacy', 0.022896958515048027)","('Business_Ethics', 0.01214465219527483)","(['Information Security/Cybersecurity & System Availability'], 0.9220349788665771)","('NON-ESG', 0.022896958515048027)","('NON-ESG', 0.01214465219527483)"
Line 376,"This  continuous process ensures that measures are in place to  improve and update our cybersecurity program using key  methods such as independent assessments, penetration  testing, vulnerabilities scanning and maintaining key  industry certifications.
","('Data_Security', 0.9046791195869446)","('Systemic_Risk_Management', 0.02714455872774124)","('Business_Ethics', 0.010465267114341259)","(['Information Security/Cybersecurity & System Availability'], 0.9046791195869446)","('NON-ESG', 0.02714455872774124)","('NON-ESG', 0.010465267114341259)"
Line 377,"Zimmer Biomet strives to ensure all third-party vendor management, governance and  data protection programs are aligned to best practices,  regulations and standards in order to reduce organizational  risk.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4539989233016968)","('Systemic_Risk_Management', 0.1474035084247589)","('Business_Ethics', 0.13636404275894165)","('NON-ESG', 0.4539989233016968)","('NON-ESG', 0.1474035084247589)","('NON-ESG', 0.13636404275894165)"
Line 378,"We have a dedicated global security operations team that  executes the cybersecurity incident response plan and  threat management, and conducts regular exercises to  assure our preparedness and effectiveness.
","('Critical_Incident_Risk_Management', 0.6213224530220032)","('Data_Security', 0.14510031044483185)","('Physical_Impacts_Of_Climate_Change', 0.05122314766049385)","(['Risk & Crisis Management'], 0.6213224530220032)","('NON-ESG', 0.14510031044483185)","('NON-ESG', 0.05122314766049385)"
Line 379,"Our global  cybersecurity awareness program has increased awareness  of cyber threats for users and we continue to share best  practices with all our team members.
","('Data_Security', 0.9499421119689941)","('Systemic_Risk_Management', 0.006028023548424244)","('Physical_Impacts_Of_Climate_Change', 0.004601292312145233)","(['Information Security/Cybersecurity & System Availability'], 0.9499421119689941)","('NON-ESG', 0.006028023548424244)","('NON-ESG', 0.004601292312145233)"
Line 380,"The cybersecurity program is led by Zimmer Biomet’s Chief  Information Security Officer and the Chief Information  Officer, and regular progress updates are presented to the  Audit Committee of the Board of Directors.
","('Data_Security', 0.9400296211242676)","('Systemic_Risk_Management', 0.0073315356858074665)","('Director_Removal', 0.004758727271109819)","(['Information Security/Cybersecurity & System Availability'], 0.9400296211242676)","('NON-ESG', 0.0073315356858074665)","('NON-ESG', 0.004758727271109819)"
Line 381,"Corporate Governance We are committed to effective corporate governance,  adhering to the highest ethical standards and acting as a  responsible member of our communities.
","('Business_Ethics', 0.7763161063194275)","('Management_Of_Legal_And_Regulatory_Framework', 0.08153471350669861)","('Competitive_Behavior', 0.02157941460609436)","(['Business Ethics'], 0.7763161063194275)","('NON-ESG', 0.08153471350669861)","('NON-ESG', 0.02157941460609436)"
Line 382,"Our business is managed under the direction of our Board  of Directors, which has responsibility for establishing broad  corporate policies and for our overall performance.
","('Director_Removal', 0.5939279198646545)","('Business_Model_Resilience', 0.0773703083395958)","('Management_Of_Legal_And_Regulatory_Framework', 0.06935421377420425)","(['Anti-Crime Policy & Measures'], 0.5939279198646545)","('NON-ESG', 0.0773703083395958)","('NON-ESG', 0.06935421377420425)"
Line 383,"As of March 1, 2022, our Board is made up of 10 Directors  who have been nominated based on their skills, experiences,  backgrounds and the needs of the Board and our Company.
","('Director_Removal', 0.4545098841190338)","('Employee_Engagement_Inclusion_And_Diversity', 0.22787350416183472)","('Business_Model_Resilience', 0.0534961074590683)","('NON-ESG', 0.4545098841190338)","('NON-ESG', 0.22787350416183472)","('NON-ESG', 0.0534961074590683)"
Line 384,"Every Director must stand for election annually.
","('Director_Removal', 0.7801920175552368)","('Management_Of_Legal_And_Regulatory_Framework', 0.03126776963472366)","('Data_Security', 0.015798041597008705)","(['Anti-Crime Policy & Measures'], 0.7801920175552368)","('NON-ESG', 0.03126776963472366)","('NON-ESG', 0.015798041597008705)"
Line 385,"At all  times, a majority of the Board of Directors must meet the  criteria for independence established by applicable laws  and regulations and the New York Stock Exchange.
","('Director_Removal', 0.7151802182197571)","('Management_Of_Legal_And_Regulatory_Framework', 0.10491600632667542)","('Business_Ethics', 0.01913800835609436)","(['Anti-Crime Policy & Measures'], 0.7151802182197571)","('NON-ESG', 0.10491600632667542)","('NON-ESG', 0.01913800835609436)"
Line 386,"All of  our Directors, except our Chairman, President and Chief  Executive Officer, are independent.
","('Director_Removal', 0.7543202638626099)","('Business_Model_Resilience', 0.0250543300062418)","('Management_Of_Legal_And_Regulatory_Framework', 0.022672604769468307)","(['Anti-Crime Policy & Measures'], 0.7543202638626099)","('NON-ESG', 0.0250543300062418)","('NON-ESG', 0.022672604769468307)"
Line 387,"Directors are recruited to strengthen the Board’s diversity  and ensure that the Board reflects and understands the  diverse perspectives of Zimmer Biomet’s stakeholders  around the globe.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9229373335838318)","('Director_Removal', 0.012295958586037159)","('Business_Model_Resilience', 0.006311529781669378)","(['Human Capital Development'], 0.9229373335838318)","('NON-ESG', 0.012295958586037159)","('NON-ESG', 0.006311529781669378)"
Line 388,"Three of our ten Directors (30%) are  women, three (30%) are ethnically diverse, one (10%)  identifies as LGBTQ+, and four (40%) were born outside the  United States.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9696404933929443)","('Human_Rights_And_Community_Relations', 0.0026358463801443577)","('Customer_Privacy', 0.00260187778621912)","(['Human Capital Development'], 0.9696404933929443)","('NON-ESG', 0.0026358463801443577)","('NON-ESG', 0.00260187778621912)"
Line 389,"Additionally, of our four Board committees,  one (25%) is chaired by a woman.
","('Director_Removal', 0.7290427088737488)","('Management_Of_Legal_And_Regulatory_Framework', 0.0346144437789917)","('Employee_Engagement_Inclusion_And_Diversity', 0.02964836359024048)","(['Anti-Crime Policy & Measures'], 0.7290427088737488)","('NON-ESG', 0.0346144437789917)","('NON-ESG', 0.02964836359024048)"
Line 390,"The Board recognizes the importance of having a  strong independent Board leadership structure to  ensure accountability.
","('Director_Removal', 0.678568959236145)","('Management_Of_Legal_And_Regulatory_Framework', 0.05541551858186722)","('Employee_Engagement_Inclusion_And_Diversity', 0.036069728434085846)","(['Anti-Crime Policy & Measures'], 0.678568959236145)","('NON-ESG', 0.05541551858186722)","('NON-ESG', 0.036069728434085846)"
Line 391,"Accordingly, our Corporate  Governance Guidelines provide for the appointment of  a Lead Independent Director when the Chairman is not  independent.
","('Director_Removal', 0.7563479542732239)","('Management_Of_Legal_And_Regulatory_Framework', 0.059638239443302155)","('Business_Ethics', 0.023018550127744675)","(['Anti-Crime Policy & Measures'], 0.7563479542732239)","('NON-ESG', 0.059638239443302155)","('NON-ESG', 0.023018550127744675)"
Line 392,"The Board believes that a Lead Independent  Director is an integral part of our Board structure and  facilitates the effective performance of the Board in its role  of providing governance and oversight.
","('Director_Removal', 0.7442052960395813)","('Management_Of_Legal_And_Regulatory_Framework', 0.053541552275419235)","('Business_Ethics', 0.022066792473196983)","(['Anti-Crime Policy & Measures'], 0.7442052960395813)","('NON-ESG', 0.053541552275419235)","('NON-ESG', 0.022066792473196983)"
Line 393,"Among other duties and responsibilities, the Lead  Independent Director convenes and presides at meetings  of the independent Directors, including executive sessions of the independent Directors held in conjunction with each  regularly scheduled Board meeting, reviews and provides  input on meeting agendas for the Board and its committees,  and provides feedback on the flow of information from  management to the Board.
","('Director_Removal', 0.7663798332214355)","('Management_Of_Legal_And_Regulatory_Framework', 0.04384386166930199)","('Employee_Engagement_Inclusion_And_Diversity', 0.017106035724282265)","(['Anti-Crime Policy & Measures'], 0.7663798332214355)","('NON-ESG', 0.04384386166930199)","('NON-ESG', 0.017106035724282265)"
Line 394,"The Lead Independent Director  is also available, as appropriate, for direct communication  with shareholders.
","('Director_Removal', 0.7693650126457214)","('Management_Of_Legal_And_Regulatory_Framework', 0.02959505096077919)","('Business_Ethics', 0.021000778302550316)","(['Anti-Crime Policy & Measures'], 0.7693650126457214)","('NON-ESG', 0.02959505096077919)","('NON-ESG', 0.021000778302550316)"
Line 395,"Zimmer Biomet has developed risk management processes  designed to promote long-term shareholder value with  oversight by the Board of Directors.
","('Director_Removal', 0.33319148421287537)","('Business_Model_Resilience', 0.20624631643295288)","('Systemic_Risk_Management', 0.08106018602848053)","('NON-ESG', 0.33319148421287537)","('NON-ESG', 0.20624631643295288)","('NON-ESG', 0.08106018602848053)"
Line 396,"Sustainability topics  are incorporated into our risk management processes,  and various executive leadership team members have  responsibility for implementing processes designed to  identify, evaluate, mitigate and monitor risks.
","('Systemic_Risk_Management', 0.8768675923347473)","('Physical_Impacts_Of_Climate_Change', 0.028788242489099503)","('Business_Model_Resilience', 0.02806173451244831)","(['Risk & Crisis Management'], 0.8768675923347473)","('NON-ESG', 0.028788242489099503)","('NON-ESG', 0.02806173451244831)"
Line 397,"Reviews  of key risks occur at regularly scheduled meetings of the  Board of Directors and its committees.
","('Director_Removal', 0.6885661482810974)","('Management_Of_Legal_And_Regulatory_Framework', 0.06268083304166794)","('Business_Ethics', 0.0324234813451767)","(['Anti-Crime Policy & Measures'], 0.6885661482810974)","('NON-ESG', 0.06268083304166794)","('NON-ESG', 0.0324234813451767)"
Line 398,"The Board executes  its oversight responsibility for risk management directly  and through its committees: Audit Committee Oversight Areas: • The integrity of our financial statements • The performance of our Internal Audit function • Our compliance with legal and regulatory  requirements • Our Corporate Compliance Program • Privacy, data security, business continuity and  cybersecurity-related risk exposures Compensation and Management   Development Committee Oversight Areas: • The compensation of our senior executives • Our incentive and equity-based compensation plans  and programs • Senior management talent and development plans (in  conjunction with the full Board) • Our policies and strategies relating to human capital  management (in conjunction with the full Board) GOVERNANCE20Corporate Governance Committee Oversight Areas: • Our public policy, government relations and advocacy  activities • Our sustainability activities, including initiatives  related to the environment and climate change • Our community relations activities and charitable  contributions, including the underlying philosophy,  goals and purposes of our contribution activities • Our initiatives related to promoting access to  healthcare and other social responsibility issues Quality, Regulatory and Technology Committee Oversight Areas: • Product quality and safety • Risks relating to our compliance with laws and  regulations enforced by the U.S. Food and Drug  Administration and comparable foreign government  regulators • Research, innovation and technology initiatives Executive Compensation Our executives receive fixed compensation (base salary),  as well as short-term and long-term performance-based  compensation.
","('Business_Ethics', 0.9083042740821838)","('Management_Of_Legal_And_Regulatory_Framework', 0.01917598955333233)","('Data_Security', 0.018181119114160538)","(['Business Ethics'], 0.9083042740821838)","('NON-ESG', 0.01917598955333233)","('NON-ESG', 0.018181119114160538)"
Line 399,"The Board executes  its oversight responsibility for risk management directly  and through its committees: Audit Committee Oversight Areas: • The integrity of our financial statements • The performance of our Internal Audit function • Our compliance with legal and regulatory  requirements • Our Corporate Compliance Program • Privacy, data security, business continuity and  cybersecurity-related risk exposures Compensation and Management   Development Committee Oversight Areas: • The compensation of our senior executives • Our incentive and equity-based compensation plans  and programs • Senior management talent and development plans (in  conjunction with the full Board) • Our policies and strategies relating to human capital  management (in conjunction with the full Board) GOVERNANCE20Corporate Governance Committee Oversight Areas: • Our public policy, government relations and advocacy  activities • Our sustainability activities, including initiatives  related to the environment and climate change • Our community relations activities and charitable  contributions, including the underlying philosophy,  goals and purposes of our contribution activities • Our initiatives related to promoting access to  healthcare and other social responsibility issues Quality, Regulatory and Technology Committee Oversight Areas: • Product quality and safety • Risks relating to our compliance with laws and  regulations enforced by the U.S. Food and Drug  Administration and comparable foreign government  regulators • Research, innovation and technology initiatives Executive Compensation Our executives receive fixed compensation (base salary),  as well as short-term and long-term performance-based  compensation.
","('Physical_Impacts_Of_Climate_Change', 0.9180667400360107)","('Business_Model_Resilience', 0.024299537762999535)","('Systemic_Risk_Management', 0.006352663971483707)","(['Climate Change'], 0.9180667400360107)","('NON-ESG', 0.024299537762999535)","('NON-ESG', 0.006352663971483707)"
Line 400,"The Board executes  its oversight responsibility for risk management directly  and through its committees: Audit Committee Oversight Areas: • The integrity of our financial statements • The performance of our Internal Audit function • Our compliance with legal and regulatory  requirements • Our Corporate Compliance Program • Privacy, data security, business continuity and  cybersecurity-related risk exposures Compensation and Management   Development Committee Oversight Areas: • The compensation of our senior executives • Our incentive and equity-based compensation plans  and programs • Senior management talent and development plans (in  conjunction with the full Board) • Our policies and strategies relating to human capital  management (in conjunction with the full Board) GOVERNANCE20Corporate Governance Committee Oversight Areas: • Our public policy, government relations and advocacy  activities • Our sustainability activities, including initiatives  related to the environment and climate change • Our community relations activities and charitable  contributions, including the underlying philosophy,  goals and purposes of our contribution activities • Our initiatives related to promoting access to  healthcare and other social responsibility issues Quality, Regulatory and Technology Committee Oversight Areas: • Product quality and safety • Risks relating to our compliance with laws and  regulations enforced by the U.S. Food and Drug  Administration and comparable foreign government  regulators • Research, innovation and technology initiatives Executive Compensation Our executives receive fixed compensation (base salary),  as well as short-term and long-term performance-based  compensation.
","('Product_Quality_And_Safety', 0.8753421902656555)","('Product_Design_And_Lifecycle_Management', 0.027453571557998657)","('Selling_Practices_And_Product_Labeling', 0.022154828533530235)","(['Product Quality & Recall Management'], 0.8753421902656555)","('NON-ESG', 0.027453571557998657)","('NON-ESG', 0.022154828533530235)"
Line 401,"The Board executes  its oversight responsibility for risk management directly  and through its committees: Audit Committee Oversight Areas: • The integrity of our financial statements • The performance of our Internal Audit function • Our compliance with legal and regulatory  requirements • Our Corporate Compliance Program • Privacy, data security, business continuity and  cybersecurity-related risk exposures Compensation and Management   Development Committee Oversight Areas: • The compensation of our senior executives • Our incentive and equity-based compensation plans  and programs • Senior management talent and development plans (in  conjunction with the full Board) • Our policies and strategies relating to human capital  management (in conjunction with the full Board) GOVERNANCE20Corporate Governance Committee Oversight Areas: • Our public policy, government relations and advocacy  activities • Our sustainability activities, including initiatives  related to the environment and climate change • Our community relations activities and charitable  contributions, including the underlying philosophy,  goals and purposes of our contribution activities • Our initiatives related to promoting access to  healthcare and other social responsibility issues Quality, Regulatory and Technology Committee Oversight Areas: • Product quality and safety • Risks relating to our compliance with laws and  regulations enforced by the U.S. Food and Drug  Administration and comparable foreign government  regulators • Research, innovation and technology initiatives Executive Compensation Our executives receive fixed compensation (base salary),  as well as short-term and long-term performance-based  compensation.
","('Labor_Practices', 0.946483314037323)","('Employee_Engagement_Inclusion_And_Diversity', 0.009361007250845432)","('Director_Removal', 0.005456471350044012)","(['Labor Practice Indicators'], 0.946483314037323)","('NON-ESG', 0.009361007250845432)","('NON-ESG', 0.005456471350044012)"
Line 402,"Applicable performance metrics and targets  align executives’ interests with those of Zimmer Biomet  shareholders and are approved by the Compensation and  Management Development Committee of our Board of  Directors.
","('Director_Removal', 0.615310788154602)","('Management_Of_Legal_And_Regulatory_Framework', 0.05455389618873596)","('Business_Model_Resilience', 0.046544209122657776)","(['Anti-Crime Policy & Measures'], 0.615310788154602)","('NON-ESG', 0.05455389618873596)","('NON-ESG', 0.046544209122657776)"
Line 403,"We are committed to the highest standards of patient safety  and quality in our products and services and to world-class  integrity and ethical business practices.
","('Product_Quality_And_Safety', 0.9009372591972351)","('Product_Design_And_Lifecycle_Management', 0.01297296304255724)","('Selling_Practices_And_Product_Labeling', 0.011710074730217457)","(['Product Quality & Recall Management'], 0.9009372591972351)","('NON-ESG', 0.01297296304255724)","('NON-ESG', 0.011710074730217457)"
Line 404,"In support of this  commitment, and to drive accountability for compliance  with, and sustained improvements in, our global quality  system, the Compensation and Management Development  Committee included a global quality bonus modifier  component to executives’ annual cash incentive plan in  2021.
","('Business_Ethics', 0.4858950078487396)","('Management_Of_Legal_And_Regulatory_Framework', 0.3427358865737915)","('Labor_Practices', 0.029979219660162926)","('NON-ESG', 0.4858950078487396)","('NON-ESG', 0.3427358865737915)","('NON-ESG', 0.029979219660162926)"
Line 405,"The modifier was designed such that, based on the  achievement of specified global quality metrics related to  our FDA inspection results, it could result in a decrease (but not an increase) to executives’ 2021 bonus payouts by up to  5%.
","('Labor_Practices', 0.5200170874595642)","('Business_Ethics', 0.19053997099399567)","('Management_Of_Legal_And_Regulatory_Framework', 0.07719947397708893)","(['Labor Practice Indicators'], 0.5200170874595642)","('NON-ESG', 0.19053997099399567)","('NON-ESG', 0.07719947397708893)"
Line 406,"In 2021, across our global network, we received no new  FDA Warning Letters and our average number of Form 483  observations per inspection was less than 3.0. As a result,  the global quality bonus modifier had no impact on our  executives’ 2021 bonus payouts.
","('Labor_Practices', 0.357723593711853)","('Management_Of_Legal_And_Regulatory_Framework', 0.2581043243408203)","('Business_Ethics', 0.14651940762996674)","('NON-ESG', 0.357723593711853)","('NON-ESG', 0.2581043243408203)","('NON-ESG', 0.14651940762996674)"
Line 407,"For more information on our executive compensation  philosophy and programs, please see our 2022 proxy  statement .
","('Management_Of_Legal_And_Regulatory_Framework', 0.4584483802318573)","('Competitive_Behavior', 0.12410599738359451)","('Labor_Practices', 0.08505627512931824)","('NON-ESG', 0.4584483802318573)","('NON-ESG', 0.12410599738359451)","('NON-ESG', 0.08505627512931824)"
Line 408,"Ethical Business Conduct We are committed to being a leader in the area of ethics and  compliance.
","('Business_Ethics', 0.9691653847694397)","('Product_Quality_And_Safety', 0.002460602903738618)","('Customer_Privacy', 0.0024052311200648546)","(['Business Ethics'], 0.9691653847694397)","('NON-ESG', 0.002460602903738618)","('NON-ESG', 0.0024052311200648546)"
Line 409,"Every day, we strive for the highest standards  of patient safety, quality and integrity in all that we do.
","('Product_Quality_And_Safety', 0.6623311042785645)","('Employee_Health_And_Safety', 0.1706104576587677)","('Access_And_Affordability', 0.017398474738001823)","(['Product Quality & Recall Management'], 0.6623311042785645)","('NON-ESG', 0.1706104576587677)","('NON-ESG', 0.017398474738001823)"
Line 410,"Whether working with surgeons, regulators, distributors,  partners or fellow team members, we know that what we do  to contribute to our mission is as important as how we do it.
","('Management_Of_Legal_And_Regulatory_Framework', 0.28657007217407227)","('Business_Model_Resilience', 0.17860601842403412)","('Human_Rights_And_Community_Relations', 0.09554172307252884)","('NON-ESG', 0.28657007217407227)","('NON-ESG', 0.17860601842403412)","('NON-ESG', 0.09554172307252884)"
Line 411,"Our commitment to doing business with integrity is guided  by the comprehensive compliance policies and procedures  that help team members and business partners navigate  the applicable laws, regulations and industry codes, as well  as Zimmer Biomet’s own ethical standards.
","('Business_Ethics', 0.9649388194084167)","('Management_Of_Legal_And_Regulatory_Framework', 0.007682612631469965)","('Product_Quality_And_Safety', 0.002940288046374917)","(['Business Ethics'], 0.9649388194084167)","('NON-ESG', 0.007682612631469965)","('NON-ESG', 0.002940288046374917)"
Line 412,"These standards  are outlined in Zimmer Biomet’s Code of Business Conduct  and Ethics.
","('Business_Ethics', 0.9710025787353516)","('Management_Of_Legal_And_Regulatory_Framework', 0.002705718157812953)","('Director_Removal', 0.0023086932487785816)","(['Business Ethics'], 0.9710025787353516)","('NON-ESG', 0.002705718157812953)","('NON-ESG', 0.0023086932487785816)"
Line 413,"The Code defines Zimmer Biomet’s approach to delivering  high performance with high integrity, and articulates  the ethical standards by which team members are held  accountable.
","('Business_Ethics', 0.954217255115509)","('Product_Quality_And_Safety', 0.003614529501646757)","('Human_Rights_And_Community_Relations', 0.0033368943259119987)","(['Business Ethics'], 0.954217255115509)","('NON-ESG', 0.003614529501646757)","('NON-ESG', 0.0033368943259119987)"
Line 414,"It also guides and inspires positive interactions  with customers and with people in the communities in  which we live and work.
","('Human_Rights_And_Community_Relations', 0.9326108694076538)","('Access_And_Affordability', 0.011638911440968513)","('Employee_Engagement_Inclusion_And_Diversity', 0.007027554791420698)","(['Community Relations'], 0.9326108694076538)","('NON-ESG', 0.011638911440968513)","('NON-ESG', 0.007027554791420698)"
Line 415,"So that every team member understands and is accountable  for our Code, and has access to it, it is available online in  33 languages.
","('Management_Of_Legal_And_Regulatory_Framework', 0.33600345253944397)","('Access_And_Affordability', 0.16218040883541107)","('Data_Security', 0.12286264449357986)","('NON-ESG', 0.33600345253944397)","('NON-ESG', 0.16218040883541107)","('NON-ESG', 0.12286264449357986)"
Line 416,"Zimmer Biomet also requires training for  all newly hired team members within the first 60 days of  employment and retrains all team members annually.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6169179677963257)","('Labor_Practices', 0.13361415266990662)","('Director_Removal', 0.05852718651294708)","(['Human Capital Development'], 0.6169179677963257)","('NON-ESG', 0.13361415266990662)","('NON-ESG', 0.05852718651294708)"
Line 417,"In 2021, 100% of team members put their collective integrity  into action, successfully completing the Code of Business  Conduct & Ethics training in addition to Conflicts of Interest  and Anti-Bribery and Anti-Corruption trainings.
","('Business_Ethics', 0.9760773777961731)","('Management_Of_Legal_And_Regulatory_Framework', 0.001922348514199257)","('Competitive_Behavior', 0.001896561705507338)","(['Business Ethics'], 0.9760773777961731)","('NON-ESG', 0.001922348514199257)","('NON-ESG', 0.001896561705507338)"
Line 418,"100% COMPLETED ETHICS TRAININGIn 2021:  • 100 percent of team  members successfully  completed the Code   of Business Conduct   & Ethics training Annually, we mark our commitment to the highest levels  of integrity and ethical business practices by hosting  “Compliance Week”.
","('Business_Ethics', 0.9651707410812378)","('Product_Quality_And_Safety', 0.0031772786751389503)","('Customer_Privacy', 0.0025206906720995903)","(['Business Ethics'], 0.9651707410812378)","('NON-ESG', 0.0031772786751389503)","('NON-ESG', 0.0025206906720995903)"
Line 419,"The intent is to maintain and increase  awareness about the Compliance program and the  resources available, further strengthening our compliance  culture by engaging team members in activities and  communications that promote ethics and integrity.
","('Business_Ethics', 0.9651572108268738)","('Management_Of_Legal_And_Regulatory_Framework', 0.004814943764358759)","('Product_Quality_And_Safety', 0.0029834844172000885)","(['Business Ethics'], 0.9651572108268738)","('NON-ESG', 0.004814943764358759)","('NON-ESG', 0.0029834844172000885)"
Line 420,"In 2021, the format for Zimmer Biomet’s sixth annual  Compliance Week celebration was largely virtual due to the  COVID-19 pandemic.
","('Physical_Impacts_Of_Climate_Change', 0.3191072344779968)","('Systemic_Risk_Management', 0.15142597258090973)","('Air_Quality', 0.08899834007024765)","('NON-ESG', 0.3191072344779968)","('NON-ESG', 0.15142597258090973)","('NON-ESG', 0.08899834007024765)"
Line 421,"Team members participated in group  video watch parties of two thought-provoking and engaging  discussions about the importance of raising concerns and  how that protects Zimmer Biomet, including a review of  real-life examples where Zimmer Biomet team members  have spoken up.
","('Systemic_Risk_Management', 0.21527694165706635)","('Business_Ethics', 0.1129557192325592)","('Business_Model_Resilience', 0.10350609570741653)","('NON-ESG', 0.21527694165706635)","('NON-ESG', 0.1129557192325592)","('NON-ESG', 0.10350609570741653)"
Line 422,"Locally, team members participated in  discussions with leaders, meet-and-greet events with  Compliance team members, and educative trivia contests.
","('Employee_Engagement_Inclusion_And_Diversity', 0.4412669837474823)","('Human_Rights_And_Community_Relations', 0.13542883098125458)","('Director_Removal', 0.08264531940221786)","('NON-ESG', 0.4412669837474823)","('NON-ESG', 0.13542883098125458)","('NON-ESG', 0.08264531940221786)"
Line 423,"We are also committed to compliance with a variety of  industry codes designed to ensure that relationships  with healthcare professionals and other customers  are conducted in accordance with the highest ethical  standards and transparency.
","('Business_Ethics', 0.9721385836601257)","('Management_Of_Legal_And_Regulatory_Framework', 0.0025465511716902256)","('Product_Quality_And_Safety', 0.00236461590975523)","(['Business Ethics'], 0.9721385836601257)","('NON-ESG', 0.0025465511716902256)","('NON-ESG', 0.00236461590975523)"
Line 424,"These codes each recognize  that adherence to ethical standards and compliance  with applicable laws is critical to the industry’s ability to  preserve and promote its collaboration with healthcare  professionals and serve to clarify and distinguish between  appropriate and inappropriate activity between healthcare  professionals and companies.
","('Business_Ethics', 0.9532704949378967)","('Management_Of_Legal_And_Regulatory_Framework', 0.0104448851197958)","('Product_Quality_And_Safety', 0.006740348879247904)","(['Business Ethics'], 0.9532704949378967)","('NON-ESG', 0.0104448851197958)","('NON-ESG', 0.006740348879247904)"
Line 425,"Without reservation, Zimmer Biomet strongly endorses the  spirit and the letter of the industry codes for associations of  which Zimmer Biomet is a member, including:• ABHI (UK)  • ABIMED Code of Conduct (Brazil) • ABIMO (Brazil) • ABRAIDI (Brazil) • AdvaMed China (China) • AdvaMed Code of Ethics (United States) • American Medical Devices and Diagnostics  Manufacturers’ Association (Japan)  • AMID (Mexico) • APOMED (Portugal)  • ARTED (Turkey) • Austromed: Verhaltenskodex (Austria) • beMedTech (Belgium) • BVMed: Kodex Medizinprodukte (Germany) • CANIFARMA (Mexico) • Confindustria dispositivi medici (Italy) • CZECHMED (Czech Republic)  • Fenin Code of Ethics (Spain) • IMEDA (CIS)  • Instituto Ética Saúde (Brazil) • Korea Medical Devices Industry Association (Korea)  • Mecomed Code of Ethical Business Practice   (Middle East) • Medical Technology Association of India (India)  • Medical Technology Industry Group (Singapore)  • Medicoindustrien (Denmark) • MedTech Europe: Code of Ethical Business Practice • MedTech Sweden (Sweden) • MTAA Code of Practice (Australia)  • MTANZ Code of Practice (New Zealand)  • Nefemed (Netherlands) • ORDER (Turkey)  • Salib-MedTech (Finland)  • SAMED: Medical Device Code of Ethical Marketing  and Business Practice (South Africa) • SNITEM (France) • Swiss Medtech (Switzerland) • Thai Medical Device Technology Industry  Association (Thailand) Countering Corruption The cornerstone of our best-in-class compliance program  is Zimmer Biomet’s commitment to ensuring that team  members and business partners conduct themselves  ethically and in compliance with all applicable laws,  regulations, industry codes, and our own policies, including  refraining from any bribery, kickback or corruption-related  activities.
","('Business_Ethics', 0.5345478653907776)","('Product_Quality_And_Safety', 0.12646956741809845)","('Management_Of_Legal_And_Regulatory_Framework', 0.09154193848371506)","(['Business Ethics'], 0.5345478653907776)","('NON-ESG', 0.12646956741809845)","('NON-ESG', 0.09154193848371506)"
Line 426,"Without reservation, Zimmer Biomet strongly endorses the  spirit and the letter of the industry codes for associations of  which Zimmer Biomet is a member, including:• ABHI (UK)  • ABIMED Code of Conduct (Brazil) • ABIMO (Brazil) • ABRAIDI (Brazil) • AdvaMed China (China) • AdvaMed Code of Ethics (United States) • American Medical Devices and Diagnostics  Manufacturers’ Association (Japan)  • AMID (Mexico) • APOMED (Portugal)  • ARTED (Turkey) • Austromed: Verhaltenskodex (Austria) • beMedTech (Belgium) • BVMed: Kodex Medizinprodukte (Germany) • CANIFARMA (Mexico) • Confindustria dispositivi medici (Italy) • CZECHMED (Czech Republic)  • Fenin Code of Ethics (Spain) • IMEDA (CIS)  • Instituto Ética Saúde (Brazil) • Korea Medical Devices Industry Association (Korea)  • Mecomed Code of Ethical Business Practice   (Middle East) • Medical Technology Association of India (India)  • Medical Technology Industry Group (Singapore)  • Medicoindustrien (Denmark) • MedTech Europe: Code of Ethical Business Practice • MedTech Sweden (Sweden) • MTAA Code of Practice (Australia)  • MTANZ Code of Practice (New Zealand)  • Nefemed (Netherlands) • ORDER (Turkey)  • Salib-MedTech (Finland)  • SAMED: Medical Device Code of Ethical Marketing  and Business Practice (South Africa) • SNITEM (France) • Swiss Medtech (Switzerland) • Thai Medical Device Technology Industry  Association (Thailand) Countering Corruption The cornerstone of our best-in-class compliance program  is Zimmer Biomet’s commitment to ensuring that team  members and business partners conduct themselves  ethically and in compliance with all applicable laws,  regulations, industry codes, and our own policies, including  refraining from any bribery, kickback or corruption-related  activities.
","('Business_Ethics', 0.890708863735199)","('Competitive_Behavior', 0.015990041196346283)","('Product_Quality_And_Safety', 0.010254327207803726)","(['Business Ethics'], 0.890708863735199)","('NON-ESG', 0.015990041196346283)","('NON-ESG', 0.010254327207803726)"
Line 427,"Without reservation, Zimmer Biomet strongly endorses the  spirit and the letter of the industry codes for associations of  which Zimmer Biomet is a member, including:• ABHI (UK)  • ABIMED Code of Conduct (Brazil) • ABIMO (Brazil) • ABRAIDI (Brazil) • AdvaMed China (China) • AdvaMed Code of Ethics (United States) • American Medical Devices and Diagnostics  Manufacturers’ Association (Japan)  • AMID (Mexico) • APOMED (Portugal)  • ARTED (Turkey) • Austromed: Verhaltenskodex (Austria) • beMedTech (Belgium) • BVMed: Kodex Medizinprodukte (Germany) • CANIFARMA (Mexico) • Confindustria dispositivi medici (Italy) • CZECHMED (Czech Republic)  • Fenin Code of Ethics (Spain) • IMEDA (CIS)  • Instituto Ética Saúde (Brazil) • Korea Medical Devices Industry Association (Korea)  • Mecomed Code of Ethical Business Practice   (Middle East) • Medical Technology Association of India (India)  • Medical Technology Industry Group (Singapore)  • Medicoindustrien (Denmark) • MedTech Europe: Code of Ethical Business Practice • MedTech Sweden (Sweden) • MTAA Code of Practice (Australia)  • MTANZ Code of Practice (New Zealand)  • Nefemed (Netherlands) • ORDER (Turkey)  • Salib-MedTech (Finland)  • SAMED: Medical Device Code of Ethical Marketing  and Business Practice (South Africa) • SNITEM (France) • Swiss Medtech (Switzerland) • Thai Medical Device Technology Industry  Association (Thailand) Countering Corruption The cornerstone of our best-in-class compliance program  is Zimmer Biomet’s commitment to ensuring that team  members and business partners conduct themselves  ethically and in compliance with all applicable laws,  regulations, industry codes, and our own policies, including  refraining from any bribery, kickback or corruption-related  activities.
","('Business_Ethics', 0.9182906746864319)","('Product_Quality_And_Safety', 0.01169551070779562)","('Competitive_Behavior', 0.011151625774800777)","(['Business Ethics'], 0.9182906746864319)","('NON-ESG', 0.01169551070779562)","('NON-ESG', 0.011151625774800777)"
Line 428,"Without reservation, Zimmer Biomet strongly endorses the  spirit and the letter of the industry codes for associations of  which Zimmer Biomet is a member, including:• ABHI (UK)  • ABIMED Code of Conduct (Brazil) • ABIMO (Brazil) • ABRAIDI (Brazil) • AdvaMed China (China) • AdvaMed Code of Ethics (United States) • American Medical Devices and Diagnostics  Manufacturers’ Association (Japan)  • AMID (Mexico) • APOMED (Portugal)  • ARTED (Turkey) • Austromed: Verhaltenskodex (Austria) • beMedTech (Belgium) • BVMed: Kodex Medizinprodukte (Germany) • CANIFARMA (Mexico) • Confindustria dispositivi medici (Italy) • CZECHMED (Czech Republic)  • Fenin Code of Ethics (Spain) • IMEDA (CIS)  • Instituto Ética Saúde (Brazil) • Korea Medical Devices Industry Association (Korea)  • Mecomed Code of Ethical Business Practice   (Middle East) • Medical Technology Association of India (India)  • Medical Technology Industry Group (Singapore)  • Medicoindustrien (Denmark) • MedTech Europe: Code of Ethical Business Practice • MedTech Sweden (Sweden) • MTAA Code of Practice (Australia)  • MTANZ Code of Practice (New Zealand)  • Nefemed (Netherlands) • ORDER (Turkey)  • Salib-MedTech (Finland)  • SAMED: Medical Device Code of Ethical Marketing  and Business Practice (South Africa) • SNITEM (France) • Swiss Medtech (Switzerland) • Thai Medical Device Technology Industry  Association (Thailand) Countering Corruption The cornerstone of our best-in-class compliance program  is Zimmer Biomet’s commitment to ensuring that team  members and business partners conduct themselves  ethically and in compliance with all applicable laws,  regulations, industry codes, and our own policies, including  refraining from any bribery, kickback or corruption-related  activities.
","('Business_Ethics', 0.9760050177574158)","('Management_Of_Legal_And_Regulatory_Framework', 0.0026340223848819733)","('Competitive_Behavior', 0.002015321981161833)","(['Business Ethics'], 0.9760050177574158)","('NON-ESG', 0.0026340223848819733)","('NON-ESG', 0.002015321981161833)"
Line 429,"We have established anti-bribery and anti-corruption  policies and procedures that cover, among other things,  interactions with healthcare providers and government  officials.
","('Business_Ethics', 0.9754212498664856)","('Management_Of_Legal_And_Regulatory_Framework', 0.0027028280310332775)","('Competitive_Behavior', 0.0019245569128543139)","(['Business Ethics'], 0.9754212498664856)","('NON-ESG', 0.0027028280310332775)","('NON-ESG', 0.0019245569128543139)"
Line 430,"These policies and procedures are reinforced  by a robust, interactive, annual training program as well  as periodic auditing and monitoring.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9236342906951904)","('Business_Ethics', 0.014448227360844612)","('Human_Rights_And_Community_Relations', 0.009454325772821903)","(['Corporate Governance'], 0.9236342906951904)","('NON-ESG', 0.014448227360844612)","('NON-ESG', 0.009454325772821903)"
Line 431,"Zimmer Biomet  has a zero-tolerance policy when it comes to bribery and  corruption.
","('Business_Ethics', 0.9743273854255676)","('Competitive_Behavior', 0.0022987471893429756)","('Management_Of_Legal_And_Regulatory_Framework', 0.0020360175985842943)","(['Business Ethics'], 0.9743273854255676)","('NON-ESG', 0.0022987471893429756)","('NON-ESG', 0.0020360175985842943)"
Line 432,"Zimmer Biomet’s Global Third-Party Compliance team  supports and monitors business partners, such as  distributors, to help ensure they adhere to the same  ethical standards as our team members.
","('Business_Ethics', 0.9358208179473877)","('Product_Quality_And_Safety', 0.011074191890656948)","('Management_Of_Legal_And_Regulatory_Framework', 0.00923059694468975)","(['Business Ethics'], 0.9358208179473877)","('NON-ESG', 0.011074191890656948)","('NON-ESG', 0.00923059694468975)"
Line 433,"Zimmer Biomet  also performs anti-corruption due diligence prior to  engaging a third party, and periodically during the course  of our relationship with a third-party, in addition to third- party compliance audits.
","('Business_Ethics', 0.9696810245513916)","('Management_Of_Legal_And_Regulatory_Framework', 0.004374625161290169)","('Systemic_Risk_Management', 0.0026605085004121065)","(['Business Ethics'], 0.9696810245513916)","('NON-ESG', 0.004374625161290169)","('NON-ESG', 0.0026605085004121065)"
Line 434,"In 2021, we introduced a new  due diligence platform that provides improved real-time  visibility of the due diligence process, a more user-friendly  interface and enhanced reporting capabilities.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8672823309898376)","('Business_Ethics', 0.025231869891285896)","('Competitive_Behavior', 0.015279985964298248)","(['Corporate Governance'], 0.8672823309898376)","('NON-ESG', 0.025231869891285896)","('NON-ESG', 0.015279985964298248)"
Line 435,"Zimmer Biomet also has a dedicated global compliance  investigations team staffed by experienced anti-corruption  investigators who manage and conduct all compliance  investigations.
","('Business_Ethics', 0.9689621925354004)","('Management_Of_Legal_And_Regulatory_Framework', 0.00610866816714406)","('Data_Security', 0.00215325434692204)","(['Business Ethics'], 0.9689621925354004)","('NON-ESG', 0.00610866816714406)","('NON-ESG', 0.00215325434692204)"
Line 436,"Whistleblower Program Team members, business partners, customers and  members of the public are encouraged and empowered to  speak up when they become aware of behavior that may be  in violation of Zimmer Biomet’s policies, applicable laws, or  industry practices.
","('Business_Ethics', 0.9521647095680237)","('Management_Of_Legal_And_Regulatory_Framework', 0.006879254709929228)","('Data_Security', 0.006051403470337391)","(['Business Ethics'], 0.9521647095680237)","('NON-ESG', 0.006879254709929228)","('NON-ESG', 0.006051403470337391)"
Line 437,"Every team member and business partner has a  responsibility as outlined in the Code of Business Conduct  and Ethics to be a voice of integrity.
","('Business_Ethics', 0.9634303450584412)","('Customer_Privacy', 0.003137642750516534)","('Employee_Engagement_Inclusion_And_Diversity', 0.002750750631093979)","(['Business Ethics'], 0.9634303450584412)","('NON-ESG', 0.003137642750516534)","('NON-ESG', 0.002750750631093979)"
Line 438,"In 2021, Zimmer Biomet introduced the new “Speak Up  Hotline” where concerns can be raised confidentially or  anonymously, 24 hours a day, seven days a week.
","('Data_Security', 0.39601099491119385)","('Customer_Privacy', 0.3514076769351959)","('Business_Ethics', 0.06968388706445694)","('NON-ESG', 0.39601099491119385)","('NON-ESG', 0.3514076769351959)","('NON-ESG', 0.06968388706445694)"
Line 439,"The  “Speak Up Hotline” replaced a prior compliance hotline  platform that had been utilized for many years.Team members can use the hotline to report any concern  about a known or potential violation, concerns about safety  in the workplace, potential discrimination or harassment,  unethical behavior by another team member or a third- party vendor or distributor, falsification of documents or  misuse of Zimmer Biomet resources.
","('Business_Ethics', 0.606741189956665)","('Employee_Health_And_Safety', 0.08914612233638763)","('Employee_Engagement_Inclusion_And_Diversity', 0.07336121797561646)","(['Business Ethics'], 0.606741189956665)","('NON-ESG', 0.08914612233638763)","('NON-ESG', 0.07336121797561646)"
Line 440,"In addition to the “Speak Up Hotline”, concerns can also be  raised directly to managers or Compliance or HR business  partners.
","('Business_Ethics', 0.5619069933891296)","('Systemic_Risk_Management', 0.1193147599697113)","('Management_Of_Legal_And_Regulatory_Framework', 0.08967452496290207)","(['Business Ethics'], 0.5619069933891296)","('NON-ESG', 0.1193147599697113)","('NON-ESG', 0.08967452496290207)"
Line 441,"Zimmer Biomet prohibits retaliation against anyone  who makes a good faith report of a known or suspected  compliance or legal issue.
","('Business_Ethics', 0.9039357900619507)","('Management_Of_Legal_And_Regulatory_Framework', 0.04439077526330948)","('Product_Quality_And_Safety', 0.005618207156658173)","(['Business Ethics'], 0.9039357900619507)","('NON-ESG', 0.04439077526330948)","('NON-ESG', 0.005618207156658173)"
Line 442,"Retaliation in any form is  unacceptable and not tolerated.
","('Business_Ethics', 0.869886040687561)","('Labor_Practices', 0.02296995185315609)","('Competitive_Behavior', 0.011853125877678394)","(['Business Ethics'], 0.869886040687561)","('NON-ESG', 0.02296995185315609)","('NON-ESG', 0.011853125877678394)"
Line 443,"Our Compliance team tracks and oversees all reported  concerns from investigation to resolution.
","('Business_Ethics', 0.8355777859687805)","('Management_Of_Legal_And_Regulatory_Framework', 0.07922336459159851)","('Product_Quality_And_Safety', 0.009795957244932652)","(['Business Ethics'], 0.8355777859687805)","('NON-ESG', 0.07922336459159851)","('NON-ESG', 0.009795957244932652)"
Line 444,"We have  instituted a robust and rigorous remediation process to  ensure appropriate corrective actions are implemented  following all substantiated investigations, such as team  member separations, documented warnings and retraining.
","('Business_Ethics', 0.23731876909732819)","('Employee_Health_And_Safety', 0.17012391984462738)","('Critical_Incident_Risk_Management', 0.16016195714473724)","('NON-ESG', 0.23731876909732819)","('NON-ESG', 0.17012391984462738)","('NON-ESG', 0.16016195714473724)"
Line 445,"The Hotline Investigations Steering Committee guides and  ensures consistent disciplinary decision-making of these  actions.
","('Business_Ethics', 0.5455359220504761)","('Management_Of_Legal_And_Regulatory_Framework', 0.23769988119602203)","('Product_Quality_And_Safety', 0.025294823572039604)","(['Business Ethics'], 0.5455359220504761)","('NON-ESG', 0.23769988119602203)","('NON-ESG', 0.025294823572039604)"
Line 446,"In addition, the Audit Committee of our Board of  Directors receives frequent reports on hotline complaints,  investigations and corrective actions.
","('Business_Ethics', 0.4880558252334595)","('Management_Of_Legal_And_Regulatory_Framework', 0.3200085759162903)","('Director_Removal', 0.04604073241353035)","('NON-ESG', 0.4880558252334595)","('NON-ESG', 0.3200085759162903)","('NON-ESG', 0.04604073241353035)"
Line 447,"In 2021, there were more than 90 compliance concerns  reported and investigated.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5823452472686768)","('Business_Ethics', 0.2370421588420868)","('Product_Quality_And_Safety', 0.02024734579026699)","(['Corporate Governance'], 0.5823452472686768)","('NON-ESG', 0.2370421588420868)","('NON-ESG', 0.02024734579026699)"
Line 448,"We had 100% completion of  all remediation activities arising from these compliance  investigations, in addition to audits and monitoring.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6718745231628418)","('Business_Ethics', 0.1598452925682068)","('Human_Rights_And_Community_Relations', 0.022030847147107124)","(['Corporate Governance'], 0.6718745231628418)","('NON-ESG', 0.1598452925682068)","('NON-ESG', 0.022030847147107124)"
Line 449,"100% COMPLETION REMEDIATION ACTIVITIES 2223Ethical Marketing Zimmer Biomet is committed to marketing our products  and services truthfully, responsibly and professionally.
","('Product_Design_And_Lifecycle_Management', 0.5663676857948303)","('Selling_Practices_And_Product_Labeling', 0.20234651863574982)","('Product_Quality_And_Safety', 0.05394216999411583)","(['Product Stewardship'], 0.5663676857948303)","('NON-ESG', 0.20234651863574982)","('NON-ESG', 0.05394216999411583)"
Line 450,"We engage in marketing activities to, among other things,  announce the availability of new products and services,  reinforce existing customer choices, differentiate Zimmer  Biomet products and services from other products and  services in the marketplace, and increase awareness  of medical technologies and treatments to healthcare  professionals (HCPs), patients and others.
","('Product_Design_And_Lifecycle_Management', 0.8467769622802734)","('Selling_Practices_And_Product_Labeling', 0.043454401195049286)","('Customer_Welfare', 0.02917122282087803)","(['Product Stewardship'], 0.8467769622802734)","('NON-ESG', 0.043454401195049286)","('NON-ESG', 0.02917122282087803)"
Line 451,"All marketing activities conducted by Zimmer Biomet must  have a commercially reasonable and legitimate business  purpose, and cannot involve cash, fees or other forms  of compensation provided directly or indirectly to HCPs  or public officials.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6250786781311035)","('Business_Ethics', 0.16343513131141663)","('Competitive_Behavior', 0.053299032151699066)","(['Corporate Governance'], 0.6250786781311035)","('NON-ESG', 0.16343513131141663)","('NON-ESG', 0.053299032151699066)"
Line 452,"Marketing activities are also expected  to be separate from any company-sponsored training or  education program.
","('Access_And_Affordability', 0.17545095086097717)","('Customer_Welfare', 0.13603447377681732)","('Product_Quality_And_Safety', 0.09022361785173416)","('NON-ESG', 0.17545095086097717)","('NON-ESG', 0.13603447377681732)","('NON-ESG', 0.09022361785173416)"
Line 453,"We do not use marketing to improperly  influence purchasing, leasing, recommendation, use,  prescription or coverage decisions associated with our  products and services.Zimmer Biomet’s Statement of  Engagement on Public Policy Issues  We operate in a heavily regulated global marketplace and  it is important to be able to express our views on a variety  of proposals to policymakers and other stakeholders in  a transparent manner.
","('Selling_Practices_And_Product_Labeling', 0.3773314654827118)","('Management_Of_Legal_And_Regulatory_Framework', 0.09608444571495056)","('Competitive_Behavior', 0.08488734066486359)","('NON-ESG', 0.3773314654827118)","('NON-ESG', 0.09608444571495056)","('NON-ESG', 0.08488734066486359)"
Line 454,"These efforts include monitoring  public policy proposals, analyzing these proposals and  advocating for those policies that enhance patient and  healthcare provider access to innovative technologies to  treat debilitating joint pain and musculoskeletal conditions.
","('Employee_Health_And_Safety', 0.8456416726112366)","('Access_And_Affordability', 0.022913143038749695)","('Employee_Engagement_Inclusion_And_Diversity', 0.014657552354037762)","(['Operational Eco-Efficiency'], 0.8456416726112366)","('NON-ESG', 0.022913143038749695)","('NON-ESG', 0.014657552354037762)"
Line 455,"Zimmer Biomet is committed to participating constructively  and responsibly in the public policy process.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9145978093147278)","('Human_Rights_And_Community_Relations', 0.013873191550374031)","('Physical_Impacts_Of_Climate_Change', 0.007863697595894337)","(['Corporate Governance'], 0.9145978093147278)","('NON-ESG', 0.013873191550374031)","('NON-ESG', 0.007863697595894337)"
Line 456,"Government  policy proposals to regulate the healthcare system may  directly affect Zimmer Biomet’s business and the incentives  for innovation.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9666688442230225)","('Access_And_Affordability', 0.003994416911154985)","('Human_Rights_And_Community_Relations', 0.0024459506385028362)","(['Corporate Governance'], 0.9666688442230225)","('NON-ESG', 0.003994416911154985)","('NON-ESG', 0.0024459506385028362)"
Line 457,"There are also important policy proposals  that can further our business interests, including those of  our shareholders.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7944828867912292)","('Director_Removal', 0.031235210597515106)","('Business_Model_Resilience', 0.02886105328798294)","(['Corporate Governance'], 0.7944828867912292)","('NON-ESG', 0.031235210597515106)","('NON-ESG', 0.02886105328798294)"
Line 458,"Zimmer Biomet actively seeks to inform the debate on these  proposals in the United States and in other countries.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9210110306739807)","('GHG_Emissions', 0.008789094164967537)","('Physical_Impacts_Of_Climate_Change', 0.008547734469175339)","(['Corporate Governance'], 0.9210110306739807)","('NON-ESG', 0.008789094164967537)","('NON-ESG', 0.008547734469175339)"
Line 459,"We  also support policies that advance the interests of patients,  improve public health and promote access to healthcare  and innovation.
","('Access_And_Affordability', 0.8676876425743103)","('Human_Rights_And_Community_Relations', 0.017775647342205048)","('Product_Quality_And_Safety', 0.011232990771532059)","(['Health Outcome Contribution'], 0.8676876425743103)","('NON-ESG', 0.017775647342205048)","('NON-ESG', 0.011232990771532059)"
Line 460,"Our engagement in the political process is focused on the  following areas: • Access to musculoskeletal care • Transparent, timely, and scientifically-based regulatory  decision-making • Market-based payment or reimbursement • Strong protection of patents and other intellectual  property rights • Open and competitive access to international markets • Tax policies that support innovation and global  competitiveness  • Sensible medical malpractice reform Specific policies of interest to Zimmer Biomet include the  following: • Corporate Tax Policy  – Zimmer Biomet supported  the changes to the U.S. corporate tax code in 2017 ,  which created a more globally competitive system for  U.S. businesses by lowering the corporate tax rate and  shifting to a territorial system.
","('Competitive_Behavior', 0.8046143054962158)","('Management_Of_Legal_And_Regulatory_Framework', 0.09822964668273926)","('Business_Ethics', 0.02396213635802269)","(['Business Ethics'], 0.8046143054962158)","('NON-ESG', 0.09822964668273926)","('NON-ESG', 0.02396213635802269)"
Line 461,"Our engagement in the political process is focused on the  following areas: • Access to musculoskeletal care • Transparent, timely, and scientifically-based regulatory  decision-making • Market-based payment or reimbursement • Strong protection of patents and other intellectual  property rights • Open and competitive access to international markets • Tax policies that support innovation and global  competitiveness  • Sensible medical malpractice reform Specific policies of interest to Zimmer Biomet include the  following: • Corporate Tax Policy  – Zimmer Biomet supported  the changes to the U.S. corporate tax code in 2017 ,  which created a more globally competitive system for  U.S. businesses by lowering the corporate tax rate and  shifting to a territorial system.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9646768569946289)","('Competitive_Behavior', 0.005394831765443087)","('Energy_Management', 0.0032460507936775684)","(['Corporate Governance'], 0.9646768569946289)","('NON-ESG', 0.005394831765443087)","('NON-ESG', 0.0032460507936775684)"
Line 462,"• Stability in Payment Policies  – As innovation in  medical technology changes the way that care is  delivered, Zimmer Biomet supports payment and  reimbursement policies that ensure stability and  access for patients, providers, innovators and the  entire healthcare ecosystem.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5227261185646057)","('Business_Ethics', 0.1525350660085678)","('Systemic_Risk_Management', 0.1279590129852295)","(['Corporate Governance'], 0.5227261185646057)","('NON-ESG', 0.1525350660085678)","('NON-ESG', 0.1279590129852295)"
Line 463,"• Diversity, Equity and Inclusion – Zimmer Biomet  supports policies that strengthen a diverse and  inclusive medical technology workforce and ensure  equitable patient access to innovative devices and  therapies.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9746125340461731)","('Employee_Health_And_Safety', 0.0021498682908713818)","('Human_Rights_And_Community_Relations', 0.0016170217422768474)","(['Human Capital Development'], 0.9746125340461731)","('NON-ESG', 0.0021498682908713818)","('NON-ESG', 0.0016170217422768474)"
Line 464,"• Medical Device User Fee Amendments (MDUFA)  – Zimmer Biomet supports a well-resourced and well- functioning U.S. Food and Drug Administration (FDA).
","('Management_Of_Legal_And_Regulatory_Framework', 0.6149132251739502)","('Competitive_Behavior', 0.07667873799800873)","('Customer_Welfare', 0.04330259561538696)","(['Corporate Governance'], 0.6149132251739502)","('NON-ESG', 0.07667873799800873)","('NON-ESG', 0.04330259561538696)"
Line 465,"The long-standing user fee program has helped FDA  make significant improvements to the regulatory  approval process for new medical devices.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8865981698036194)","('Competitive_Behavior', 0.03997935727238655)","('Product_Quality_And_Safety', 0.007172728423029184)","(['Corporate Governance'], 0.8865981698036194)","('NON-ESG', 0.03997935727238655)","('NON-ESG', 0.007172728423029184)"
Line 466,"In 2021,  Zimmer Biomet and its industry trade group began  negotiations with FDA and Congress regarding  changes to MDUFA in anticipation of legislation in  2022.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9347241520881653)","('Competitive_Behavior', 0.00741902319714427)","('GHG_Emissions', 0.006509610451757908)","(['Corporate Governance'], 0.9347241520881653)","('NON-ESG', 0.00741902319714427)","('NON-ESG', 0.006509610451757908)"
Line 467,"• Support for International Trade Agreements  –  Zimmer Biomet supports trade policy initiatives that  seek to improve access to medical devices in overseas  export markets.How Zimmer Biomet Engages The primary means by which we engage in public policy  debate is through communication of information to  government officials, policy makers and their staffs.
","('Management_Of_Legal_And_Regulatory_Framework', 0.901526927947998)","('Competitive_Behavior', 0.01583857275545597)","('Human_Rights_And_Community_Relations', 0.009244638495147228)","(['Corporate Governance'], 0.901526927947998)","('NON-ESG', 0.01583857275545597)","('NON-ESG', 0.009244638495147228)"
Line 468,"Zimmer  Biomet’s Government Affairs office in Washington, D.C. is  responsible for advocacy activities with the U.S. Congress  and the Executive Branch, as well as advocacy at the  state level.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9385911822319031)","('Human_Rights_And_Community_Relations', 0.007084826938807964)","('Director_Removal', 0.006309676915407181)","(['Corporate Governance'], 0.9385911822319031)","('NON-ESG', 0.007084826938807964)","('NON-ESG', 0.006309676915407181)"
Line 469,"The Government Affairs office, which also has  staff outside the United States, reports to the Senior Vice  President and General Counsel.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8712693452835083)","('Director_Removal', 0.0190114788711071)","('Business_Ethics', 0.008834361098706722)","(['Corporate Governance'], 0.8712693452835083)","('NON-ESG', 0.0190114788711071)","('NON-ESG', 0.008834361098706722)"
Line 470,"Globally, we currently have  seven full-time employees wholly dedicated to Government  Affairs matters.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6569468975067139)","('Director_Removal', 0.08492693305015564)","('Labor_Practices', 0.03682408109307289)","(['Corporate Governance'], 0.6569468975067139)","('NON-ESG', 0.08492693305015564)","('NON-ESG', 0.03682408109307289)"
Line 471,"To assist with its advocacy and policy analysis work,  Zimmer Biomet occasionally contracts with private firms  specializing in government affairs advocacy.
","('Management_Of_Legal_And_Regulatory_Framework', 0.934499979019165)","('Human_Rights_And_Community_Relations', 0.009098520502448082)","('Director_Removal', 0.004745831713080406)","(['Corporate Governance'], 0.934499979019165)","('NON-ESG', 0.009098520502448082)","('NON-ESG', 0.004745831713080406)"
Line 472,"These firms  provide the organization with expertise on issues that are  important to Zimmer Biomet and our shareholders.
","('Management_Of_Legal_And_Regulatory_Framework', 0.504652738571167)","('Systemic_Risk_Management', 0.09631642699241638)","('Business_Ethics', 0.07504921406507492)","(['Corporate Governance'], 0.504652738571167)","('NON-ESG', 0.09631642699241638)","('NON-ESG', 0.07504921406507492)"
Line 473,"In compliance with the U.S. Lobbying Disclosure Act ,  Zimmer Biomet files quarterly reports with the U.S.  Congress describing our advocacy activities in Washington,  D.C. and the amount of money spent each quarter to  support these activities.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9167860746383667)","('Director_Removal', 0.01055851485580206)","('Business_Ethics', 0.007397431880235672)","(['Corporate Governance'], 0.9167860746383667)","('NON-ESG', 0.01055851485580206)","('NON-ESG', 0.007397431880235672)"
Line 474,"These reports also include the cost  of maintaining the Government Affairs office in Washington,  D.C. and the portion of Zimmer Biomet’s trade association  dues associated with advocacy activities.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9499933123588562)","('Director_Removal', 0.0055716861970722675)","('Business_Ethics', 0.005133521743118763)","(['Corporate Governance'], 0.9499933123588562)","('NON-ESG', 0.0055716861970722675)","('NON-ESG', 0.005133521743118763)"
Line 475,"To view Zimmer  Biomet’s quarterly lobbying expenditures, click on the  above link and search for Zimmer Biomet under registrant.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7830579876899719)","('Competitive_Behavior', 0.06448131799697876)","('Business_Ethics', 0.022270215675234795)","(['Corporate Governance'], 0.7830579876899719)","('NON-ESG', 0.06448131799697876)","('NON-ESG', 0.022270215675234795)"
Line 476,"All Zimmer Biomet team members and agents must abide  by our Code of Business Conduct and Ethics.
","('Business_Ethics', 0.9595661759376526)","('Customer_Privacy', 0.00456285523250699)","('Director_Removal', 0.0034547392278909683)","(['Business Ethics'], 0.9595661759376526)","('NON-ESG', 0.00456285523250699)","('NON-ESG', 0.0034547392278909683)"
Line 477,"This Code  covers a wide range of business practices and procedures,  and is designed to deter wrongdoing and promote the  highest ethical standards.
","('Business_Ethics', 0.971839189529419)","('Management_Of_Legal_And_Regulatory_Framework', 0.002628694288432598)","('Product_Quality_And_Safety', 0.0022902791388332844)","(['Business Ethics'], 0.971839189529419)","('NON-ESG', 0.002628694288432598)","('NON-ESG', 0.0022902791388332844)"
Line 478,"Among other things, the Code  makes clear that no illegal payments of any kind (monetary  or otherwise) are to be offered or made to an individual or  entity—including officials or employees of national, state,  local or foreign governments or national or foreign political  candidates—at any time or under any circumstances.
","('Business_Ethics', 0.9135029315948486)","('Management_Of_Legal_And_Regulatory_Framework', 0.02024383284151554)","('Labor_Practices', 0.009865078143775463)","(['Business Ethics'], 0.9135029315948486)","('NON-ESG', 0.02024383284151554)","('NON-ESG', 0.009865078143775463)"
Line 479,"24Industry Groups and Trade Associations We have membership in several industry and trade  groups and we work with these groups on a variety of  issues of importance to Zimmer Biomet and the medical  device industry.
","('Management_Of_Legal_And_Regulatory_Framework', 0.51317298412323)","('Competitive_Behavior', 0.1329897940158844)","('Labor_Practices', 0.06785954535007477)","(['Corporate Governance'], 0.51317298412323)","('NON-ESG', 0.1329897940158844)","('NON-ESG', 0.06785954535007477)"
Line 480,"These groups can help the industry reach  consensus on policy issues and be more effective with issue  advocacy.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7888920903205872)","('Human_Rights_And_Community_Relations', 0.06453129649162292)","('Physical_Impacts_Of_Climate_Change', 0.02858939953148365)","(['Corporate Governance'], 0.7888920903205872)","('NON-ESG', 0.06453129649162292)","('NON-ESG', 0.02858939953148365)"
Line 481,"With Zimmer Biomet representatives on the boards and  committees of industry groups and associations, we can  ask questions and voice concerns about policy or related  activities.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8960965275764465)","('Director_Removal', 0.023799272254109383)","('Human_Rights_And_Community_Relations', 0.009389819577336311)","(['Corporate Governance'], 0.8960965275764465)","('NON-ESG', 0.023799272254109383)","('NON-ESG', 0.009389819577336311)"
Line 482,"At times, we may not agree fully with the views of  these associations or their individual member companies;  in such instances, Zimmer Biomet reserves the right to  remove itself from related association or industry group  activities when we determine it is appropriate to do so.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3430332839488983)","('Director_Removal', 0.14973971247673035)","('Competitive_Behavior', 0.14106589555740356)","('NON-ESG', 0.3430332839488983)","('NON-ESG', 0.14973971247673035)","('NON-ESG', 0.14106589555740356)"
Line 483,"Following is a list of U.S. industry and trade groups of which  Zimmer Biomet is a member and for which we pay at least  $25,000 per year in membership fees, with the percentage  of fees attributable to non-tax deductible, federal lobbying  expenditures noted in italics:  • Advanced Medical Technology Association   (AdvaMed) – 10% • Medical Device Competitiveness Coalition   (MDCC) – 100%  • U.S. Chamber of Commerce – 20-25%  Political Contributions Zimmer Biomet’s policies prohibit contributions of  corporate funds to candidates, political party committees  and political action committees.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6631125807762146)","('Competitive_Behavior', 0.18176676332950592)","('Business_Ethics', 0.03540303558111191)","(['Corporate Governance'], 0.6631125807762146)","('NON-ESG', 0.18176676332950592)","('NON-ESG', 0.03540303558111191)"
Line 484,"Following is a list of U.S. industry and trade groups of which  Zimmer Biomet is a member and for which we pay at least  $25,000 per year in membership fees, with the percentage  of fees attributable to non-tax deductible, federal lobbying  expenditures noted in italics:  • Advanced Medical Technology Association   (AdvaMed) – 10% • Medical Device Competitiveness Coalition   (MDCC) – 100%  • U.S. Chamber of Commerce – 20-25%  Political Contributions Zimmer Biomet’s policies prohibit contributions of  corporate funds to candidates, political party committees  and political action committees.
","('Management_Of_Legal_And_Regulatory_Framework', 0.848004162311554)","('Human_Rights_And_Community_Relations', 0.019969971850514412)","('Director_Removal', 0.018173838034272194)","(['Corporate Governance'], 0.848004162311554)","('NON-ESG', 0.019969971850514412)","('NON-ESG', 0.018173838034272194)"
Line 485,"Contributions by Zimmer  Biomet’s Political Action Committee (Z-PAC) – which is  supported entirely by voluntary contributions made by  eligible employees and non-employee directors – support  candidates, parties or committees whose views on specific  issues are consistent with Zimmer Biomet’s priorities.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5443825721740723)","('Director_Removal', 0.1036095917224884)","('Human_Rights_And_Community_Relations', 0.06708590686321259)","(['Corporate Governance'], 0.5443825721740723)","('NON-ESG', 0.1036095917224884)","('NON-ESG', 0.06708590686321259)"
Line 486,"The  Z-PAC is governed by an Advisory Committee consisting of  representatives from across the Company’s U.S. business  units and business functions.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4218556582927704)","('Director_Removal', 0.17000305652618408)","('Competitive_Behavior', 0.04922833666205406)","('NON-ESG', 0.4218556582927704)","('NON-ESG', 0.17000305652618408)","('NON-ESG', 0.04922833666205406)"
Line 487,"The Advisory Committee  reviews Z-PAC activities and establishes policies and  priorities.The Z-PAC contributes to candidates and political  committees on a bi-partisan basis, and does not make  contributions in connection with U.S. Presidential elections.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7879151701927185)","('Director_Removal', 0.0488169901072979)","('Competitive_Behavior', 0.020837293937802315)","(['Corporate Governance'], 0.7879151701927185)","('NON-ESG', 0.0488169901072979)","('NON-ESG', 0.020837293937802315)"
Line 488,"Contribution decisions are not made to reflect the personal  political views or interests of senior management.
","('Director_Removal', 0.1568872332572937)","('Management_Of_Legal_And_Regulatory_Framework', 0.12966251373291016)","('Customer_Privacy', 0.12494395673274994)","('NON-ESG', 0.1568872332572937)","('NON-ESG', 0.12966251373291016)","('NON-ESG', 0.12494395673274994)"
Line 489,"In  deciding whom to support, consideration is given to  candidates who represent the communities Zimmer Biomet  serves, those who serve on relevant committees or in  leadership and those who have shown support for policies  and initiatives of importance to the U.S.  Z-PAC contribution guidelines also emphasize the character  and integrity of candidates, including the candidate’s  position on issues that may impair Zimmer Biomet’s  corporate reputation or are contrary to its values, such as  the candidate’s positions and record in the area of diversity,  equity and inclusion.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3781825304031372)","('Business_Ethics', 0.24896934628486633)","('Competitive_Behavior', 0.0765170231461525)","('NON-ESG', 0.3781825304031372)","('NON-ESG', 0.24896934628486633)","('NON-ESG', 0.0765170231461525)"
Line 490,"In  deciding whom to support, consideration is given to  candidates who represent the communities Zimmer Biomet  serves, those who serve on relevant committees or in  leadership and those who have shown support for policies  and initiatives of importance to the U.S.  Z-PAC contribution guidelines also emphasize the character  and integrity of candidates, including the candidate’s  position on issues that may impair Zimmer Biomet’s  corporate reputation or are contrary to its values, such as  the candidate’s positions and record in the area of diversity,  equity and inclusion.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9727909564971924)","('Employee_Health_And_Safety', 0.002203881274908781)","('Human_Rights_And_Community_Relations', 0.0020683016628026962)","(['Human Capital Development'], 0.9727909564971924)","('NON-ESG', 0.002203881274908781)","('NON-ESG', 0.0020683016628026962)"
Line 491,"Contributions made by the Z-PAC  are, as required by law, reported in filings with the Federal  Election Commission (FEC).
","('Management_Of_Legal_And_Regulatory_Framework', 0.8663074374198914)","('Director_Removal', 0.01570836454629898)","('Ecological_Impacts', 0.01234497968107462)","(['Corporate Governance'], 0.8663074374198914)","('NON-ESG', 0.01570836454629898)","('NON-ESG', 0.01234497968107462)"
Line 492,"The most recent FEC report is  available here .
","('Management_Of_Legal_And_Regulatory_Framework', 0.6859965920448303)","('GHG_Emissions', 0.04644915461540222)","('Physical_Impacts_Of_Climate_Change', 0.04623280093073845)","(['Corporate Governance'], 0.6859965920448303)","('NON-ESG', 0.04644915461540222)","('NON-ESG', 0.04623280093073845)"
Line 493,"Following the events of January 6, 2021 at the U.S. Capitol  in Washington, DC, we halted our Z-PAC contributions, but  these contributions have since been partially reinstated.
","('Management_Of_Legal_And_Regulatory_Framework', 0.593081533908844)","('Director_Removal', 0.08674465119838715)","('Labor_Practices', 0.03456251323223114)","(['Corporate Governance'], 0.593081533908844)","('NON-ESG', 0.08674465119838715)","('NON-ESG', 0.03456251323223114)"
Line 494,"We  continue to review our contribution decisions to ensure that  our contribution strategy remains in line with the criteria  outlined above.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7486933469772339)","('Business_Model_Resilience', 0.04304620996117592)","('Human_Rights_And_Community_Relations', 0.032028667628765106)","(['Corporate Governance'], 0.7486933469772339)","('NON-ESG', 0.04304620996117592)","('NON-ESG', 0.032028667628765106)"
Line 495,"252021 Sustainability Accounting Standards Board Index We are proud to publish Zimmer Biomet’s first Sustainability Accounting Standards Board (SASB) Index.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5090166926383972)","('Product_Quality_And_Safety', 0.10774248838424683)","('Systemic_Risk_Management', 0.0653260350227356)","(['Corporate Governance'], 0.5090166926383972)","('NON-ESG', 0.10774248838424683)","('NON-ESG', 0.0653260350227356)"
Line 496,"This reflects our  continued commitment to our sustainability efforts and increased transparency in our sustainability disclosures.
","('Business_Ethics', 0.6387910842895508)","('Systemic_Risk_Management', 0.07192594558000565)","('Management_Of_Legal_And_Regulatory_Framework', 0.05458856374025345)","(['Business Ethics'], 0.6387910842895508)","('NON-ESG', 0.07192594558000565)","('NON-ESG', 0.05458856374025345)"
Line 497,"Topic Code SASB Metric 2021 Reporting Affordability & Pricing HC-MS-240a.2 Description of how price information for each  product is disclosed to customers or to their  agentsIn the United States, a customer will typically  engage with a local sales representative who  will work with their local office to provide  pricing for products the customer is interested  in purchasing.
","('Product_Design_And_Lifecycle_Management', 0.3986021876335144)","('Selling_Practices_And_Product_Labeling', 0.34120696783065796)","('Customer_Welfare', 0.07699145376682281)","('NON-ESG', 0.3986021876335144)","('NON-ESG', 0.34120696783065796)","('NON-ESG', 0.07699145376682281)"
Line 498,"Larger systems issue RFPs, which  Zimmer Biomet responds and then enters into  a formal agreement.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9259650111198425)","('Business_Ethics', 0.011031397618353367)","('Competitive_Behavior', 0.008765693753957748)","(['Corporate Governance'], 0.9259650111198425)","('NON-ESG', 0.011031397618353367)","('NON-ESG', 0.008765693753957748)"
Line 499,"Pricing is communicated  during the contract process and can either  be shared by hard copy (local, state or federal  government accounts), email or through  electronic interchanges.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7430921196937561)","('Customer_Privacy', 0.047891758382320404)","('Business_Ethics', 0.03740813955664635)","(['Corporate Governance'], 0.7430921196937561)","('NON-ESG', 0.047891758382320404)","('NON-ESG', 0.03740813955664635)"
Line 500,"Product Safety HC-MS-250a.1 Number of recalls issued, total units recalled 5 recalls in 2021.
","('Product_Quality_And_Safety', 0.8764210343360901)","('Selling_Practices_And_Product_Labeling', 0.021772103384137154)","('Employee_Health_And_Safety', 0.009565315209329128)","(['Product Quality & Recall Management'], 0.8764210343360901)","('NON-ESG', 0.021772103384137154)","('NON-ESG', 0.009565315209329128)"
Line 501,"Product Safety HC-MS-250a.3 Number of fatalities related to products as  reported in the FDA Manufacturer and User  Facility Device ExperienceNone Product Safety HC-MS-250a.4 Number of FDA enforcement actions taken  in response to violations of current Good  Manufacturing Practices (cGMP), by typeIn 2021, Zimmer Biomet did not receive any  warning letters, seizures or consent decrees.
","('Product_Quality_And_Safety', 0.9194889664649963)","('Selling_Practices_And_Product_Labeling', 0.013638429343700409)","('Employee_Health_And_Safety', 0.007718237582594156)","(['Product Quality & Recall Management'], 0.9194889664649963)","('NON-ESG', 0.013638429343700409)","('NON-ESG', 0.007718237582594156)"
Line 502,"Ethical Marketing HC-MS-270a.1 Total amount of monetary losses as a result  of legal proceedings associated with false  marketing claimsNone Ethical Marketing HC-MS-270a.2 Description of code of ethics governing  promotion of off-label use of productsPlease see page Product Design &  Lifecycle ManagementHC-MS- 410a.1 Discussion of process to assess and  manage environmental and human health  considerations associated with chemicals in  products, and meet demand for sustainable  productsN/A Product Design &  Lifecycle ManagementHC-MS-410a.2 Total amount of products accepted for takeback  and reused, recycled, or donated, broken down  by: 1) devices and equipment and 2) suppliesNone 26Topic Code SASB Metric 2021 Reporting Supply Chain  ManagementHC-MS-430a.1 Percentage of 1) entity's facilities and 2) tier I  suppliers' facilities participating in third-party  audit programs for manufacturing and product  quality100% of Zimmer Biomet manufacturing  sites are audited by a third party and are ISO  certified.
","('Product_Design_And_Lifecycle_Management', 0.805503249168396)","('Product_Quality_And_Safety', 0.06679654121398926)","('Selling_Practices_And_Product_Labeling', 0.04074558988213539)","(['Product Stewardship'], 0.805503249168396)","('NON-ESG', 0.06679654121398926)","('NON-ESG', 0.04074558988213539)"
Line 503,"Ethical Marketing HC-MS-270a.1 Total amount of monetary losses as a result  of legal proceedings associated with false  marketing claimsNone Ethical Marketing HC-MS-270a.2 Description of code of ethics governing  promotion of off-label use of productsPlease see page Product Design &  Lifecycle ManagementHC-MS- 410a.1 Discussion of process to assess and  manage environmental and human health  considerations associated with chemicals in  products, and meet demand for sustainable  productsN/A Product Design &  Lifecycle ManagementHC-MS-410a.2 Total amount of products accepted for takeback  and reused, recycled, or donated, broken down  by: 1) devices and equipment and 2) suppliesNone 26Topic Code SASB Metric 2021 Reporting Supply Chain  ManagementHC-MS-430a.1 Percentage of 1) entity's facilities and 2) tier I  suppliers' facilities participating in third-party  audit programs for manufacturing and product  quality100% of Zimmer Biomet manufacturing  sites are audited by a third party and are ISO  certified.
","('Product_Design_And_Lifecycle_Management', 0.9244657754898071)","('Supply_Chain_Management', 0.015699153766036034)","('Product_Quality_And_Safety', 0.011492825113236904)","(['Product Stewardship'], 0.9244657754898071)","('NON-ESG', 0.015699153766036034)","('NON-ESG', 0.011492825113236904)"
Line 504,"50% of Tier 1 suppliers are audited  by a third party.
","('Supply_Chain_Management', 0.8744347095489502)","('Systemic_Risk_Management', 0.01494059432297945)","('Labor_Practices', 0.011219507083296776)","(['Supply Chain Management'], 0.8744347095489502)","('NON-ESG', 0.01494059432297945)","('NON-ESG', 0.011219507083296776)"
Line 505,"The highest risk suppliers are  audited by a third party as part of their ISO  certification or are audited by a Zimmer Biomet  facility.
","('Supply_Chain_Management', 0.9126579761505127)","('Systemic_Risk_Management', 0.01611712947487831)","('Waste_And_Hazardous_Materials_Management', 0.005468291696161032)","(['Supply Chain Management'], 0.9126579761505127)","('NON-ESG', 0.01611712947487831)","('NON-ESG', 0.005468291696161032)"
Line 506,"Those suppliers not participating in  third-party audit programs have been vetted as  the lowest risk,  given the minimal likelihood of  severity to the Zimmer Biomet quality system  based on a failure of the product or service to  meet specifications.
","('Product_Design_And_Lifecycle_Management', 0.5879120826721191)","('Product_Quality_And_Safety', 0.16040901839733124)","('Supply_Chain_Management', 0.09126005321741104)","(['Product Stewardship'], 0.5879120826721191)","('NON-ESG', 0.16040901839733124)","('NON-ESG', 0.09126005321741104)"
Line 507,"Supply Chain  ManagementHC-MS-430a.2 Description of efforts to maintain traceability  within the distribution chainZimmer Biomet and all distributors, including  all sales and office staff, are required to  implement identification and traceability  controls.
","('Supply_Chain_Management', 0.9355299472808838)","('Waste_And_Hazardous_Materials_Management', 0.006902001332491636)","('Product_Design_And_Lifecycle_Management', 0.005181336309760809)","(['Supply Chain Management'], 0.9355299472808838)","('NON-ESG', 0.006902001332491636)","('NON-ESG', 0.005181336309760809)"
Line 508,"Distribution records must include  the customer's name, address, part number,  control number, date and quantity shipped.
","('Customer_Privacy', 0.7350096106529236)","('Waste_And_Hazardous_Materials_Management', 0.041715286672115326)","('Selling_Practices_And_Product_Labeling', 0.03795922175049782)","(['Privacy Protection'], 0.7350096106529236)","('NON-ESG', 0.041715286672115326)","('NON-ESG', 0.03795922175049782)"
Line 509,"The distribution record is maintained by  Zimmer Biomet from the time of receipt  through storage, handling and distribution  until the product is implanted into a patient,  permanently retired from use or permanently  disposed.
","('Product_Design_And_Lifecycle_Management', 0.783944845199585)","('Selling_Practices_And_Product_Labeling', 0.07825185358524323)","('Waste_And_Hazardous_Materials_Management', 0.027075575664639473)","(['Product Stewardship'], 0.783944845199585)","('NON-ESG', 0.07825185358524323)","('NON-ESG', 0.027075575664639473)"
Line 510,Supply Chain  ManagementHC-MS-430a.3 Description of the management of risks  associated with the use of critical materialsPlease see page Business Ethics HC-MS-510a.1 Total amount of monetary losses as a result of  legal proceedings associated with bribery or  corruptionNone Business Ethics HC-MS-510a.2 Description of code of ethics governing  interactions with health care professionalsPlease see page For ESG surveys please contact surveys@zimmerbiomet.com For ESG inquiries please contact Keri Mattox at keri.mattox@zimmerbiomet.com    or Ezgi Yagci at ezgi.yagci@zimmerbiomet.com   27©2022 Zimmer Biomet | www.zimmerbiomet.com  | 3821.1-GLBL-en-Issue Date 2022-04,"('Business_Ethics', 0.9726650714874268)","('Data_Security', 0.002094999887049198)","('Systemic_Risk_Management', 0.0020188309717923403)","(['Business Ethics'], 0.9726650714874268)","('NON-ESG', 0.002094999887049198)","('NON-ESG', 0.0020188309717923403)"
Line 511,Supply Chain  ManagementHC-MS-430a.3 Description of the management of risks  associated with the use of critical materialsPlease see page Business Ethics HC-MS-510a.1 Total amount of monetary losses as a result of  legal proceedings associated with bribery or  corruptionNone Business Ethics HC-MS-510a.2 Description of code of ethics governing  interactions with health care professionalsPlease see page For ESG surveys please contact surveys@zimmerbiomet.com For ESG inquiries please contact Keri Mattox at keri.mattox@zimmerbiomet.com    or Ezgi Yagci at ezgi.yagci@zimmerbiomet.com   27©2022 Zimmer Biomet | www.zimmerbiomet.com  | 3821.1-GLBL-en-Issue Date 2022-04,"('Customer_Welfare', 0.36218538880348206)","('Competitive_Behavior', 0.07958047837018967)","('Selling_Practices_And_Product_Labeling', 0.0743258148431778)","('NON-ESG', 0.36218538880348206)","('NON-ESG', 0.07958047837018967)","('NON-ESG', 0.0743258148431778)"
